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ABSTRACT
INTERACTION OF CHEMOTHERAPY AND THE IMMUNE RESPONSE
IN EXPERIMENTAL MALARIA INFECTIONS
by
ityint Lwin
Plasmodium chabaudl malaria Infections in CBA mice showed 
a characteristic and consistent pattern. Primary parasitaemias 
reached a peak of 30-50% but resolved within 3 weeks. Small recrude­
scences occurred at 4 and at 8 weeks and parasites were demonstrable 
up to 9 weeks by subinoculation of blood and other tissues. Infec­
tions in T-lymphocyte deprived mice were not fatal but the mice re­
mained parasitaemic for at least 120 days. By contrast, P. berghel 
killed both intact and deprived mice; the survival time of the T-cell 
deprived mice was significantly longer.
Treatment of P. chabaudl infections with chloroquine, 
quinine or pyrimethamine was generally more effective in intact than 
in T-cell deprived mice. Chloroquine and quinine treatment of P. 
berghel infections, however, was more effective in the deprived mice. 
None of the recrudescences of either P. berghel or P. chabaudl infec­
tions following treatment showed evidence of increased resistance to
Mice treated with cortisone acetate died of P. chabaudi 
infections and were not as effectively treated with quinine or 
chloroquine as infected controls. Induced protein energy malnu­
trition prolonged P. chabaudi parasitaemias but these were as 
readily treated as infections in controls on balanced diet.
Suppression of P . chabaudi infections by subcurative 
chemotherapy gave rise to a strong immunity. Curative treatment 
given early in infections resulted in only partial immunity to 
challenge whereas treatment late in the infection gave a high 
degree of resistance to infection.
Generalized immunodépression during P. chabaudi infection 
was related to the degree of parasitaemia. There was some increase 
in the rate of catabolism of immunoglobulins as a result of the 
infection.
P. chabaudi infections were significantly suppressed in 
mice which had mature Schistosoma mansoni infections but acute or 
chronic infections did not influence development of the schisto­
somiasis.
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I. GENERAL INTRODUCTION
This study is concerned with the interactions of 
chemotherapy and the immune response in malarial infections. 
Two different types of parasite-host systems were used to 
determine the mechanisms, one benign (Plasmodium chabaudi) 
the other virulent (P.berghei),in mice.
The initial experiments were designed to establish basic 
data on the parasite-host relationship and the nature and 
the intensity of its immunodepressive effect. The 
immunodepressive effects of the antimalarial drugs to be 
used were also examined.
The best method of treatment in immunologically intact 
mice to obtain a maximal immunity was also determined. A 
large proportion of my experiments dealt with the chemotherapy 
of immunologically (T-cell) deprived mice as well as intact 
control mice to demonstrate the importance of immune 
mechanisms in drug treatment. This included studies on 
the possibility that drug resistant strains might arise as 
a result of chemotherapy of T-cell deprived mice.
I then studied the effectiveness of antimalarial 
chemotherapy in mice suffering from protein-energy mal­
nutrition, and after treatment with a commonly used 
immunodepressive drug (corticosteroid).
A* detailed study was carried out on the interactions 
of malaria and sohistosomiasis (Schistosoma mansoni) in
mice
17
Since X dealt with four major subjects — parasitology, 
immunology, chemotherapy and protein-energy malnutrition,
I had to do a wide literature review. However, I have tried 
to review only the background information for each section 
rather than go into great detail. The first part of my 
literature research deals with speciation, infection and 
immunity to malaria. Later, protein-energy deficiency and 
the effects on immunity to infection are reviewed and then 
concurrent infections of malaria and other parasites are 
also studied.
It is Important to try to understand the mode of actions 
of the drugs used and mechanisms of resistance to them, so
a section is included on this. In the field of immunity and
%chemotherapy, not much work has been done on the Interactions 
of chemotherapy and immunity with parasite models, so I have 
extended my review a little further to include other
diseases.
l
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II LITERATURE REVIEY/
A. Rodent malarias
1. Isolation and speciation
The malaria parasites infecting rodents constitute 
part of the subgenus Vinckeia (Garnham,1964) from the genus 
Plasmodium.
The first rodent malaria found, P.berghei was isolated 
by Vincke and Lips in 1948 from thicket rats, Grammomys 
surdaster. in the highlands of Katanga Province (Zaire).
Four more murine malaria parasites resembling P.berghei 
were isolated in lowland areas from Thamnomys rutilans, 
and were specified as subspecies of P.berghei, P.berghei 
yoelii from the Central African-Republic (Landau and Killick- 
Kendrick;1966), P.berghei killicki from Brazzaville (Landau, 
Micheál and Adam,1968) and P.berghei nigeriensis from 
Nigeria (Killick-Kendricl^l973) •
Another species of .Plasmodium, which was morphologically 
and biologically different from P.berghei was isolated from 
Anopheles dureni millecampsi mosquitoes caught in the same 
forests of Katanga and was named Plasmodium vinckei 
(Rodhain, 1952). Though A . dureni feeds exclusively 
on rodent* the natural vertibrate host of the parasite 
is still unknown.
Three subspecies of P.vinckei have been isolated up to 
now, P.vinckei bruoe-chwatti was originally found by 
Bruce-Chwatt and Gidson (1955) from wild rodents, Praomys
tullergi in West Afrioa and later by Bafort (1970) and by
19
Killick-Kendrick (1975) in T.rutilans from the same area. 
Another subspecies P.vinckei lentum was isolated from 
T.surdaster from the Democratic Republic of Congo (Adam 
et al., 1966) and was named by Landau et al. (1970). Carter 
and Walliker derived a number of lines of malaria parasites 
from the rodents,T.surdaster, in the Central African 
Republic. For one of these lines they proposed the name 
P.vinckei petteri (Carter and Walliker. 1975).
Landau (1965) detected another new malaria 
parasite, morphologically similar to P.vinckei, in 
T.surdaster. from the tropical rain forests of the Central 
African Republic and named it P.chabaudi. Bafort (1968) 
reduced it to a subspecies P.vinckei chabaudi. but later 
workers accepted the parasite as a species distinct from 
P.vinckei (Ott, 1969; Peters, 1967a; Carter and Walliker, 
1975; and Rosario, 1976).
The validity of the speciation and subspeelation: 
was repeatedly questioned by Bafort. He said that some 
of the strains were overlapping (Bafort _ 1970). -
and postulated :......... that the murine malaria
parasites were simply one polymorphic species with P.vinckei 
at one pole and P.berghei on the other (Bafort, 1971).
However, Killick-Kendrick later raised P. berghei 
yoelii from a subspecies to a species, P.yoelii. with 
subspecies killicki and nigeriensis transferred from the
species P, berghei to P. yoelii (Killick-Kendrick, 1974a; 
1974b).
20
P.berghei reverted to a monotypic species when Killick- 
Kendrickused the distribution (Vincke and Lips, 1948, 
Killick-Kendrick , 1973} Landau, Michel and Adam,1968),
morphology (Garnham,1966; Rodhain,1952) and biology of all 
stages of life cycles (Landau and Killick-Kendrick, 1966; 
Garnham et al., 1967; Wery,1968) as the main criteria. The 
speciation was in agreement with the work of Carter (1973), 
who showed that the enzymes GPI<5c6PGD were never the
same between P .berghei and the other three isolates. Chance 
and Warhurst (1973)’ also showed by DNA hybridization that 
P.berghei is widely separated from P.yoelii nigeriensis. 
Innate resistance to chloroquine in P.yoelii (Warhurst and 
Killick-Kendrick, 1967) the sensitivity of P.berghei 
(Peters,1965b;Warhurst and Hockley,1967) might also favour 
this view.
Carter and Walliker (1976), after studying the parasites 
derived from naturally infected thicket rats, T.rutilans, 
from the Congo (Brazzaville),concluded that a third species 
was present together with the former two species, p.y.killicki 
and P.v.lentum. According to them this is a subspecies of 
P.chabaudi. which prefers mature red cells, which they named 
P .c.adami. They said that the two subspecies of P.chabaudi 
are morphologically identical but P .c.adami is less virulent 
and is different in enzyme patterns from P.c.chabaudi. Thus 
the authors claim that there are two subspecies of P.chabaudi, 
P.c.chabaudi and P .c.adami. and four subspecies of P.vinckei, 
P.v.lentum. P.v.petteri, P.v. bruce-chwatti and P.v.vinckei.
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2. Infections in laboratory animals
i. Plasmodium chabaudi
P .chabaudi occurs naturally in wild-thicket rats, 
Thamnomys rutilans (Landau, 1965) in the Central African 
Republic. In the laboratory, Swiss TO mice (Garnham,1966),
CP mice (Ott, 1969) , C5? black mice (Walliker et aL.,1975) 
and multimammate rats (Garnham,1966) are susceptible both 
to inoculation of blood and to sporozoite stages. Though 
hamsters and rats are refractory to the parasite, it can be 
adapted to rats by infecting them after splenectomy 
(Musoke and Cox, 1977) which subsequently grows well even 
in intact rats. There is a single record of a successful 
infection of a guinea pig (Garnham,1966).
There is no difference between infection in conventional 
and in specific pathogen free mice, but factors such as 
route of inoculation, size of inoculum and preparation 
procedures influence the course of the infection (Ott, 1969). 
Associated E.coccoides infections and low PABA content in 
the diets (Peters, 1967a) can inhibit the P.chabaudi infection
While mice infected with P.chabaudi usually recover 
from the infection (Cox and Voller, 1966) there may sometimes 
be some deaths (Cox, 1970) . The parasitaemia can be 
enhanced by rapid blood passage (Cox and Voller, 1966;
Gar.nhara ,1966). Different strains of mice may have different 
patterns of infection (Peters, 1967a) .
The maximal peak parasitaemias are also variable.
Peters (1967*0 recorded 35#, Cox (1970) 40#, and Ott and
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Stauber (1967) and Carter and Walliker (1975) recorded 80# 
as the peak parasitaemia. Probably the strains of parasites, 
strains of mice (Peters,1967a), different laboratory 
conditions, E.coccoides infections (Ott and Stauben 1967), 
the preparations and dosage of inoculum (Ott,1969) and PA.BA 
contents of the diets (Peters, 1970e$ need to be considered 
as factors which determine these variations in their results:.
P.chabaudi preferentially invades the mature erythrocytes 
and gives rise to a synchronous infection in mice and thicket- 
rats, with a periodicity of 24 hours (Carter and Walliker, 1975). 
The ring trophozoites are similar to those of P .vinckei 
(Garnham,1966). Infected oells containing single parasites 
predominate at first but multiple infections appear in the 
late stage (Carter and Walliker,1975). Gametocytes became 
more frequent after the peak of parasitaemia (Carter and 
Walliker,1975).
According to Cox (1970) the parasites appeared in blood 
on the second day of the blood induced P.chabaudi infection 
in Swiss TO mice and reached a peak of 10# on the seventh 
day. Thereafter, parasitaemia declined and no parasites 
could be seen after day 14. During the fourth or fifth week 
after infection a recrudescence occured in certain mice, 
the level of parasitaeraia never reaching that of the first 
peak.
ii, P.berghei
The natural vertebrate hosts of P.berghei are the 
thicket-rats, Orammomys surdaster. (Vincke and Lips,1948),
C,Praomys jafksoni and mgada bella (Vincke,1954) • In the
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laboratory, many species of rodents, rabbits, bats and some 
species of monkeys are susceptible to blood-induced infections 
(Wellde et al., 1966; Cox, 1967); most strains of mice (Most 
et al.t 1966; Vincke and Bafort, 1968), white rats and 
hamsters (Yoelii and Most, I960; 1965b) are susceptible to 
infection by blood stages or sporozoites.
Blood stage infections are usually given by intra­
peritoneal, intravenous or subcutaneous injections of 
infected red blood cells, of which the intraperitoneal 
route is the easiest and is 100^ successful. Mice and rats 
are the main laboratory animals used for P.berghei infections. 
The early infections of blood stages in white rats and 
mice occur in normocytes, later there is a predilection 
for immature erythrocytes, polyparasitism often causing 
hypertrophy of the host cell and ring forms occasionally 
have twin nuclei. Sbhizonts produce 6-10 merozoites in mice 
and 16 in rats and hamsters (Garnham, 1966). The asexual 
cycle takes 22-25 hours (Thurston, 1952). Gametocyte 
production declines and disappears after several passages 
(Vincke, 1963).
P.berghei infections are invariably fatal in most 
strains of mice (Greenberg et al., 1933) golden hamsters 
(Wright, 1968) and in young rats, though the adult rats 
have only li° mortality (Sergent and Poncet, 1955). The 
mortality depends on several factors. The survival time is 
much longer in some strains of mice, female mice survive 
longer than the male mice and the survival time also increases 
with age (Greenberg et al., 1953)• P.berghei infections in rats
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show that as the age of the host increases, the mortality 
decreases, the day of malarial crises occurs earlier and 
the parasite burden decreases. The causes of this age 
immunity, according to Smalley (1975), did not appear to 
involve non-antibody serum factors and he proposed; that it 
was due to the differences in the effectiveness of acquired 
protective responses. However Tosta and Filho (1976) 
showed that normal adult rat serum prolonged the mean survival 
time to seven-day old rats and concluded that a factor 
or factors) in normal adult rat serum, not related to 
malarial antibodies, decreased the infectivity of P.berghei.
The course of P.berghei infection depends on the size 
of inoculum (Wellde et al.. 1966) and so if the size of 
inoculum was increased by a factor of 10 the latent period 
decreased by one day (Warhurst and Folwell, 1968). In 
P.berghei infections in Swiss TO mice there was no correlation 
between the log inoculum and the number of deaths (Sengers 
et al., 1971*>|; the survival time was inversely proportional 
to the size of inoculum (Schindler & Xehiitz»1965t Sadun, 1966; 
and Sengers et al., 1971b.
The mean rate of increase in parasiteamia was not 
different when parasites were injected from different phases 
of the infection of the donor mice (Sengers and Elteren,
1971). In rats, by increasing the body temperature by 
injecting TAB vaccine (0.02 ml) or by lowering the body 
temperature to 15-20°C, the parasitaemia was very depressed 
(Basu et al., 1962) and the liver sohizonts also decreased 
in size and number (Yoeli et al., 1975) when the body 
temperature was lowered.
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Dietary factors play a major role in P.berghei 
infections. Maegraith et al.(1952) observed that P.berghei 
infections were less severe in mice maintained on a milk 
diet than on the normal one. Adler (1958) also found that 
mice kept on a meat diet were relatively resistant to 
P .vinckei infections. Hawking (1953) demonstrated that 
PABA was the essential factor for the growth of P.berghei 
which was lacking in a milk diet. Kretschmar (1965) showed 
the correlation of the PABA content of the diet and the 
mortality of the mice infected with P.berghei.
P.berghei preferentially invades immature erythrocytes 
(Corradetti and Verulini, 1951; and Singer,1954a), so the 
conditions which evoke reticulocytosis, like repeated 
bleedings (Viens et al.,1971). phenylhydrazine treatments 
(Ott,1968j Pabriani et al.. 1952; Viens et al.. 1971) and anaemia 
provoked by eperythrozoon infections (Ott et al.. 1967) 
increase the parasitaemia. On the other hand, transfusion 
of blood (Fabiani et aL,1952; Ladd and Lalli,1966), 
corticosteroid treatments (Cox,1974^) and oyclophosphamide 
treatments (Spiva et al.,1972) will decrease the number of 
reticulocytes in the blood and with this the P.berghei 
parasitaemia and so increase the survival time.
In P.berghei infections in mice, the animals become 
progressively more anaemic as the infection progresses, as 
shown by total erythrocyte counts and haematocrit values, 
with an increase in the number of circulating reticulocytes. 
Erythrocyte destruction exceedes the rate of erythropolesis, 
though erythropoietin production is not impaired (Rencricca 
et alL.,1974) •
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3. Immunity
a. Mechanism of acquired immunity in malaria
Innate immunity can operate against all the stages of 
the life cycle of malaria infection (Gamham,1966) but 
specific acquired immunity of the host is directed primarily 
against the asexual blood stages (Targett,1973). Sporozoites 
remain extracellular only a matter of hours at most (Parley, 
1947? Nusoergweiget al.,1972). There is evidence that a 
strong immunity to sporozoites can be induced by vaccination 
with attenuated or viable sporozoites (Nussenzweig et al.,1969; 
Nussenzweig et_al», 1972» Vehave,1975) but the occurrence of an 
immune response to sporozoites in natural infections has not 
yet been shown (WHO*1973). There is no evidence for synthesis 
of specific antibody against the exoerythrocytic stage nor 
is it known at present if repeated natural infections induce 
immunity against this stage of infection (Cohen and Butcher, 
.1971).
The first indication of the immune reaction by the host 
is a slowing in the rate of parasite increase in the 
peripheral blood (Brown,1975).
i. Humoral immunity
Humoral immunity plays a major -role in acquired resistance 
to malaria infection (WHO,1975). Humoral immunity involves 
the production of antibody by the plasma cells (B-cells).
For many antigens co-operation of T cells and a third cell 
referred to variously as an accessory or adherent cell, which 
adheres to glass or plastic surfaces in cultures and is
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found in populations rich in macrophages, are required for 
antibody formation (Pitch, 1975).
In malaria infections, both human and experimental, 
there is a marked increase in concentration of immunoglobulins 
(Cohen and McGregor, 1963). Repeated infection with malaria, 
in man is associated with considerable elevation of IgG and 
IgM (Rowe et al.. 1966). In vitro and in vivo tests have been 
carried out with antisera to determine the effects of different 
types of immunoglobulins. Serum transfer experiments have 
been carried out in rodents (Fabiani and Fulchiron, 1953 s 
Bruce-Chwatt and Gibson, 1955; Isfanr 1966; Briggs et al. ,
1968; Diggs and Osier, 1969; i975; and Roberts and Tracey—Fatte,
1969) in monkeys (Coggsshall and Kumm, 1937) and in human 
infections (Cohen et al., 1961; and Cohen and McGregor, 1963).
Antisera lengthen the prepatent period in rats and mice 
(Roberts and Tracey-Patte, 1969; Briggs et al.. 1968; and 
Jayawardena , 1975 ) • 1 :or can produce complete neutralisation
(Golenser et al., 1975). The protective effect of serum is 
known to increase with the number of immunizing injections in 
both monkey (Coggeshall and Kumm, 1938) and rodent malaria 
(Briggs et al., 1966). Antisera may also have suppressive 
effects on pre-existing parasitaemias (Fabiani gnd Fulchiron;.953; 
Cohen and McGregor, 1963; Diggs and Osier, 1969; and 
Zuckerman et al., 1969) and is dose dependent in rats (Diggs 
and Osier, 1975; and Golenser et al., 1975). The effective­
ness of the antisera also depends on the time it was taken 
after infeotion (Phillip and Jones, 1972). Cohen et al. (1961) 
also showed the antiparasitic action of immune IgG in humans.
In vitro assays of protective antibodies in immune serum
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have shown that IgG is mainly responsible though some 
activity has also been shown in IgM fractions as well (Cohen 
and Butcher, 1970} and WHO, 1975). A purified IgG fraction 
had been shown to have a lower protective effect than the 
whole immune serum in monkeys (Butcher et al.. 1970).
Freeman et al. (1970) were able to show that less than 5# of
the IgG was parasite specific by inoculating 1^1I labeled
125homologous immune IgG and I labeled normal serum into 
P.knowlesi infected monkeys. Similarly, actual Ig which 
could be specifically absorbed from immune sera by various 
parasite preparations was shown to be 2.6# of total IgG in 
immune New Guinea serum, 5«4# in immune Gambian serum and
0.9# in immune rhesus monkey serum (Cohen and Butcher, 1969; 
and Butcher et al., 1970).
Cohen and Butcher (1970), by incorporation of leucine 
into protein in vitro culture, were able to demonstrate that 
the growth of P.knowlesl within the erythrocytes was unaffected 
by the immune serum but the invasion of new red cells by the 
merozoites and the subsequent parasite multiplication were 
inhibited. The malaria antibody seemed to directly attack 
the surface coat of the merozoites (Miller et al.. 1975) 
in the culture medium,caused them to agglutinate, and 
reduced the ability to invade new red cells (Butcher and 
Cohen, 1970} and Miller et al.. 1975). The inhibitory effect 
of immune serum is speoies specific as shown by the failure 
of serum from a monkey immune to
inhibit P.knowlesi (Cohen and Butoher, 1971). This is 
consistent with that of malaria immunity generally which 
also seems to be speoies and strain specific (Cox and Voller, 
1966} and Targett, 1968).
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The protective action of immune serum was shown to be 
complement independent being unaffected by heating to 56°C 
for 3 hours or by the addition of fresh normal guinea pig 
serum (Cohen and Butcher, 1971). Cobra venom factor (CVP) 
also had no effect on the parasitaemia (Atkinson et al.,1975) 
but Ree (1976) observed a low level of in the acute 
infection and a return to normal level after treatment of 
malaria in Gambian children and suggested C-j and parasitaemia 
were correlated.
Jerusalem and Bruchhausen (1967) reported that there 
are antibodies in the serum of the acute stage of rodent 
malaria infection involved in protecting against the toxic 
products -of the malaria.
Brown and Hills (1974)* after studying chronic P.knowlesi 
in rhesus monkeys, reported that there are two types of 
variant-specific antibody in the serum. The first antibody 
was detectable by a schizont infected cell agglutination 
(SICA) test (Brown, K.N. and Brown,1965), specific for the 
infecting intrastrain variant (Brown et a]., 1970a and b) and 
is not protective. The other variant specific antibody is 
parasiticidal, opsonizing antibody* and can be detected by 
an opsonization test (Brown, K.N. et al, 1970b). Although 
opsonizing antibodies have not been found without SICA 
antibodies being present, SICA antibodies may be found when 
opsonizing antibodies are not detectable (Brown and Hill,1974). 
After the end of the crisis of malaria infection damaged 
intracellular parasites of all stages of maturity are 
always seen (WHO,1975) which was supposed to be due to
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direct cytotoxic action of antibody on the parasitised red 
cells (Taliaferro,1949)• This effect has not been shown 
in vitro by incubation of parasitised red cells in immune 
serum or with immune lymphocytes (WHO,1975). Clark and his 
colleagues (1976) were also able to demonstrate intra- 
erythrocytic death of P.vinckei parasites in mice infected 
one month after intravenous inoculation of 2 x 10^ BCG.
Clark et al.(1977) showed that formalin killed Corynebacterium 
parvum given intravenously or intraperitone ally in mice gave 
similar results.. According to them there was no evidence 
that antibody to the parasites was involved in the resistance 
and in discussing other possible mechanisms, the authors 
concluded that protection was most likely afforded by non­
specific soluble mediators.
Although serum antibody appears to play a primary role 
in acquired malarial immunity, its clinical effectiveness 
may be dependent upon a synergistic action with the macrophage 
system (Cohen and Butcher,1971)• The fact that immune serum 
is more effective in intact than in splenectomised animals 
(Mulligan,(1940; Zuckerman et al. 1973» Brown and Phillips, 1974) 
and that the histological appearances of the livers and spleen 
of the malaria infected animals shows considerable phago­
cytosis (WHO,1968) reveals that phagocytosis is an important 
mechanism of acquired immunity. The role of specific 
antibody in promoting macrophage ingestion of parasites has 
been demonstrated in vitro . Brown and ■' -
Hills (1974) produced some more evidence for production of 
such antibodies using an experimental system involving serum 
and P.knowlesi from infected monkeys and murine macrophages.
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Criswell et al. (1971) demonstrated the enhanced killing 
of parasites by macrophages in association with humoral 
factors by implanting millipore chambers containing macro­
phages and parasitised red cells into the peritoneal 
cavities of normal mice and of others with chronic infections 
of P.berghei. In vitro study of specific antibody that 
induced phagocytosis of P.berghei infected erythrocytes has 
been shown in rat macrophages by Chow and Kreier (1972) 
but surprisingly of only the damaged RBC.
ii. Cell-mediated immunity
The specifio. effector cells of cell-mediated immune 
responses arise directly from the antigen-driven proliferative 
response of progenitors that are members of a circulation 
pool of T-cells (Thymus dependent lymphocytes) (WHO,1974). 
T-cells initiate delayed hypersensitivity reactions, the 
specific recognition and rejection of allografts and some 
tumors, non-specific activation of macrophages and co­
operation with B-cells during induction of antibody synthesis. 
(Cohen,1975).
In malaria infection there is as yet no direct evidence 
of the part played by T-cells though there is indirect 
evidence (WHOtl975). Many people have tried to suppress 
the cell-mediated immune response by procedures that deplete 
the recirculating pool of T—cells e.g. neonatal thymectomy 
(Miller and Osba,1967)» antilymphocyte serum (ALS) treatment 
(Medewar,1969), or adult thymectomy followed by lethal 
irradiation and bone marrow reoonstitution (Parrot et al.,
1970). But according to Doenhoff (1972) even thymectomy
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followed by irradiation does not totally deplete the 
animals of their T-cell pool for 10$ is left behind.
The ability of rats to control a P .berghei infection 
is thymus dependent. P .berghei produces a resolving type 
of infection in adult rats. .; Brown et al. (1968), Stechschulte 
et al. (1969) and Hanson £ chapman($97l)showed that anaemia, 
parasitaemia and mortality were higher in neonatally 
thymectomised rats than in thenon-deprived controls. Spira 
et al. (1970) also demonstrated similar results in ALS 
treated rats infected with P.berghei. Antibody titres 
measured by agglutination and fluorescent antibody techniques 
were not lowered in the neonatally thymectomised rats 
(Stechschulte et al.,1969) or irr ALS treated rats (Spira et al., 
1970).
The ability of mice to control P.yoelii infections was 
also shown to be thymus dependent.
In nude mice (Clark and Allison,1974) or in thymectomised\
irradiated and bond marrow reconstituted mice (Jayawardena 
et_a3j,1975) the P.yoelii infection is fulminant and fatal, 
though in intaat mice it is self resolving. Jayawardena 
et al, (1975) showed by chromosome marking of T-cells, that 
P.yoelii infections induce massive T-cell activation.
P.berghei infections in normal mice are fatal but T-cell 
deprivation either by treatment with ALS or by adult thymectomy, 
irradiation and bone marrow reconstitution prolonged survival 
(Sheagren and Monaco, 1969» Jayawardena et a]», 1975)« The same 
is true with fatal P.berghei infections in hamsters , which 
could be prolonged by either neonatal thymectomy or ALS
treatment (Wright,1968; Wright et al,1971). The fatal 
P .berghei infections in mice, in contrast to resolving 
P.yoelii infections, elicit a weak T-cell response with 
generalised failure of T-cell activity (Jayawardena et al.,
1975)• In mice infected with P.berghei the T-cell numbers 
detected by cytotoxic tests with anti-theta antiserum and 
B—cell papulations (Rosette test) were lowered while there 
was an increase in the "null“ cell population (Krettli and 
Nussenzweig.1974). Patients infected with P.falciparum, 
especially children, also showed a reduction in T-cells 
(E rosette forming cells) no change in B-cell numbers (EAC 
rosettes) and an increase in null cells. T-cell reduction 
was most marked in patients with splenomegaly and it was 
suggested that there is sequestration of T lymphocytes 
during infection (Wyler,1976). Histological studies showed 
that there was marked thymus involution with P.falciparum 
infections in children and in mice infected with P.berghei 
though there were none with mild P.yoelii infections (WHO,1975) 
Phillips (1970) demonstrated the possible role of cell- 
mediated immunity by showing the protective effects of 
adoptive cell transfer from the immune rats to non-immune 
rats infected with P.berghei. The cells were either from 
the spleen, lymph nodes, thymus, peritoneal exudate or bone 
marrow. Also spleen cell transfer from the immune to non- 
immune rats has been shown to give some protection from 
P.berghei (Stechschulte et al.. 1969; Roberts, 1971; Phillips 
and Jones, 1972; Cabrera et al.. 1973; Brown,
i;
1974)» The degree of protection was shown to depend upon 
the time the spleen cells were taken and the dosage of the 
of the cells given (Roberts.1971; Cabrera et a]., 1973; Kasper
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and Alger,1973)» Brown (1971) demonstrated the importance 
of T—cells by showing recrudescence of a chronic infection 
in rats treated with ALS. Spleen cells from ALS treated 
rats also failed to confer immunity in adoptive transfer 
experiments. Later, Zuckerman and Jacobson (1976) tried 
to prove the same fact by showing that spleen cells from 
cyclophosphamide treated P.berghei immune rats could still 
transfer immunity to recipient animals. The authors 
suggested that the cyclophosphamide treated rats have spleens 
depleted of B lymphocytes with a higher proportion of T-cells. 
Thus, according to them, T-cells are involved in acquired 
immunity to malaria. On the other hand Jayawardena et al. 
(1975) demonstrated that anti-theta treatment in vitro of 
cells from mice which had recovered from infection did not 
impair their ability to transfer immunity to either intact 
or T-cell deprived recipients.
Since passive transfer of eerum is relatively ineffective 
(Phillips,1970; Phillips and Jones,1972) and since the 
development of protection is dependent on the viable T-cells 
(Cabrera,and Alger,1973), Brown (1971) suggested that the 
key to strain-specific immunity resided in sensitisation of 
the T-cell population. He postulated that protective 
antibody in malaria is variant-specific end that protection 
is mediated through a succession of variant-specific 
protective antibody responses. He added that T-cells 
responded to the antigenic determinant common to all variants 
of a strain and that these T-cells act as »helper' cells 
in synthesis of variant specific protective antibody by 
direct bone marrow derived B-cells (review by Brown,1975).
35
Some in vitro studies also indicate an important role 
for cell-mediated immunity in malaria infections. Wyler 
and Oppenheim (1974) showed that lymphocytes taken from 
the circulation of P.falciparum infected patients proliferated 
in the presence of malaria antigen more than cells from 
uninfected controls. Zuckerman (1974) showed that spleen 
cells from rats infected with P.berghei have enhanced 
lymphocyte transformation and macrophage migration ihhibition 
responses. Coleman et al. (1976) also reported an in vitro 
correlate of cell-mediated immunity, the macrophage 
migration inhibition test, is positive in mice infected 
with P.berghei. They demonstrated the inhibition of peritoneal 
macrophages by splenic lymphocytes from P.berghei infected 
mice in the presence of parasite antigen. Attempts to 
show cell-mediated cytotoxicity in vitro in malaria infections 
have not yet been successful. Phillips et al. (1970) tried 
to show a cytotoxic effect on P.knowlesi infected erythrocytes 
with spleen cells from immunized monkeys and Ade-serrano and 
Osunkoya (1975) attempted the same with cells from chronically 
infected rhesus monkeys without success.(cited by WHO, 1975)« 
Coleman et al. (1975) did obtain indications of a cytotoxic 
effect in P.herghei in mice which they considered involved both 
lymphocyte and antibody. Isfan and Dinculescu (1971) 
extracted a factor from P.berghei parasites and from the 
infected liver and spleen, which had a cytotoxic effect on 
chicken embryo cells in vitro and could be neutralised by 
immune serum. According to them the cytotoxic factor was 
present in the plasma.
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Though people try to separate the functions of T and 
B cells or humoral and cell-mediated immune responses, 
there is in fact no natural demarcation line between them 
at all. The continuous changing life cycle, the unending 
process of cellular reorganization causing antigenic 
plasticity and a massive and everchanging antigenic challenge 
of malaria infection causes the complex host responses 
(Brown, 1975).
b. Survival of malaria parasites in the immune host.
The persistence of malaria parasites for long periods 
in the host is due to survival of the parasites as either 
exoerythrocytic (EE) or erythrocytic stages. Though Yoeli 
and. Most (1965a) suggested that the persistence of an 
exoerythrocytic stage is due to antigenic variation, because 
of difficulty in the experimental procedures we know little 
about the EE stages. The intracellular location is probably 
of considerable importance in protecting them from immune 
attack (Gamham, 1966).
The ways in which the blood stages, mainly the asexual 
stages, might evade the immune mechanisms have been 
reviewed in detail (CIBA, 1974| WHO, 1975; and Ogilvie and 
Wilson, 1976).
i .
i. Antigenic variation
The occurence of a wide spectrum of intra-strain 
antigenic variants during the course of the asexual cycle 
has been clearly demonstrated in P .knowlesi malaria in 
rhesus monkeys by Brown and his colleagues (Brown,
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-^974) with the schizont infected cell agglutination (SICA) 
test. The SICA test shows no correlation with protective
immunity and, according to Brown, antigenic variation is/
antibody induced and not an immunoselective process. So 
the growth of P.knowlesi parasites in the presence of serum 
containing variant specific SICA antibodies triggers a 
change of serotype without detectable destruction of parasites 
(Brown,1974). The appearance of intra-strain antigenic 
variants has been shown in other ways in P.cynomolgi in 
monkeys, P.berghei in mice, some avian malarias and with 
less certainty in the human malaria parasite P.falciparum 
(WHO,1975). The schizont agglutinins have been shown to 
be present in P.gallinaceum infections (Todorovic et al.1968) 
but not in many other malaria infections. Though a capacity 
to express different serotypes in P.knowlesi malaria infection 
in rhesus monkeys is an important phenomena for the survival 
of the parasite, the importance of it in other plasmodium 
species remains uncertain.
ii. Antigenic tolerance
Soluble malaria antigens have been described in 
monkeys infected with P .knowlesi, ducks infected with 
P .lophurae, chickens infected with P.gallinaceum, rats 
infected with P.berghei and in humans infected with P.falciparum 
( Cited by Boonpu'cknavig et aL,1976).Wilson et al.( 1969,1973) 
by using the agar gel double diffusion technique of 
Ouchterlony to indicate soluble plasma antigens and antigens 
extracted from infected red cells in Gambian children, 
thought that both antigens were associated with P.falciparum 
infections. The antigens were classified on the basis of
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their heat stability as S, L and R antigens. Prom in vitro 
studies on uptake of amino acids, Wilson (1974) suggested 
that S antigens which are most common in plasma during 
acute infections are of host origin (Wilson et al«,1975a.
1975b). After chemotherapy the antigens never circulate for 
more than a week, their disappearence frequently being 
associated with the appearence of homologous antibody 
(V/ilson ,1974) • Houba and Williams (1972) have shown that 
when an antigen if in excess, the serum antigens may 
circulate as complexes with IgM.
Dooris and McGhee (1975) have shown that immunological 
tolerance to serum antigens in neonatal chickens is present 
by infecting them intravenously with serum obtained from a 
P ♦gallinaceum infected chicken. They were able to demonstrate 
that there were no antibody responses in the chicken 
previously injected with the infected serum if the chickens 
were rechallenged with P .gallinaceum after the 11th day 
though control birds did respond. Wilson (1974) discussed 
some ways in which such antigens might affect the immune 
response to the parasite and prolong its survival by 
blocking or neutralizing the effective immune response 
through for example tolerance, antigenic competition or 
immune deviation.
iii. Immunodepression
Malaria infection is associated with immunodepression 
and the extent of this parallels the degree of parasitaemia.
It is short-lived in p.yoelii infections but long lasting 
in chronic experimental malarias (Wedderburn,1974).
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Prom epidemiological data there is some evidence that 
raaiaria diminishes the incidence of auto—immune diseases 
in man (Greenwood, 1968). The incidence of auto—immune 
haemolytic anaemia and renal disease in strains of mice 
which develop these disorders spontaneously is also reduced 
by P.berghei infections (Greenwood, Herrick and. Voiler, 1970). 
Antibody production to some antigens is also reduced in mice 
during P.berghei infections; these include sheep red blood 
cells (Salaman, Wedderburn and Bruce-Chwatt, 1969), human 
immunoglobulins (Greenwood, Playfair and Torrigiani, 1971a) 
and Salmonella typhimurium (Kaye et al., 1965). The incidence 
of lymphoma following inoculation of Maloney virus is increased 
in mice infected with P.berghei (Wedderburn, 1970). This 
might support the view of association of Burkitt's lymphoma 
and malaria in Africa (Salaman et al., 1969)»
But the antibody response to Keyhole limpet haemocyanin, 
and bacteriophage is not significantly impaired and also 
the allograft skin rejection and contact sensitivity to 
picryl chloride or oxazolone was not depressed in mice 
infected with P.yoelii (Greenwood et al.t 1971a). Greenwood
(1974) showed that children with malaria, and their controls, 
responded similarly to dinitrochlorobenzene (DNP) and to 
skin testing with purified protein derivative, Candida and 
streptococcal antigens though they responded significantly 
less frequently to tetanus toxoid and 0 antigen of S.typhi.
He suggested that in malaria, the cell—mediated immune 
response is not affected and the immunosuppressive effeot 
is due to its effect on bursa derived lymphocytes, on 
macrophages or on cell co-operation.
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In contrast Sengers et al. (1971c1 )showed. that Swiss 
mice infected with P «berghei failed to reject both syngeneic 
and allogeneic skin grafts. Also Abdel-Wahab et al. (1974) 
showed the impairment of cell—mediated immune responses by 
showing a highly significant reduction in size of the 
granuloma around schistosome eggs in sensitized malaria 
infected mice, in comparison with uninfected controls.
Whitmore (1974) also demonstrated delayed hypersensitivity 
reactions to methylated human serum albumin and SRBC in 
P.berghei infected mice. According to him, there could be a 
marked suppressive effect on the cell mediated immune response 
in P.berghei infections but that the timing of infection was 
a critical factor in the demonstration of this suppression.
Greenwood (1974) pointed out that in malaria, massive 
amounts of immunoglobulins are produced because of the 
production of a mitogen effective against B lymphocytes.
He suggested that immunoglobulin synthesis is not impaired 
during acute malaria infection and he also found that 
malaria has no suppressive effect on an established humoral 
immune response in man. Steward and Voller (1973) reported 
that though mice infected with P.yoelii developed normal 
levels of antibody to human serum transferrin, the affinity 
of it was lower than that of the uninfected control.
Barker (1971) suggested degradation of SRBC antigens, 
particulate overloading of the RES and a depletion of the 
population of SRBC sensitive lymphoid cells as three 
possible mechanisms which could operate during a malaria 
infection. But Greenwood et al. (1971b) found no evidence of
reticuloendothelial blockade in P.yoelii infected mice. On
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the contrary, at the time of maximal parasitaemia and 
maximal immunosuppression the clearance of carbon or 51Cr- 
labelled SRBC from the peripheral blood was enhanced, an 
observation of the evidence for RES hyperactivity in 
infected mice.
Loose et al. (1972) showed that peritoneal macrophages 
obtained from malaria infected mice had a normal ability to 
ingest SRBC in vitro ; such SRBC exposed macrophages induced 
significantly fewer plaque forming cells than mice not 
infected with malaria. Loose et al.(1971) have shown that 
macrophages from malaria-infected mice are very ineffective 
in detoxifying endotoxin. This defect in handling and 
processing of antigen by macrophages was proposed to play 
a major role in immunosuppression of malaria infection 
(Loose et al.,1972, Greenwood, 1974) •
Salaman et al. (1969) considered the phenomenon of 
antigenic competition to be a possible 'mechanism' in 
malarial immunosuppression. But Greenwood et al»(1970) 
found that infection of rats with P.yoelii one week before, 
or at the time of, an injection of adjuvant reduced the 
incidence and severity of the ensuing adjuvant arthritis. 
According to them antigenic competition was not responsible 
for the suppression of adjuvant arthritis.
Hudson et al. (1976) suggested a possible link between 
high IgM levels of Trypanosoma brucei brucei infection in 
mice and immunodepression. According to them, the increased 
background count of IgM in the infected unimmunised mice 
and the enhanced responsiveness of both IgM and IgG PPC to 
SRBC in the early part of the infection in T.brucei
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infected mice were suggested to be due to polyclonal 
activation. The polyclonal activation of B—cells in the 
presence of a continuous trypanosome infection is likely 
to result in a progressive depletion of antigen reactive 
B lymphocytes as these are activated to change into 
secretor cells, resulting in the depletion of B-cells 
capable of recognising the introduced antigen. Polyclonal 
B-cell activation has previously been suggested to occur 
in malaria (Greenwood,1974) and in trypanosomiasis (Freemant
1975).
The exact mechanism of immunodépression is still obscure. 
It is a complex phenomenon and pi*obably T-cells, B-cells 
and macrophages are all involved, either directly or in 
co-operation and antigenic competition either at the 
macrophage level or to B or T cells may be present as well.
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B. Protein-energy deficiency and immunity to infection
The interaction of infection and malnutrition may be 
considered to be cyclic insofar as one condition is 
capable of accentuating the other (WHO, 1971). "Protein 
and energy deficiencies affect the ability of the organism 
to make new cells and to synthesize and secrete proteins 
and so the reactive capacity of the organism to injury, 
be it microbial, toxic or genetic is severely restricted" 
(Ramalingaswami, 1975).
1. Humoral immune response
Contradictory results have been reported for immuno­
globulin levels in protein and energy deficient children.
Protein«-energy deficient children are reported to have high% %
(Keet and Thom, 1969; El-Gholmy et al.. 1970; and Neumann 
et al.. 1975), normal (McFarlane, 1970; Rosen et al., 1971; 
and Neumanet al(l97y)or Low(Brown and Katz, 1966; and Arefr\ *
et al., 1970) levels of Ig. Watson and Preeman (1970) 
suggested that high Ig levels in Kwashiorkor may be in response 
to infections. This suggestion is in agreement with the results 
of Purtilo et al. (1976), who showed that the increase in Ig 
(IgA, IgM, IgG and IgE) were related significantly to the 
intensity of the intestinal nematode infestation rather than 
to the state of the nutrition of the children. According to 
Lechtig et al. (1970 ) Ig levels in nourished and malnourished 
persons living in the same areas were similar apart from 
raised IgA in protein energy malnutrition (PEM). Price 
and Bell (1976) demonstrated in mice that the antibody 
response in PEM to T-cell independent antigens, polyvinyl 
pyrrolidone (PVP) and Brucella abortus, are not affected.
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But responses to T-cell dependent antigens like sheep red 
blood cells and tetanus toxoid are either normal, elevated 
or suppressed depending on the dose, and -in the case of 
tetanus toxoid, the age of the host. According to Bell 
et al. (1976a)though there is a reduction of lymphoid tissue 
in PEM mice, antibody production is not reduced because the 
amount of antibody produced per unit of lymphoid tissue of 
the animal is increased. Sirisinha et al. (1973) have 
reported a normal level of and low levels of C^, C^, C^,
Cg and Cg in malnourished South-East Asians. Also Olusi 
et al. (1976) reported that apart from and C^, C-^  to Cg 
were all depressed in PEM children.
2. Cell mediated immune response
Children with PEM and measles sustain a high mortality 
and morbidity and often lack a rash, which is supposed to be 
due to T-cells. - The children sometimes die of giant cell 
pneumonia (Paulk et al.,1975). This implies a depression 
of CMI in PEM. Also Smythe et al. (1971) have shown that 
PEM children have impaired responses to contact sensitivity 
to 2-4 dinitrochlorobenzene, the lymphocytes from them show 
less PHA response, and the tonsils are smaller. Chandra 
(1972) confirmed these results in the malnourished children. 
He showed reduced delayed hypersensitivity responses of 
skin to BCG. Watts (1969) also showed that children who 
died of protein and energy malnutrition had a reduced thymus/ 
bodyweight ratio and marked atrophy of the thymus. Several 
investigators have shown decreased T-cell rosettes in 
malnutrition (Bang and Bang, 1973» Chandra, 1974» Perguson 
etal.,1974). Bell et al. (1976d showed that mice maintained
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from weaning on a 4# albumin diet have only 10-20^ of the 
numbers of lymphoid cells found in normally-fed mice.
The anaemia produced by PEK is well recognised and 
may be reproduced experimentally by feeding animals diets 
deficient in protein or a variety of other nutritional 
factors. Under these conditions all the cellular 
constituents of blood fall below the levels of normally 
fed controls (Bell et al., 1976b).
The interactions of nutrition and infection have been 
reviewed in detail by Scrinehaw et al.(l959 ). There were a 
lot of controversial results but almost all of the bacterial 
infections and malnutrition give a synergistic effect 
with an -increase in the infection. Deficiency of proteins 
permits greater development of Ascaris, Trichinella, 
Nippostrongylus, Hymenolepis and Ancylostoma caninum in 
various animal hosts.
However meat diets suppress P.berghei malaria infections 
in mice (Adler ,1958), and milk diet suppresses P.berghei 
infections in mice (llaegraith et al.,1952). P.knowlesi in 
monkeys (Maegraith ,1953), and plasraodium infections in 
man (Chauduri and Dutta, 1955). These effects are due to 
lack of para-amino benzoic acid (PABA) rather than due to 
protein (Adler* 1958; Jacobs ,1964).
Rats starved for 5-10 days were able to suppress the 
parasitaemia of a P.berghei infection (Ramachrisnam 1953). 
Similarly P.knowlesi infection in monkeys was suppressed in 
animals starved for 24-48 hours ( MoKe# end Geiman, * 1948).
Seeler and Ott (1945) have shown that pure protein
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deficiency caused the enhancement of V♦loohurce infection 
in birds. Also Suntharasamai and Marsden (197 2) showed 
that protein deficiency in mice with r.yoelii infection 
gave rise to more anaemia and prolonged parasitaemia with 
less splenomegaly.
47C. Concomitant infections of malaria and other infections
Malaria has been shown to be immunosuppressive, the 
intensity of the depression being related to the parasitaemia. 
The virulent forms like P.berghei in mice and P.falciparum 
in man produce marked involution of the thymus but this 
does not occur with a milder infection like P.yoelii in 
mice (jayawardena et al.,1975)» It is also a common 
observation that generalised immunodepression may occur 
during certain bacterial, viral and parasitic infections 
(Schwab,1975)• Consequently many people are interested in 
the interactions of malaria and other infections , viruses, 
bacteria and other parasites.
Eperythrozoan coccoides infections in mice produce 
anaemia and reticulocytosiB (Peters, 1965a;Ott et al. 1967). 
P.chabaudi infections were less severe with 100JS survival- 
in the Bperythrozoan infected mice in an otherwise fatal 
infection,but P.berghei was slower in developing in 
Bperythrozoan infected mice, and was accompanied by a 
delay in time to death (Ott et al,1967> Ott and Stauber,
1967). Since P.berghei favours the reticulocytes and 
P .chabaudi the mature erythrocytes, the authors drew the 
conclusion that the effects of E.coccoides on reticulocytosis 
must be the basis for the explanation.. Ott et al. (1967) 
also found out that P.berghei and P .chabaudi infections 
caused the lengthening of the prepatent period of 
E .coccoides.
Virus infections induced the production of interferon 
in mice (Merigan ,1970) as do the erythrocytic infections 
of P.berghei (Huang et al.,1968) . Schultz end Huong (I96ff)
demonstrated that Newcastle disease virus prolonged the 
survival times and decreased mortality in P.berghei- 
infected mice. The authors proposed that it was due to 
the effect of interferon. Jahiel et al.(1970) proved the 
fact by exogenously administered serum containing interferon. 
This protected the mice against P.berghei infection, the 
level of protection depending on the dosage used. There 
are reports that malaria infection reduced the antibody 
response to tetanus toxoid in man (McGregor and Barr1962) and 
to pertussis vaccine in mice (Viens et al.,1974). Wedderburn 
(1974) has demonstrated the enhancement of lymphomagenesis 
together with depressed levels of total virus neutralizing 
antibody in mice infected with Moloney lymphomagenic virus 
(MLV) and P.yoelii infections. The mild P.yoelii infection 
also became severe in doubly infected mice. Also,P .chabaudi 
or P.yoelii infections combined with Rowson-Parr virus (RPV) 
lead to exacerbation of the plasmodium infection with 
reduction in antiparasitic antibody levels (Salaman,1970;
Cox,1974b ). Burkitt's lymphoma (Burkitt,1959) occurs mainly 
in definite geographical areas, and a causal connection 
between this lymphoma and holoendemic malaria has been 
suggested (Dalldorff et al., 1964? Burkitt,1969) •
Bacterial endotoxins, particularly from Escherichia
coli, prolonged the life of mice infected with . ...____
p. berghei (Martin et al.- 1967 )..Intravenous 
injection of killed Corvnebacterium parvum in mice was 
shown to have some protection for the mice against P.berghei 
(Nussenzwe1^1967)* P «chabaudi and P.vinckei infections 
(Clark et al, 1977)« Nuasen*weig(1967) showed that the 
stimulation of reticuloendothelial system (RES) and
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increasing phagocytosis was responsible for protection.
Bazaz ■ —  Malik (1973) also demonstrated that monkeys 
I^fscted with Mycobacterium tuberculosis of simian origin, 
had lower parasitaemias when infected with’ P .inui or 
P .cynomolgi than the control. The authors suggested that 
the initial effect was due to the non-specific stimulation 
of RES and that subsequent effects were due to the adjuvant 
nature of the tubercular infection. Intravenous infection 
of BCG into mice was shown to protect them from P.vinckei 
and P.yoelii infections (Clark et al.. 1976). The authors 
proposed that the protective effect was due to the non­
specific soluble mediators like interferon or lymphokines 
which were increased by intravenous injection of BCG or 
C.parvum (Clark et al.. 1977)»
Mice which had recovered from Babesia microti infections 
were nearly immune to P.vinckei or P.chabaudi infections 
and the reverse was also true as well (Cox, 1968£.
Strickland et al. (1972) have shown that Toxoplasma 
gondii infection in mice led to an increase in anaemia, 
parasitaemia, diminished immune response and mortality 
if the mice were infected with P.berghei. If a P.yoelii 
infection was given one week before the usually mild 
Trypanosoma musculi infection in mice, the T.musculi 
infection turned into a severe form (Cox, 1975). Also 
Jackson (1959) showed that the mild infections of T.lewisi 
and P.berghei in rats became severe when given together with 
a mortality of 68*. P.yoelii infection before, together 
with or after T.b.rhodesiense caused a shortening of the
period of survival of the mice and the T«b.rhodesiense
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enhanced the normality-mild P.yoelii infection (Dallas,1976). 
Leishmania enrietti inoculated intradermally into hamsters 
produced a granulomatous lesion. When P.yoelii infection 
was given to hamsters together with or shortly after 
L .enrietti infection, the granuloma size was larger than 
with the L .enrietti infection alone, but if it was given 
two weeks after P.yoelii infection there was a reduction 
in granuloma size compared with the control (Belehu et al.,
1976). According to the authors, the size of the granuloma 
depended on the relative timing of the two infections.
They got similar results when they did the same experiment 
with chronic malaria produced by the infection of P.berghei 
in P.yoelii immune hamsters. But Ebert (1970) demonstrated 
that, though P.vinckei was invariably fatal in white mice, 
when given together with Leishmania donovani intraperitoneally 
15 of the 35 mice recovered and 29 mice had an increased 
survival time. The numbers of leishmania parasites present 
in both infections were reduced compared with the leishmania 
infection alone. Cross-immunity between the malaria parasites 
has been shown (Yoeli et_al,,1966j Cox and Voller, 1966). 
Complete cross-resistance was demonstrated between P.chabaudi 
and P.vinckei, mice which had recovered from infections of 
either of these species being resistant to challenge with 
the other. But previous infection with P.berghei in rats
protected completely against p.yoelii, however the latter 
only induced partial protection against P.berghei. P.berghei 
did not protect against either P.chabaudi or P.vinckai nor 
did P.vinckei and P .chabaudi protect against P.berghei (Cox 
and Voller, 1966). This, according to the authors, was due 
to the differences in antigenic characteristics of P.yoelii
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and of P »berghei on the one hand, and P.vinckei and 
P.chabaudi on the other.
Concomitant infections of malaria and schistosomiasis 
have frequently been observed in areas where both diseases 
are endemic (Yoeli, 1956). According to Nelson (1958) spleen 
rate increases in younger children (below 10) where malaria 
and schistosomiasis are both prevalent as in the West Nile 
region of Kenya. Schistosomiasis is also known to produce 
immunosuppression of humoral responses to tetanus toxoid if 
the toxoid was given 6 weeks after infection (Brito et al..
1976) . A marked diminution of the response of mice infected 
with Schistosoma mansoni to injection of sheep red blood
cells has been shown (Mota-Santos et al.. 1976; 1977) and to
%lipopolysaccharide from Escherichia coli (Mota-Santos et al..
1977) * According to these authors the immunosuppression in
S.mansoni was induced by adult worms and not by eggs and the 
antigens involved in immunosuppression originated from the 
surface membrane of schistosomes. Araujo et al. (1977) 
showed that there was depression of cell-mediated immunity 
also by delayed rejection of skin grafts in mice after 60 days 
of schistosomiasis infection. Pelley et al. (1976) have 
shown that there was profound unresponsiveness to Concanavalin 
A *rd phytohaemagglutinin after 12 weeks of schistosomiasis 
infection in mice. They suggested the possibility of suppresor 
T-cel-1 activity being the explanation. Kloetzel et al.
(1973) studied the concomitant infections of Trypanosoma 
cruzi and S.mansoni in albino mice. They showed that if
the T.crusi infection preceded that of S.mansoni, the number
of trypanosomes in the blood was about double that of the
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controls and the worm recovery was sometimes reduced, the 
worms tending to be stunted. When S.mansoni infection 
preceded that of T.cruzi. the trypanosomes in the blood 
were many times more numerous and they persisted longer.
But with malaria infections Yoeli (1956) demonstrated that 
if a P.berghei infection was given shortly or 1-2 weeks 
after exposure to S .mansoni in the field vole a high 
proportion developed an infection which ran a chronic 
course. But if malaria was given 4-7 weeks after the 
S .mansoni infection, the parasitaemia was of a low mild 
course without any mortality, though there was a 21.7# 
death rate after infection with P.berghei alone. According 
to the author the latter effect was due to the nonspecific 
stimulation of reticuloendothelial system by the S .mansoni 
infection with a marked increase in phagocytosis causing the 
control of concomitant plasmodial infection. Lewinsohn
(1975) also attempted to find out the combined effect of
S.mansoni and P.yoelii infections in mice. According to 
her there were no significant differences between the single 
and double infections in the haemoglobin levels, 
reticulocyte counts and splenomegaly. There was marked 
suppression of the malaria parasitaemia level in the group 
of mice infected with P.yoelii 5 weeks after exposure to 
cercariae compared with that of the control, whereas the 
group of mice infected with P.yoelii 3 weeks after cercarial 
infection did not show any significant difference in 
parasitaemia compared with that of the malaria control.
The author suggested that this might be due to the variation 
in response of the mice.
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Abdel-Wahab et al. (1974) demonstrated a marked 
reduction in size of granulomas in lungs of mice injected 
intravenously with S.mansoni eggs 16 days after P.berghei 
infection. This effect was supposed to be due to the 
immunodepressive effects of malaria on the granuloma 
formation.
D. Chemotherapy of malaria infection
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1. r.'.ode of action of antimalariala
The established pharmacological actions of the 
antimalarial drugs are discussed in most of the standard 
textbooks of pharmacology and tropical medicine. I intend 
here to consider specifically the drugs that were used in 
my experiments. The antimalarials are grouped, in 
accordance with their modes of action, as 8-aminoquinolines, 
antimetabolites and schizonticidal groups of antimalarials 
(Warhurst,1973)•
a. 8-aminoquinoline antimalarials
The 8-aminoquinoline group of antimalarials consists 
of primaquine, pamaquine, quinocide and others, some of 
lesser importance. This group of drugs has a unique^ 
antimalarial spectrum (Pinder,1971) and is effective 
against all stages of the life cycle of plasmodia (Warhurst,
1973)• Tissue stages of malaria are more sensitive to the 
8-aminoquinolines than the erythrocytic schizonts; Warhurst 
and Killick-Kendrick (1967), Gregory and Petens(1970) and 
King et al. (1972) showed with P.yoelfl. and P.berghei 
infections in mice that exoerythrocytic stages were 
susceptible to pamaquine and primaquine though the 
erythrocytic stages were not.
The mechanism of the mode of action of the 8—amino- 
quinolines is not yet known (Warhurst,1973) but what is 
known has been reviewed by Goodwin and Rollo (1955), Peters 
(1970a,1974a) and Warhurst (1973). Greenberg et al. (1951) 
showed that pamaquine was inactive in vitro against blood
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stages of P .gallinaceum but metabolites produced by the 
chickens given the drug were active. The metabolism 
of the 8—aminoquinolines to form the active form in vivo 
has been discussed by Warhurst (1973) (referring to Tarlov 
et al,1962 and Smith,1956). The metabolism of pamaquine 
and of primaquine and pentaquine to the form active against 
P.gallinaceum blood stages is by demethylation of the 
6-methoxy group to the 6-hydroxy form, and oxidation in 
the 5 position to give the 5-6 dihydroxy derivative. This 
is in oxidation-reduction equilibrium with a reduced form, 
the 5-6 quinoline diquinone.
Skelton et al.(1968, 1970) have shown that P.lophurae,
P.knowlesi, P .cynomolgi and P.berghei synthesize ubiquinone 8 
(Coenzyme Q8). The vertebrate blood itself contains either 
ubiquinone 9 or 10 only (Warhurst, 1973)• Skelton et al. (1968) 
showed that primaquine, chloroquine and several other 
antimalarials acted by affecting the enzyme systems involving 
mitochondria and biosynthesis of ubiquinones in P.lophurae.
But the 8-aminoquinolines were shown also to bind nucleic 
acid in vitro (Morris et al^l970). Whichard et al.(1972) 
showed that the 8-aminoquinolines and two hydroxylated 
derivatives inhibited certain bacterial DNA polymerases. 
Conklin and Chou (1970) working with Tetrahymena pyriformis 
said that primaquine acted by blocking the amino acid 
uptake.
The major drawback to the clinical use of the 8-amino- 
quinolines is the toxic effects, even at the therapeutic 
dosages (Rollo,1970). They effect the central nervous 
system causing anorexia, cyanosis, pain in abdomen and
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vomiting^ and effectB on haemopoietic tissues causing leukaemia 
anaemia, mcthaeraoglobinemia, and suppression of myeloid 
activity (Hill»1963). The haemolytic sidte effects occur in 
relation to a glucose 6-phosphate dehydrogenase (G6PD) 
deficiency (Rollo,1970; Petem 1974a).
Only primaquine now has widespread therapeutic use, 
though auinocide is also used in Eastern Europe and the 
USSR (WHO/1961) for the radical cure of P .vivax and 
P.malariae infections (Hill>1963). It has been recommended 
that the 8-aminoquinolines should always be given with 
chloroquine to reduce the likelihood of drug resistance 
developing (WHO» 1961J Arnold et al.»1961).
Thus the mode of action of the 8-aminoquinolines can 
be summarized as follows:
1
X. They must be metabolised in vivo to form active compounds
2. They affect coenzyme synthesis of parasites
3. They also have an effect on DNA but the exact mechanism 
is not yet known
4. They are effective against all stages of parasites.
b. Antimetabolite antimalarials
This group of antimalarials consists of pyrimethamine, 
sulphadiazine, dapsone, proguanil and cycloguanil. This 
is the only group of antimalarials whose mode of action 
is well known, as the name implies.
Gregory and Peters (1970) and Vincke (1970) have sho 
that pyrimethamine is effective against the exo-erythroo
stages of P.berghei. Gcrberg (1971) also showed the 
susceptibility of sporozoite stages of P.gallinaceum to 
pyrimethamine and cycloguanil in Aedes ae-pypti. Terzian 
(1970) also showed pronounced, oocysticidal effects of 
pyrimethamine and cycloguanil against P.cynomolgi in 
Anooheles stenhensi, and that proguanil, cycloguanil and 
pyrimethamine interupted growth of the oocysts in P .vivax- 
infected Angpheles quadrimaculatus and A. Stephens!. In fact 
antimetabolite antimalarials are effective against all 
stages of the life cycle of plasmodia, apart from the 
gametocytic stage (Warhurst, 1973} Peters,1974a).
Pyrimethamine was claimed to be inactive in vitro 
against the asexual blood stages of P.gallinaceum by Taylor 
et al (1952). Gutteridge and Trigg (1971, 1972 ) found 
that pyrimethamine inhibited DNA and RNA synthesis of 
P.knowlesi in vitro and in vivo, mainly during the schizont 
stage, that is after most of the synthesis of DNA for 
multiplication of the parasite had already taken place.
They concluded that pyrimethamine inhibits parasite 
segmentation and schizogony, not by inhibiting DNA synthesis 
but by inhibiting some metabolic process like dehydrofolate 
reductase function for synthesis of tetrahydrofolate 
co-factor. Ferone and Hitchings (1966) have shown that 
P.berghei could not use folic acid directly from the host 
due to the lack of folate reductase but could synthesize 
its own folate co-factors. Many authors ( Ferone and 
Hitchings,1966J Peters,1970a; Warhurst, 1973) have discussed 
the role of antimetabolite-antimalarials in synthesis and 
use of folate co-factors. According to them malaria 
parasites, like some pathogenic bacteria, couple a.pter
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derived from guanosine monophosphate with PABA to give 
dihydropteroid acid, which, with the addition of glutamate 
is converted into dihydrofolic acid directly, without the 
intermediacy of folic acid itself. Dihydrofolic acid is 
then reduced to tetrahydrofolic acid, and this can be 
converted into the active co-factors by further enzymatic 
reactions. Pyrimethamine and the metabolites of proguanil 
(Cycloguanil) have an affinity for the parasite enzyme 
dihydrofolate reductase and prevent its interaction with 
dihydrofolate. Sulphonamides mimic the chemical structure 
of PABA (as shown in figl ) and completely inhibit 7,8 di- 
hydropteroate synthetase that acts on the folate pathway, 
and it is likely that dapsone acts the same way (peters,
1971) and prevents tetrahydrofolate formation. Thus the 
combination of sulphonamide and pyrimethamine has 
potentiating effects on the parasites (Hitchings#I960).
The basis of the chemotherapeutic specificity of pyrimethamine 
lies in the extremely high affinity of the parasite enzyme 
for the drug compared with the mammalian enzyme dihydro— 
folate reductase (Warhurst.1973). If a sufficient amount 
of pyrimethamine is administered either alone or together 
with sulphadiazine, the host's enzyme will be affected 
(Peters,1974a). Thus pyrimethamine can cause macrocytic 
anaemia with manifestation of folic acid deficiency which 
can be reversed by cessation of treatment or by administration 
of folio acid (Pinder, 1973)- Administration of folic 
acid together with pyrimethamine will not reduce the effeot 
(Tong et al.,1970).
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c. Schizonticidal drugs
These consist of the most'commonly used drugs for 
clinical treatment of malaria: chloroquine, quinine, 
amodiaquine and mepacrine.
Chloroouine
The early clinical work on chloroquine is summarised 
by Findlay (1951) and Pinder (1973). It is effective 
against the asexual blood forms in all species of human 
plasmodia but inactive against exoerythrocytic stages and 
sporozoites. Chloroquine is also gametocidal in infections 
with P.malariae, P .vivax and P.ovale but not active against; 
mature gametocytes of P.falciparum. Many theories have been 
put forward to explain the mode of action of chloroquine 
against malaria infections. The following sequence of 
changes was seen after.80 minutes exposure to chloroquine 
in a concentration 10-^M (Ladda and Amoldtigôô):
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primary effect on nuclear metabolism with both primary 
and secondary cytoplasmic effects. Most studies on the 
biochemical effects of chloroquine action have focused 
on nucleic acid metabolism (Newton, 1970 ). The 
observation that chloroquine interacts with DNA and RNA 
polymerase reactions led to the hypothesis that the primary 
action of chloroquine was associated with inhibition of 
DNA replication (Cohen and Yielding, 1965, O'Brien et al 
1966). Gutteridge et al» (1972) showed that a chloroquine 
concentration of 10-  ^M had a marked effect on the growth 
and morphology in vitro of P.knowlesi and also on the 
incorporation of %  adenosine into DNA and RNA, 
isoleucine into protein, and respiration. According to 
them, binding to DNA is not the only action of chloroquine. 
Drug concentrations less than 10~^M had little effect 
in vitro. Van Dyke and Szustkiewicz (1969) had also shown 
that chloroquine inhibits the uptake of adenosine by 
trophozoites in short-term culture. Theakston et al. (1972) 
studied the effects of chloroquine treatment on the uptake 
of labelled adenosine and methionine by the erythrocytic 
stages of P.berghei using combined eleatron microscopia 
and autoradiographic techniques, and found that the uptake 
of both was reduced in the chloroquine treated infected 
blood. They thought that chloroquine interacts with the 
membranes of infected red cells altering their permeability 
in such a manner as to make them less permeable to certain 
small molecular weight substances and thus depriving the 
rapidly growing parasites of essential nutrients derived 
from the plasma of the host.
Träger (1967) has shown that chloroquine, pyrimethamine,
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sulphadiazine and quinoline had inhibitory effects on 
P »lophurae maintained in vitro in duck red cell suspensions, 
but none of the drugs at the same concentrations 
inhibited the development of extracellular parasites.
He suggested that it might be due to the lack of concentration 
of drug in the freed parasites. It has been well documented 
that chloroquine, amadiaquine and mepacrine are concentrated 
in plasmodiuÿ-parasitised erythrocytes (Peters,1970a).
Macomber et al. ( 1966) followed the uptake of labelled 
chloroquine following a single intraperitoneal injection 
of 40 mg kg- "^ into P .berghei infected mice and showed that 
there was a 25 times greater uptake of chloroquine by the
parasitised erythrocytes compared with that by the
%
erythrocytes of uninfected controls, the level in the 
infected cells presented a 100 fold concentration from the 
plasma. Polet and Barr (1968) found a greater concentration 
(300-600 fold) in erythrocytes infected with a chloroquine 
sensitive strain of P.berghei. The mechanism of 
concentration of drugs by parasitised erythrocytes 
remains obscure (Peters, 1970a) . Warhurst et al. (1972) 
considered that quinine and chloroquine bound to the same .... . 
receptor site in the intraerythrocytic parasite from their 
studies in vitro on P.berghei infected erythrocytes.
Warhurst (1973) has reviewed in detail the actions of 
chloroquine on formation of autophagic vacuoles in 
plasmodium. According to him the digestive vacuoles 
incorporate high affinity sites for chloroquine since it 
is the place where the first changes take place after drug 
treatment. Prom that site, he thought that the drug is
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released into the parasite cytoplasm in high concentration. 
Interaction of the concentrated drug with the cellular 
synthetic machinery is supposed then to take place.
At present the exact mechanism of the antimalarial 
action of chloroquine is not yet known. But we now know 
that: 1. it concentrates in the erythrocytic membrane
2. it is effective against the intraerythrocytic stages 
of Plasmodium 3« it does not act on freed parasites in vitro, 
exoerythrocytic stages or on sporozoites. It is a drug of 
choice as a suppressive in both the acute clinical attack 
and for the prevention of symptoms; its toxicity is very 
low.
Quinine
Some twenty alkaloids have been isolated from the 
cinchona bark. The few most important are quinine, 
quinidine, cinchonidine and cinchanine (Plnder, 1973).
Their chemistry (Turner and Woodward»1953) and pharmacology 
(Findlay, 1951*, Schmidt and Coatney,1955; Hill, 1963J Peters, 
1974a) have been reviewed. Yorke (1925) had shown that 
quinine did not destroy sporozoites since injection of 
quinine (lOg) starting 5 days before and continuing until 
7 days after infected mosquito bites did not prevent the 
P.vivax infection in man. Quinine controls the blood 
induced infections of P.cynomolgi in monkeys (Genther et al., 
1948), P.berghei infection in mice (peters, 197Ch) and 
P.falciparum and P.vivax infections in man (Findlay, 1950). 
Mackerras and Ecole (1949) observed that quinine and 
mepacrine acted on the stages of P.vivax infection where
,00*
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active digestion of haemoglobin was taking place. They 
also found that quinine had no immediate effect on 
pigment but the highly motile amoeboid trophozoites in 
the red cells had ceased to move 6 hours after administration 
of the drug. Yorke (1925),referring to Muhlens and 
Kirchbaum (1924), found that a mixture of equal parts of 
defibrinated P .vivax-infected blood and a Is 5000 solution of 
quinine was still infective after incubation for 12 hours 
at 37°C and, if the strength of the quinine solution were 
doubled, infection was still possible after 5 hours.
This according to them was definite evidence that quinine, 
in concentrations considerably greater than that occurring 
in the blood stream, does not destroy the malaria parasites 
in vitro. Clarke (1952) showed that quinine, at a 
concentration of 10“^M, stopped incorporation of ^^P into 
DNA in erythrocytes parasitised with P .gallinaceum in vitro, 
but 4 times the concentration had no effect on the 
incorporation by parasites freed from erythrocytes.
According to Warhurst (1973) quinine competed with 
chloroquine for high affinity binding sites in P.berghei.
He also stated that quinine concentrated in erythrocytic 
parasites of P«knowlesi three hours after treatment.
Ceithaml and Evans (1946) confirmed this concentration of 
drug in plasmodium infected erythrocytes by quantitative 
methods.
Conklin and Chou (1970) observed that in Tetrahymena 
pyriformis quinine and other antimalarials block amino 
aoid uptake.
So the actions of quinine can be summed up ast
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1. concentration in the parasite 2. cessation of movement
3. it has no action in vitro especially on erythrocyte 
freed parasites 4. it prevents the incorporation of ^ P  
into DNA and 5. quinine acts mainly on asexual blood stages 
of parasites.
2. Mechanism of drug resistance
The mechanism of development of drug resistance in 
malaria is not yet clear. It may be due to the selection 
of resistant mutants under drug pressure, to the spread of 
naturally resistant forms in the parasite populations 
(Peteis,1970b), the transfer of genetic information from 
resistant to sensitive strains (Yoeli et al.,1969) or to 
adaptation to the drug by previously sensitive parasites.
Under experimental conditions drug resistance seems to 
depend on the immune mechanism.
The host immunity plays an important role in the 
successful activity of anti-protozoal drugs, and so any 
measure aimed at a reduction of the host's immune response 
will facilitate the emergence of resistance (Peters,1970a). 
Under laboratory conditions, drug resistant strains are 
easily produced by suppressing or avoiding the immune 
response of the host. Warhurst (1965) and Hawking (1966 
used a single injection of 500 mg kg”1 of ethyl palmitate 
into mice to produce 'clinical splenectomy' and then used 
these mice in experiments to produce resistance to chloroquine. 
Another effective way of avoiding the influence of immunity 
is to transfer parasites to a new host before the previous 
one has had time to produce an effective immune response to 
their presence, this is called the short passage method
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(Peters,1970a). Two methods have been generally used in 
malaria infections. The first is the 'short passage method' 
by which parasites are passaged after exposure to the 
drug but before it has produced any obvious effect. The 
second method is the technique originally described by 
Warhurst (1966) for use in bioassays and later modified 
by Peters (1968i ) for development of drug resistance in 
P.berghei. WHO (1973) reported that a person's immunity 
should be taken into account before testing.the drug 
sensitivity of their malaria parasites.
The problem of drug resistance in malaria is a major 
subject and it is impossible and inappropriate to discuss
it comprehensively in this thesis. The subject has been
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extensively reviewed by Peters (1970a,1974a). in this 
chapter it is intended to review only the mechanism of 
drug resistance relevant to chloroquine, quinine and 
pyrimethamine.
i. Chloroquine and related schizonticidal drugs
At the present time the resistance to the 4-amino- 
quinolines has been confirmed with P.falciparum infections 
in man and has been recognised to be present in South- 
East Asia and parts of South and Central America (WHO>1973). 
Chloroquine resistance is both increasing in virulence and 
spreading throughout the malarious areas of the world 
(Pinder, 1973).
There are at present two main theories for the 
development of chloroquine resistance in malaria. The 
first is based on the decreased uptake of chloroquine by
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resistant parasitised red cells. Macomber et al.(1966) 
followed the uptake of labelled chloroquine and - 
showed that this was 2—3 times less by a chloroquine 
resistant strain than by parasitized cells of a drug 
sensitive strain.
Pitch (1970) showed that, in erythrocytes of mice
infected with P.berghei and exposed to 10“®M chloroquine
at 27®C and a pH of 7.2 to 7.4, the steady state internal
to external distribution of the drug was approximately
600:1 for chloroquine sensitive parasites, 100:1 for
resistant and 14:1 for uninfected cells. Homewood et al.
(1972) found that an increase in the extracellular pH
increased the intracellular pH of the erythrocytes and
%
also increased the amount of clumping of pigment in the 
chloroquine treated parasitised erythrocytes. They 
proposed that resistant parasites may have less acid food 
vacuoles than sensitive parasites and hence attract into 
them less chloroquine.
However, Williams and Fanimo (1975) showed that the 
mean intracellular pH values of erythrocytes parasitized 
with either chloroquine sensitive or resistant strains of 
P.berghei were very similar and were not significantly 
different from that of the extracellular pH. Pitch (1969) 
showed that the ability of chloroquine sensitive parasites 
to concentrate the drug was due to the availability of 
high affinity sites, but in the drug resistant strains, 
there was either a decrease in number or in the accessibility 
of chloroquine receptor sites on a constituent of the 
malaria parasite. Kramer and Matusik (1971) tried to
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localise the different sites in lysates of P.berghei 
and found that the high affinity sites were associated 
with parasite membranes and the sites of lower affinity 
were cytoplasmic. According to YYarhurst and Thomas (1973) 
the binding site was possibly a phosphate or a carboxyl group 
associated with lipid. So far the exact mechanism of 
concentrating the drug by the parasitized red cells is 
not known (Peters,1974a) but drug-resistant parasites take 
up less chloroquine than the sensitive ones.
Another theory, put forward by Howells et al. (1970). 
was that chloroquine resistance was due to the ability of 
certain parasites, under chloroquine pressure, to switch 
prematurely from an anaerobic to an aerobic pathway 
involving succinate oxidation. They supported their theory 
by showing the presence of succinate dehydrogenase in the 
chloroquine resistant line which was absent in the sensitive 
parent line. The trophozoites of chloroquine-sensitive 
P.berghei lack a Krebs cycle (Theakston et alv1970) though 
sporogonic stages utilize this pathway (Howells et al.,1970)
It is postulated that chloroquine resistance in the 
trophozoites is expressed by a switch to Krebs cycle 
activity and the synthesis of amino-acids by transamination 
of intermediates of this cycle . This theory 
was reinforced by Palecek et al. (1967) and Cho and Aviado
(1968) who showed that chloroquine resistant strains of 
p.berghei take up twice as much oxygen as do the normal 
parasites. Ali and Fletcher (1971) have also shown that 
there was an increased uptake of oxygen by the chloroquine 
resistant parasites. But, avian malarias utilize the 
Krebs cycle, synthesize amino acids by transamination, and
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still produce haemozoin and are sensitive to chloroquine.
Long term investigations by Peters (1970b) suggested 
that the mechanism underlying chloroquine resistance 
requires a genetic mutation that is expressed when 
drug selection pressure is exerted. He drew the inference 
from the changes in response to chloroauine in P.berghei 
as it gained or lost resistance to the drug. This concept 
is strongly supported by the variation in the rate of 
development of resistance in different species and in its 
relative stability. Chloroquine resistance in P.falciparum 
is stable through repeated blood passages and mosquito 
transmissions in man, gibbons and chimpanzees; but for 
P .vivax. because of its low mutation rate, chloroquine 
resistance has not yet appeared and, moreover, the number 
of P .vivax parasites that are ever exposed at one time in 
an acute infection is much lower than those of P .falciparum 
(Pinder, 1973). It is also true in P.berghei infections 
that there are no natural variations in response to the 
drug treatment amongst different geographical isolates 
(Peters,1970a).
Chloroquine resistance in rodent malarias seems to 
take different forms. Spontaneous resistance to chloroquine 
was shown in the wild population of the rodent malaria 
P.yoelii by Warhurst and Killick-Kendrick (1967)« P.berghei,
P .chabaudi and P.vinckei are sensitive to chloroquine.
Stable chloroquine resistance has been produced in P.vinckei 
(Powers et al.,1969) and in P .chabaudi (Rosario, 1976) 
by drug selection in the laboratory but resistance to P.berghei 
developed in a similar way is usually unstable in the
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absence of drug pressure.
11. Antifolic antimalarials
Pyrimethamine and proguanil have extremely flat dose 
response curves, they have significant antimalarial activity 
at smaller doses (Jig) but are not 100£ effective in 
curing apparently susceptible infections even at multi­
milligram levels because both are intrinsically slow in
action, allowing at least one full development of the cycle 
before the infection is controlled (Pinder,1973)• Hence
the rapid emergence of resistance to these drugs in the
field (Peters, 1974a).
Single or multiple drug resistance may be transferred 
from one strain of bacteria to another during 
conjugation by means of a 'package' of DNA or episome that 
carries the necessary code to the recipient (Peters,1967h). 
Yoeli et al. (1969) proposed the term 'synpholia' for the 
transfer of drug resistance in their experiments. They 
injected a pyrimethamine resistant strain of P .vinckei and 
a sensitive strain of P.berghei simultaneously into CP-j^ 
mice. Selection of strains of P.berghei was achieved by 
subsequently passing the mixed infection into hamsters, in 
which host P.vinckei does not grow. This biological filter 
allowed the isolation of P.berghei which became resistant 
to pyrimethamine. According to them it was due to the 
transfer of an unidentified factor from drug resistant 
P.vinckei to drug sensitive P.berghei at a time during the 
height of the mixed infection when the chances of 
trophosoites of both species invading the same individual 
mouse erythrocyte would be quite likely. Fef<>n® et al.
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(1970) supported the theory of •synpholia' by showing that 
the character of the dihydrofolate reductase extracted 
from the resistant P .berghei was intermediate between 
that of the drug resistant P ♦vinckei and the drug sensitive 
P.berghei. They suggested that P.berghei acquired resistance 
from P.vinckei through direct transfer of genetic material 
for mutant enzymes. However, other workers have been 
unable to repeat the work on 'synpholia' (Peters,1970a; 
Walliker et al.,1971). Walliker et al. (1973) proved that 
genetic exchange takes place during cross-fertilization of 
gametes in the mosquito between a pyrimethamine sensitive 
and a pyrimethamine resistant strain of P.yoelii and 
dismissed the possibility of •synpholia'.
Ferone. 2*_al, (1970) aBd' Fe^ane • (1973) have shown that 
resistance to pyrimethamine is due to a decreased binding 
affinity of.the enzyme for this compound, associated with 
an increased enzyme production by the resistant parasites.
This is true with pyrimethamine, cycloguanil and trimethoprim. 
Diggens et al-(1970) also showed that dihydrofolate 
reductase from the pyrimethamine resistant line of P.berghei 
showed a reduced affinity for substrate, a decreased 
sensitivity to pyrimethamine, and was present at a higher 
level in the parasites when compared with the parent strain 
enzyme.
Resistance to pyrimethamine can follow a single 
exposure of a population of malaria parasites to this drug. 
According to Jacota(1964) the pyrimethamine resistant 
P.berghei needs more PABA than the sensitive one. Diggens
and Gregory (1970) showed that the oxoerythrocytic stages
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of a pyrimethamine resistant line of P«berghei were 
resistant to cycloguanil and proguanil, but sensitive to 
primaquine and sulphadiazine. So most strains resistant 
to pyrimethamine can be treated with sulphonamides, 
especially if combined with higher than normal levels of 
pyrimethamine (Peters;1970a).
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E. Immunity and chemotherapy
Ehrlich (1909) suggested that "the drug Icills some of 
the parasites and releases antigens which result in a strong 
•ictus immunosatorius"' (Cited by Taliaferro and Taliaferro, 
1949). The resulting antibodies were then supposed to kill 
the remainder of the parasites. Since that time, the co­
operative effects of immunity and chemotherapy have been the 
subject of much study and speculation. However, since 
immunology at that time was a new subject most of the studies 
were only superficial. Here I will review interactions of 
immunity and chemotherapy in some bacterial, helminth and 
haemoprotozoan infections. Also I will include some studies 
on cancer since most advances in immunotherapy have been made 
in this field.
1. Bacterial infections
Much has been published on the effect of the immune 
responses of the host on antibiotic treatment. Fleming 
(1938a) had shown that sulphonamide (T693) alone inhibited 
bacterial growth and production of toxins, while patient's 
serum alone killed the cocci of pneumococci and streptococci 
bacteria in vitro within two days. Fleming (1938b) 
showed the synergistic effect of passive immunization with 
specific antiserum and sulphonamide (T693) treatment in 
pneumococcal infection. From these experiments he . 
suggested that patients should be immunized actively or 
passively before treatment. Branham (1940) demonstrated 
that combination of immune serum and sulphanilamide gave a 
far better result than either agent alone in the treatment 
of meningococcal infections and streptococcal infections of
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mice (Lowenthal, 1939{ Boyer,I960) or staphylococcal 
infections in mice (De and Basu,1938). Weil and Gall 
(1941) showed that Salmonella typhi infection caused a 
generalised infection in 10 day old chick embryos and, 
when treated with sulphanilamide and antibody, a cumulative 
effect was obtained. They also proposed clinical possibilities 
of combined chemotherapy and immunotherapy. Boyer (I960) 
prepared hyperimmune serum in rabbits by injecting them 
repeatedly with killed streptococcal A and C. The immune 
serum administered in low doses by itself gave low 
protection in mice,' but when given with sulphanilamide or 
penicillin the curative action was increased. Treffers 
and Muschel(1954) used turbidimetric growth assays for 
in vitro measurements of the iitfiibitory actions of 
chloramphenicol and of specific, antibody and complement; 
additive effects were seen when the two were combined.
Bringhurst and Marcus (1961) demonstrated in vitro 
that human gammoglobulin and normal serum has an anti­
bacterial effect. When gammaglobulin was added in the 
same concentration as that of normal serum the antibacterial 
activity of penicillin was increased 35 times against 
three different strains of Staphylococcus aureus. Normal 
pooled serum acted in the same manner. Pisher (1957) 
proved the same fact in vivo by showing that commercial 
gammaglobulin (poliomyelitis immune globulin, human, Parke 
Davis and Co.) as well as pooled human gammaglobulin had a 
synergistic effect with chloramphenicol in mice infected 
with species of staphlyococci, streptococci, pseudomonas 
and proteus. Also,samples of commercial gammaglobulin 
given alone without antibiotic were therapeutically active
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against staphylococcus and streptococcus infections.
In a staphylococcus infection as little as 0.02 ml of 
gammaglobulin solution per kg of mouse proved synergistic 
with chloramphenicol. The author suggested using either 
gammaglobulin alone or combined with antibiotic in known 
cases of gammaglobulin deficiency. Waisbren (1957) used 
a combination of antibiotics and gammaglobulin for 
treatment of 46 patients suffering from different bacterial 
infections. The combined treatment was far superior to 
antibiotic alone. Gammaglobulin alone was tried only in 
one case of endocarditis due to staphylococcus and two 
cases of pyelonephritis but the results were not 
satisfactory.
Though gammaglobulin acted very well either alone or 
with antibiotics (Fisher, 1957; Bringhurst and Marcus, 1961; 
and Waisbren, 1957) in vitro as well as in vivo, no-one 
attempted to explain the phenomenon. It might be due to 
the presence of specific antibody in the gammaglobulin or 
due to the presence of a substance or substances which will 
activate the alternative complement pathway and cause the 
lysis of the bacteria.
Combination of antitoxin or antiserum with drug has 
been tried in the hope of neutralising the toxins produced 
■jjy some bacteria. Gordon and McLeod (1941) experimented 
with infections of Clostridium septicum in mice and 
Cl.welchi, Cl.septicum or Cl.morgi in guinea pigs. They 
showed that multiple injections of serum into the muscles 
of animals infected with gas gangrene were beneficial but 
sulphonamides were not effective as prophylactics. However,
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Henderson and Gorer (1940) showed a striking synergy of 
antitoxin and sulphonamide both for prophylaxis and cure 
Cl«welchii and Cl.oepticum but not Cl.oedaematiens 
infections in the guinea-pig. Recent practice has been 
to treat tetanus (Cl.tetani), gas-gangrene (Cl.welchii) 
and diptheria (Corynebacterium diptheriae) by giving high 
doses of antitoxin and antibiotic as a routine procedure 
(Davies et al.,1967). There have been some attempts at 
active immunization and drug treatment as well. Cokkinis 
and McElligott (1938) found that active immunization of 
patients with gonorrhoea before treatment with sulphonamide 
gave better prospects of cure. Maclean et al. (1939) proved 
the value of active immunization experimentally by showing 
the increased survival rate of pneumococcal infected mice 
and rabbits treated with a single dose of vaccine at the 
time of sulphonamide therapy.
Marcus et al. (1955) tried to prove the importance 
of host immune mechanisms during drug treatment of Klebsiella 
pneumonia infection by treating intact and X-irradiated 
(350 rads) mice with antibiotics. According to them 
streptomycin and Chlortetracycline treated irradiated mice 
showed a significantly higher mortality than the intact 
control animals. Chloramphenicol treatment did not give 
a significant difference between the two. Marston et al. 
(1953) showed that streptomycin treatment was more effective 
in treatment of staphylococcus, proteus and streptococcus 
infections in mice exposed to 250 rads than 475 rads of 
total body irradiation. Depression of resistance in mice 
by cortisone treatment impaired the antibiotic action of 
streptomycin and aureomycin against K .pneumoniae infection.
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(Jawetz and Merrill,1953). Skinsnes and Wool ridge (1948) 
made rats abnormally susceptible to pneumococci by feeding 
them a low protein diet (I.85I). Despite massive antibiotic 
therapy the viable microbes persisted in the blood and 
tissues of the protein depleted host significantly longer 
than in control animals given similar treatment.
According to Smith and Wood (1956a) the timing of the 
antibiotic treatment was most important in treatment of 
pneumococci infected mice. When penicillin therapy was 
begun 9 hours after inoculation, the pneumococci were 
cleared from the lesions with equal rapidity in the 
irradiated (650 rads) andthe intact control mice. They 
thought that the pneumococci were multiplying rapidly in 
both groups and therefore were promptly killed by the direct 
action of the penicillin. Neither showed 'cellular 
exudates' (leucocytes). When the start of the treatment 
was delayed until 24 hours after inoculation, the bacteria 
in both sets of lesions had already reached their maximum 
counts and at this stage would be more resistant to the 
bactericidal effect of the antibiotic. Under such 
circumstances the destruction of the bacteria was found to 
be significantly slower in the acellular lesions (irradiated 
mice) than in those with a normal 'cellular exudate'
(intact control). The authors concluded that in established 
pneumococcal infections in mice the curative effect of 
penicillin was due, not to the bactericidal action of the 
antibiotic alone, but rather to the combined effect of the 
drug and the cellular defences of the host. Smith and Wood 
(1956b) also showed that suppurative lesions caused by 
pneumococci were resistant to penicillin treatment. This
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was because the pus provided a poor medium, the pneumococci 
remained metabolically sluggish and, therefore, were not 
killed rapidly by penicillin; so it was the cellular 
defences of the host which played a major role in eliminating 
bacteria. Wood and Irons(19^6) studied the action of 
sulphonamide chemotherapy upon the experimental pneumococcal 
pneumonia infections in rats and showed that phagocytosis 
played an important role in bringing about the final 
destruction of the organisms in the lungs of treated 
animals. 3ut the phagocytosis which occurred in the lungs 
of rats receiving sulphonamide was due neither to the 
action of the sulphonamide nor to type specific 
antibody (Wood et al.,1946 ). Eagle et al- (1953) studied 
penicillin treatment in actively immunized and non-immunized 
mice infected with Streptococcus pyogenes. According to 
them, immunization had no effect on the direct bactericidal 
action; this proceeded at the same rate in the immunized 
animals as in the control mice. The difference in the two 
groups lay in the course of infection after penicillin 
had fallen to an ineffective level. In non-immune mice, 
the surviving bacteria regularly grew out to cause a fatal 
infection; in the immunised ones the bacteria gradually 
disappeared in the 24-48 hours after penicillin had ceased 
to be operative, and the animals survived. They concluded 
that the host defenses and the bactericidal action of 
penicillin proceeded independently of each other, but 
were mutually supplementary in effecting a cure in the 
partially immunized animals.
2. Helminth infections
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a. Nematodes
There have been some interesting studies on the 
interaction of drugs and immunity in helminth infections. 
Bell (1973) treated a sample of a population infected with 
Ascaris lumbricoides with a single dose of pyrantel pamoate. 
The patients showed negative stools until the end of the 
3rd post-treatment month, but the mean ova count then rose 
progressively, and at the end of 12 months was 230.9$ 
higher than the mean pretreatment count. It was suggested 
that the clearance of adult and Juvenile intestinal forms 
of A.lumbricoides might disturb the immunity of the host 
and allow a greater worm burden to develop if re-infestation 
occurred.
Soottish hill sheep increased their strongyle egg 
output during spring, 'the spring rise' (Soulsby, 1962).
The treatment of animals with an antihelminthic prior to 
the spring rise not only fails to eliminate the spring rise 
but was often followed by a higher level of egg output and 
a weaker curative mechanism at the end of the spring rise 
than if the antihelminthic treatment had not been given.
This was probably due to the disturbance of the immunity 
of the host as in the Ascaris infection.
When microfilariae ofLitomosoides carinii were freshly 
infused into a normal ratf diethylcarbamazine (DEC) did 
not exert its usual roicrofilaricidal action (Kobayashi 
et a1., 1969; Rao et al.,1977). Kobayashi et_al- (1969) 
also showed that though DEC (200» mg kg ) had no effect
when given 3» 5 or 40 days after microfilarial infection, 
it was effective when given 12 weeks after. They also 
showed that when adult worms were transplanted into the 
abdominal cavity of rats, DEC was effective only after 
day 15. DEC also had an immediate but transient reducing 
effect on microfilarial numbers if passive immunization 
with serum followed after DEC treatment. The authors 
concluded that the microfilaricidal effect of DEC was 
closely associated with the presence of antibodies.
Fujita and Kobayashi (1969) had already shown that 
haemagglutinating antibody became detectable 10 days after 
worm implantation. Hashigushi et al. (1972) reported that 
prednisolone had a slight antagonistic action to DEC in 
cotton rat filariasis. Takaoka et al. (1974) demonstrated 
that DEC was effective against the inoculated microfilariae 
of Litomosoides in the presence of spleen cells from the 
other infected cotton rats. Tanaka et_al.(1977) studied 
the effect of DEC on ATS or ALS treated cotton rats 
implanted with microfilaria of Litomosoides; ATS treatment 
was found to suppress the action of DEC. Also, when the 
effectiveness of DEC was tested in cotton rats treated with 
ATS and inoculated with immune serum (1 ml for 5 days), 
humoral antibody did not influence the inhibitory effect of 
ATS on DEC. The authors concluded that cell-mediated 
immunity might play a role in the action of DEC. According 
to Zahner et al.(1977) if microfilaria were injected 
intravenously into Mastomys natalensis and treated with 
DEC at different intervals, the effect when the drug was 
given after one hour was comparable with that of DEC given 
^ or 14 days after the start of the infection. Thus
DEC did not need any specific antibody for its action. 
However, they also showed that when immature microfilariae 
from the peritoneal cavity of a cotton rat were used, the 
DEC given after 1 hour was less effective than that given 
after 11 days.
b. Trematodes
McMahon (1967) showed that the suppressive treatment 
of Schistosoma mansoni infection in baboons with astiban 
produced a better immunity to rechallenge infection than 
the untreated control. He demonstrated this by the low 
level of egg excretion and relative absence of mature 
female worms in the treated baboons following the challenge 
infection. Warren et al. (1977) demonstrated that curative 
treatment of chronic S.mansoni in mice with niridazole 
caused the persistence of both immunity to reinfection and 
suppression of immunopathology.
Doenhoff and Bain (personal communication) are working 
on the involvement of immune mechanisms in the drug 
treatment of schistosomiasis in CBA mice. They have shown 
that when S.mansoni infected T-cell deprived mice are 
treated with potassium antimony tartrate the reduction 
in size of their worn burden is less than in similarly 
treated immunologically intact animals. The defect in 
deprived mice could be partially restored by administration 
of serum obtained from S.mansoni infected normal mice 
and given simultaneously with the drug but by a different 
route. A serum component obtained from rabbits injected 
with an extract from S .maneoni adult worms was also found
to aot synergistically with the drug in S.mansoni infected
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intact mice.
Prom the above studies one can see that chemotherapy 
of helminth infections clearly involves either humoral 
or cell-mediated immune responses of the host.
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3. Protozoa 
a. Flagellates
Little is known of the interactions of drug,- parasite 
and host immunity when drugs are employed against the 
amastigotes of either Trypanosoma cruzi or Leishman-ia 
species (Peters, 1974b). Convit et al. (1972) and Convit 
and Pinardi (1974) classified the American cutaneous 
leishmaniases and recognised a spectrum in relation to 
clinical aspects. The malignant pole is represented by 
diffuse cutaneous leishmaniasis, characterized by massive 
invasion of the skin and mucous'tissue of the nasopharynx 
and certain lymph nodes,, a negative Montenegro test and little 
or no improvement with treatment. At the other pole, there 
is the localised form of the disease, with few parasites, 
a positive Montenegro test and a clear tendency towards 
complete involution after treatment. The intermediate 
forms of the disease show cutaneous or mucous relapses 
with varying numbers of parasites in the lesions, the 
Montenegro test is positive and the response to treatment 
is slower than the benign localised forms. Convit et al. 
(1972) took parasites from diffuse cutaneous lesions and 
inoculated into human volunteers or into patients with 
lepromatous leprosy and showed that localised cutaneous 
lesions which disappeared without leaving any sequelae 
were obtained instead of the diffuse type. They concluded 
that this diffuse form of the disease was due to an
immunological defect in the host and not to a special 
strain of parasite. The unresponsiveness to drug 
treatment in diffuse cutaneous leishmaniasis is thus not 
due to the parasite but to the impaired immune response 
of the individual. Bryceson (1970 a,b,c) has observed 
that "immune conversion" of the skin test from negative 
to positive during prolonged chemotherapy is accompanied 
by a change in the histological picture of the lesion.
Walton (1970) showed that the PA test was a useful method 
for monitoring the effect of chemotherapeutic field trials 
in American leishmaniasis. According to him, a persistent 
detectable PA titre was interpreted as treatment failure 
even when clinical healing was attained; only conversion 
from antibody positive to antibody negative was interpreted 
as a radical cure. This, he said, was the only way to 
detect an occult infection. Beveridge and Neal (1967) 
transferred L.donovani from kala-azar patients, who did 
not respond to treatment with pentavalent antimony compounds, 
to hamsters and tested them for drug sensitivity. The 
strains were found to be drug sensitive. The authors 
claimed that this effect might be due to the difference 
in the metabolism of the drug in the two hosts. Since 
the parasite is drug sensitive in hamsters, the
ineffectiveness of the drug in the patient might probably be due 
to a defect of the patient's immune response.
Attempts have been made to use suppressive or curative 
chemotherapy to induce development of immunity in the
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host and so resistance to further infection. Bevan (1936) 
showed that when cattle suffering from trypanosomiasis were 
treated by intravenous injection of potassium antimony 
tartrate and returned to tsetse fly infested areas, they 
remained in good health in spite of re-infection. Wilson 
et al. (1969) infected a group of cattle with naturally 
infected tsetse flies (T.vivax and T.congolense were found 
in the area) which were caught wild. They then treated 
with berenil. After 6 separate challenges followed by 
berenil treatment, some cattle developed clinical resistance 
to the disease, though pathogenic trypanosomes were still 
circulating in their blood, and some even produced sterile 
immunity.'
Wilson et al. (1976) maintained three groups of Boran 
cattle under different trypanocidal drug regimes for 29 
months in an area of "median1' tsetse challenge. Cattle 
treated with berenil on the appearance of clinical disease 
developed a partial immunity to trypanosomiasis after 
2 years. Cattle treated as a group with berenil on the 
development of patent parasitaemia in any one animal of 
the group did not develop immunity though with another 
drug, samorin, they developed immunity.
Smith (1958) treated 6 cattle at two monthly intervals 
with 7 inoculations of T.congolense parasites and 
quinapyramine chemotherapy. The animals were resistant to 
re-infection when they were rechallenged with 16 ED^q of
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the same strain of trypanosomes 6 months after the last 
immunizing treatment. 2 of the 6 animals developed drug 
resistant infections. Soltys (1955) carried out a detailed 
study of resistance to T.congolense developed in cattle 
exposed to natural and artificial infections. He showed 
that when animals were kept continuously in enzootic areas 
and received prophylactic injections of antrycide every 
two months for 46 months, all the animals survived without 
giving a trypanosome positive blood or gland smear. When 
the prophylactic treatment only lasted for 28 months, 3 out 
of 6 animals died within 3 months of the last dose of 
treatment. If the animals received treatment for 28 months 
while in the enzootic area and were then transferred to an 
area free from tsetse flies for 10 months, 4 out of 6 
survived and resisted re-infection when returned to the
enzootic area. When the surviving animals from the three 
experiments were infected artificially with T.congolense, 
they were all resistant. Though the control untreated 
animals revealed complement fixing neutralizing antibodies 
when they were infected, only low titres of complement 
fixing antibody were detected in the drug treated group.
The author suggested that the results proved the fact that 
resistance to T.congolense infection can be acquired by 
cattle prophylactically treated with antrycide pro-salt 
and exposed during and after treatment to T.congolense 
infection in an enzootic area. Once resistance to 
T.congolense has been acquired it can last for a considerable 
time even in animals no longer exposed to constant infection. 
W h i t e s i d e  (1962) treated naturally occurring trypanosome 
i n feotions (T.vivax and T.congolense) in three
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groups of cattle with berenil, auinapyramine sulphate or 
ethidium bromide, and found that the duration of the 
protection was much longer than the protective effect of 
the individual drug. This according to the author was due 
to the immune response of the host. The protection oeriod 
increased with the use of the long protective drug. The 
author assumed that the prophylactic period consisted of 
two parts, one due to the drug and independent of 
trypanosome challenge, the other added to it and was due to 
the immune response of the host, which may be antigenically 
stimulated.
Soltys (1957, 1959) was able to show the importance of 
immunity during the drug treatment of trypanosomiasis. 
Strains of T.brucei, when passaged through rabbits, after 
4 weeks of infection, became more and more virulent. Sera 
from infected rabbits failed to neutralise either the 
homologous or heterologous variants, but were able to 
neutralise the parent strain. He claimed that he identified 
an "antibody resistant" strain. Soltys (1959) demonstrated 
that the"antibody resistent" strain of T.brucei was less 
sensitive to suramin and antrycide than the sensitive 
strain. When both strains were exposed to suramin and 
antrycide in vitro, "antibody resistant" strains needed 
50 times more drug than the sensitive one in order to make 
them non-infectious to mice. Also, the rabbits treated 
prophylactically with suramin or antrycide resisted 
challenge with antibody-sensitive strains for a much longer 
period than challenge with the other stock. In therapeutic 
experiments in mice, the antibody resistant strain 
required three times as much drug (0.3 mg/20g) as the
antibody sensitive parasite. Against this, a drug- 
resistant strain of" T . brucei produced by subcurative 
treatment, was as sensitive to the antibody as the parent 
strain. This, according to the author, confirmed the 
existence of combined mechanisms of drug and the 
immune defenses of the host.
Jancso and Jancso(1934) treated splenectomised and 
intact control mice infected with T.brucei by using a 
trypanocidal styryl-quinoline compound (2-p-acetyl-amino- 
styryl-6 dimethyl aminoquinoline methosulphate). Treatment 
of splenectomised mice both with border line doses and with 
doses which would normally effect a permanent cure, 
invariably led to an early re-appearence of the trypanosomes. 
The authors suggested that the parasites which managed to 
escape the immediate deleterious action of the drugs were 
killed by the host immune responses in intact animals, but 
relapses occurred in the splenectomised mice. However, 
according to Bauer (1958), berenil treatment of T.congolense 
infections was equally effective in intact and splenectomised 
mice.
S c h n i t z e r  et a l . (1946) demonstrated tha t  drug 
resistance to T .eauioerdum could be obtained w ithin 5-15 
days in s plenectomised mice though it took 100 days in 
intact mice. But, if immune serum was given, together with 
the drug, to the infected splenectomised mice, there was no 
development of resistant strains. In their experiment, one 
could see that the combined effects of drug an d  antiserum 
on T . e o u i w e r d u m  infection in splenectomised mice were far
superior (cured finally) to those of either drug or serum
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alone. Though the authors did not bring out this fact, 
the antibody seemed to supplement the effect of the drug.
Muntiu et al. (1961) have clearly shown the important 
role of immune mechanisms in the drug treatment of 
trypanosomiasis. They demonstrated that when rats were 
lethally irradiated (death occurring in 8-17 days) this 
did not influence the course of infection with a virulent 
strain of T.brucei. Hyperplasia of the spleen which normally 
occurred in the course of the infection was, however, 
inhibited. A dose level of neoarsphenamine which cleared 
the normal rats infected with this strain of T . brucei was 
without effect in rats which had previously been irradiated.
Another aspect of immunity in relation to chemotherapy 
is the combination of drug and antiserum in the treatment 
of American trypanosomiasis. Seneca and Peer (1963^.8) 
demonstrated that, by the use of hyperimmune rabbit serum 
in combination with furaltadone, there was 100# survival of 
mice infected with a lethal strain of T.cruzi. Animals 
treated with furaltadone alone had a survival rate of 86.7#. 
Though the results are not significantly different, there 
is some indication as to the superiority of the combined 
treatment.
j. Sporozoa
There has been a great deal of work on chemotherapy 
ind on immunology of malaria, but very little on the 
Interactions of the two (Peters, 1970a). There is however 
some published work on the development of immunity after 
suppressive chemotherapy. Afridi and Rahim (1959)
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followed the effects of mass chemotherapy with a single 
dose of pyrimethamine (25 mg) to adults, before the onset 
of the malaria season, in 3 villages in Pakistan. Spleen 
and parasite rates in the 3 treated villages fell and 
remained low for another two years. But later, Afridi and 
Rahim (1962) used twice as much drug (50 mg) in a similar 
study, with the hope of eliminating the small amount of 
transmission persisting, but instead of this a major break­
through of malaria occurred in the test villages. Perhaps 
the higher dose of drug removed all the parasites and as a 
result immunity in the population began to fall. Desowitz 
et al. (1966) also studied the effect of DDT spraying and 
chemotherapy in New Guinea. In Maprik, twice yearly spraying 
and-mass drug administration (chloroquine 125 mg/pyrimethamine 
25 mg) was used. After 4 years the control measures had 
resulted in a marked decrease in malaria rates associated 
with a higher than average antibody titre. In the Trobriand 
Islands, with me so to hyperendemic malaria, DDT was sprayed 
twice a year and chloroquine/pyrimethamine was given monthly 
for 5 months followed by camoquine/primaquine at 3 monthly 
intervals. This caused a reduction of transmission of 
malaria and the virtual disappearance of detectable antibody. 
The authors concluded that the campaign employing intensive 
and conservative therapeutic regimes caused the entire 
population in the Trobiand Islands to become immunologically 
sterile within four years or less.
Sergent and Poncet (1956) showed that P.berghei infected 
rats treated with nivaquine (chloroquine) during the first 
attack or later in the infection developed resistance to
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reinfection. However, when mice infected with P .berghei 
were treated with nivaquine the mice survived the primary 
attack but relapsed and all died. Carrescia and Arcoleo 
(1957) planned to promote the development of immunity 
against P.berghei by treating infected mice with small 
doses of chloroquine ( 5mg kg  ^body weight) administered 
subcutaneously during the primary attack and at each 
relapse, so as to prolong the infection. Although some of 
the mice were susceptable on challenging they managed to 
show a certain degree of immunity, long latent period, 
spontaneous recovery after infection, low grade parasitaemia 
and a great number of negative cases in the experimental 
group.
" These suppressive chemotherapy experiments of malaria 
infections show that aggressive mass suppressive chemotherapy 
will reduce the communal immunity of the people (Afridi 
and Rahim,1959, 1962, and Desowitz et al.,1966). In 
laboratory experiments, the situation depends on the host 
parasite system. In a self—resolving infection system 
(rats infected with P.berghei) treatment given in the late 
or early stage of infection will give immunity (Sergent 
and Poncet,1956), but in fatal infections (mice infected 
with P.berghei) prolonged suppressive chemotherapy is 
necessary for survival and development of immunity (Carrescia 
and Arcoleo,1957 and Cox, 1958). If suppressive chemotherapy 
is given just to suppress the primary attack, the animal 
will relapse and die (Sergent and Poncet, 1956 and Cox, 1958) 
irrespective of the day of treatment.
There are also some experiments on the development of 
immunity after curative treatment of malaria. Gingrich 
(1948) demonstrated the persistence of immunity to 
P .cathemerium in canaries in which the infection had been 
eradicated by treatment with curative drugs. This immunity 
which persisted for as long as 6 months, was demonstrated 
by the lower parasitaemia in challenged birds as compared 
to that of the controls, since the infection is a self- 
resolving one. Coggeshall (1938) and Meier and Coggeshall 
(1944) demonstrated that immunity persisted for as long as 
a year in monkeys in which P.knowlesi infection had been 
cured by treatment with sulphonamide. Treatment started 
before 5 days of the infection was not sufficient to 
protect the monkeys from death after a challenge.
Brown and Hills (1974) demonstrated two types of 
antibody in chronic infections of P.knowlesi in monkeys, 
produced by drug treatment. The two antibodies include a 
non-protective type capable of inducing antigenic variation 
which correlates with schizont infected cell agglutination 
(SICA) antibodies and a parasiticidal opsonizing type of 
antibody. According to Brown and Hills (1974) opsonizing 
antibodies are always found with SICA antibodies, but 
SICA antibodies may be found when opsonizing antibodies 
are not detectable, for example in monkeys cured by drugs 
of a primary parasitaemia or sensitized with freeze-thawed 
schizont-infected cells in Freund's incomplete adjuvant.
In vitro studies show the inhibiting antibody 
Was supposed to act against merozoites, whereas 
SICA antibody was directed against the altered surface 
membranes of erythrocytes containing schizonts (Butcher and
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Cohen, 1972). But Miller et al. (1977) tried to correlate 
the in vitro inhibition of merozoites and the resistance to 
reinfection in vivo in 3 rhesus monkeys cured of P.knowlesi 
infection. No correlation was obtained between the in vitro 
SICA antibody titre and the in vivo immunity or the merozoite 
agglutination titre and the resistance to reinfection.
Gilbertson et al. (1970) treated 10 P.berghei infected 
mice with intramuscular injections of 20 mg kg-1 chloroquine 
for 5 days starting from day 3 of the infection. 4 animals 
recrudesced and died. The remainder were challenged 20 
days after the parasites had disappeared from the blood.
All developed characteristic infections and died within.
14 days. But prolonged suppression of infection (90 days) 
with milk diet resulted in a certain amount of immunity.
So the authors concluded that a short high parasitaemia was 
not enough to promote measurable resistance and they thought 
that the duration of the first infection was important as 
well as the density.
Waki (1976) repeatedly immunized and cured white mice 
infected with' P.berghei with 4 consecutive doses of 
sulphamonomethoxine of 20 mg kg“1 per day starting from 
day 3 of the infection. According to the author, protective 
immunity depends on the repeated infections and chemotherapy 
but does not attain very high levels after a single 
infection and treatment. However, Eling and Jerusalem 
(1977) showed that mice infected with P.berghei and 
treated with sulphathiazole developed immunity. The 
degree of immunity was related to the number of surviving 
in the host which was inversely proportional toparasites
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the amount of drug administered. Too much drug diminished 
the development of immunity. Multiple infections during
drug treatment promoted better immunity. Cox and Turner
(1970) have shown by various serological methods that 
though P .vincke i infection in mice was terminated after 
5 days with chloroquine, the IgG and Igl.I concentrations 
in serum increased rapidly in the first 8-10 days after 
infection, then IgJJ decreased and IgG continued to rise. 
Also Waki and Suzuki (1974), by using the indirect 
fluorescent antibody technique, showed that IgM and IgG 
antibody titres reached a peak in 7-9 days and then 
declined after P.berghei infection in mice. But when the 
infection was terminated by chemotherapy on days 3-6, IgM 
antibody levels peaked at day 6 and then declined to 
undetectable levels by day 27, whilst specific IgG levels 
reached a maximum on day 13 and were still detectable on 
day 342.
Waki and Suzuki (1974) also showed that when mice 
treated with sulphamethoxine were challenged with either 
10^, 10^, 106, or 107 parasitized red cells 12 days after 
the last dose of drug therapy, none of the mice survived the 
challenge.
Box and Gingrich (1958) also demonstrated immunity in 
P.berghei infection in mice after curative treatment with 
primaquine diphosphate starting on day 6 of the infection.
14 out of 20 mice survived uoon rechallenge, though none 
survived in the challenged controls. The duration of 
immunity was found to be at least 3 months. Mice which
had been splenectomised after being cured, on the other 
hand, were not able to survive the challenge infection 
though they survived longer than the challenged controls.
Corradetti (1936) treated 15 patients suffering from 
general paralysis of the insame (syphilis) and infected 
with P .vivax followed by treatment with quinine in three 
different ways. Five were treated after the first attack, 
five others after the fifth attack and the last five after 
the 10th attack of fever. He followed the blood films 
for a period of 12 months* He showed that treatment after 
the first attack resulted in more frequent relapses than in 
the other groups. He argued that if immunity was to be 
maintained the treatment should be delayed, though from the 
point of view of the patient the treatment should start as 
early as possible.
The resistance to reinfection after the curative drug 
treatment in malaria seems to depend on the timing of treatment 
after infection, the later the treatment the better is the 
immunity (Corradetti, 1936; Coggeshall, 1938; Meier,
1944 and Box and Gingrich, 1958) and also on the 
immune system remaining intact (Box and Gingrich, 1958).
Some experiments in the past show the effect of treating 
malaria infections of hosts in different immunological 
states. Yorke and MacFie (1924) treated 105 cases of 
general paralysis of the insane infected with 
P.vivax with quinine plus salvisan or quinine alone.
According to these authors the infections were cured easier
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than in their* previous experience of treating l’.vivax 
infection alone during the war. However they did not 
consider the possibility of different strains of parasite. 
They suggested that "quinine given to a patient whose 
blood contains numerous malaria parasites invariably 
destroys directly, or more probably indirectly, large 
numbers, but not all, of the parasites, thus setting free 
a considerable quantity of soluble antigen. The antigen 
provokes by stimulation of the host's tissues the formation 
of ' immune-body' . The ' immune-body' , if present in 
sufficient amount, destroys the remaining parasites, thus 
resulting in sterilization of the infection and in cure of 
the patient". Taliaferro (1948), Taliaferro and Kelsey 
(1948) and Taliaferro and Taliaferro (1949) did a series of 
studies on the effect of quinine on P . gallinaceum in intact 
and splenectomised chickens. Though the quinine blood level 
was increased and prolonged in the splenectomised chickens, 
the parasitaemia level and the mortalities were higher 
than in the intact treated controls. According to these 
authors auinine and the spleen act independently in 
suppressing the infection. They also showed that a greater 
suppression of malaria occurred with the same dose of 
quinine in animals previously immunized with P.loohurae 
(which gives a slight cross immunity with P.gallinaceum). 
Acquired immunity was not necessary for the efficient action 
of quinine, but quinine predominently inhibited parasite 
reproduction whereas acquired immunity killed the parasites. 
Acquired immunity was thus necessary to prevent relapse when 
the drug was stopped. The same authors found no evidence 
that immunity makes the drug more effective nor that the
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drug stimulates antibody production or phagocytosis.
Elko and Cantrell (1970) studied the colloidal carbon 
clearance time in amodiaquine or chloroquine treated rats 
infected or uninfected with p .berghei together with the 
untreated controls. They drew the same conclusion as others 
that chemotherapy and phagocytosis are independent factors 
in suppression of P.berghei malaria.
4. Cancer
The most significant developments in the study of 
co-operation between immune mechanisms and chemotherapy 
have come from cancer research. Some results which 
influenced the planning of my experiments, or which seem to 
be particularly related to control of protozoal diseases 
are described here.
Carter et al. (1973) have shown that the successful 
treatment of Gardner lymphosarcoma of mice with L-aspariginase 
was dependent on the host's immune response. In 
imrnunologically intact animals, solid cutaneous grafts of 
the tumeurs disappeared completely following a single 
intraperitoneal injection of L-aspariginase. However, the 
same treatment in T—cell deprived mice caused the tumour 
to regress initially but leaving a residue of surviving 
tumour cells, which killed the animals with local and 
disseminated lymphosarcoma later. The recurrent tumours 
were invariable aspariginase—resistant. The authors 
beleived that L-aspariginase destroyed the sensitive tumour 
cells while the romaining aspariginase-resistant cells were 
destroyed in the intact host by the immune response.
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O'Neill et al. (1975) have shown in vitro that when C3H 
mouse thymocytes were incubated with anti- C3H serum with 
chlorambucil or with antiserum plus chlorambucil, the 
combination of antiserum and drug was more toxic than the 
drug alone; antiserum itself being non—toxic. Davies and 
O'Neill &972S)linked chlorambucil to antibody and using the 
mouse theta antigen system in vitro, they could show both 
antibody specificity and drug activity in the complex.
When such drug plus tumour-specific antibodies were tested 
in vivo the effect on the tumours was much greater than 
using either drug or antibody alone. However this effect 
was not due to the antibodies carrying the drug to the 
tumour target since the best effect was obtained when 
antibody was given after the drug. They thought that 
antibody will kill cells previously affected by chlorambucil 
but that antibody-affected cells are not more sensitive to 
the drug. In contrast, Rubens (1974) believed that antibodies 
directed against cell surface antigens rendered those cells 
more susceptible to destruction by certain cytotoxic agents. 
Rowland et al. (1976) suggested that antibodies can act as 
specific carriers for cytotoxic agents provided they are 
covalently bound; physically adsorbed antibody/drug mixtures 
rapidly dissociate under in vivo conditions. Ghose et al. 
(1972) have also shown that chlorambucil bound to antibody 
was much more effective against a mouse lymphoma and a 
case of human malignant melanoma than the drug given alone. 
According to the authors the sensitization of tumour cells 
to ionizing radiation and cytotoxic drugs brought about by 
surface localizing antibodies or antibody-mediated selective 
concentration of cell-damaging agents in tumour tissue, or
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both, was the probable explanation. Davies (1974) and 
Davies et al. (1974) have shown that, when treatment with 
drug was combined with antibody against mouse lymphoma, 
much greater protection was obtained than with drug or 
antibody alone. This was applied to drugs like melphalan, 
nitrogen mustards, cytosine arabinoside, chlorambucil and 
cyclophosphamide. Davies and O'Neill (1974) 
tested the effectiveness of a covalently linked complex 
of an alkylating agent and tumour specific antibody (DRAC) 
in protecting mice against the growth of EL4 lymphoma. 
According to these authors, DRAC (drug-antibody complex) 
behaved in vivo like a 'poisoned arrow', i.e. the antibody 
carried the drug to the tumour cells which were then killed. 
The DRAC effect was better than that of either drug or 
antibody given alone. The authors said that the drug 
antibody complex was more effective than drug and antibody 
given together without being linked. Following the in vitro 
and animal experiments, attempts were made to treat cancer 
patients with combined drug and antibody regimes. Newman and 
Ford (1977) treated 32 patients suffering from bronchial 
carcinoma with a drug/antibody combination (not covalently 
linked); and another 32 patients with drugs alone. All the 
patients had previously undergone surgery and the antiserum 
was raised in goats by immunizing with removed tumour cells. 
Although the differences were not statistically significant 
there have been 22 recurrences including 15 deaths after 
drug alone and 8 recurrences including 6 deaths in the 
combined group. Everall et al. (1977) treated 4 patients 
with widespread metastatic melanoma with chlorambucil and 
xenogeneic anti-melanoma immunoglobulin. Though there
weie not drug and immunoglobulin alone treated controls, 
the authors suggested that all the 4 patients lived beyond 
the expected median survival-time for their particular 
combination of metastasis.
Gregoriadis (1977) in his review article on "Targeting 
of drugs", pointed out the difficulties associated with 
the antibody carrier approach. According to him, the 
difficulties will be the isolation of target specific 
antigens for the production of antibodies and the purification 
from these of immunoglobulin molecules specific for the 
antigen. In addition, drugs attached to immunoglobulins 
may mask the antigen recognition site of the protein or 
alter its tertiary structure and render it prone to rapid 
removal by the reticuloendothelial system. The question of 
whether the immunoglobulin-drug complex will allow the 
active moiety (drug) to perform its task must be solved. 
Severance of the bond between carrier and agent may be 
necessary. Other difficulties include inhibition of 
immunoglobulin-antigen (target) interaction by circulating 
antibodies raised by the host against the antigen and also 
the possibility of allergic reactions to the carrier itself.
Ill MATERIAL AND METHODS
a. Mice
Female inbred CBA/lac- mice were used for most of the 
experiments. The mice were bred at the Winches Farm Field 
Station of the London School of Hygiene and Tropical 
Medicine and were used for experiments when 6-8 weeks old 
(l8-20g). One batch of CBA/lac mice was obtained from the 
Chester Beatty Cancer Research Institute. Male TO Swiss 
Albino mice were used for the drug sensitivity testing. 
They were obtained from commercial breeders and were 6-8 
weeks old (20-25g) when used.
The mice were housed either in small cages (groups of 
5-6 mice) or in larger cages (8-10 mice/group) . They were 
all kept in the same centrally heated room with the 
temperature ranging from 17°C to 22°C and humidity 42# to 
61#.. They were fed on Dixon 66 diet and given water ad lib
b. Rabbits and guinea-pigs
Albino rabbits weighing 2-3 kg and guinea-pigs of 
150-200 g were used. They were obtained from commercial 
breeders. They were caged singly and fed on Dixon RGP 
diet and given water ad lib.
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2. Strains of Plasmodium
a. Plasmodium chabaudi
Two C57B1 mice infected with P .chabaudi 35AS2 (stahilate 
314) were kindly supplied by Dr David Walliker of the 
Protozoan Genetics Unit,. University of Edinburgh. This is 
a clone and is sensitive to pyrimethamine and to chloroquine. 
The donor mice were bled and the parasites stored in 
capillaries, under liquid nitrogen as stabilate LUMP 1156 
(Lumsden et al.,1973) in the WHO cryopreservation bank of 
the Department of Medical Protozoology, London School of 
Hygiene and Tropical Medicine.
b. Plasmodium berghei
P ..berghei NK65 was also supplied from Edinburgh 
(stabilate 293). It is also sensitive to pyrimethamine 
and to chloroquine but is not a clone. It was stabilated 
as LUMP 1150.
3. Cloning and maintenance of -parasites 
a. Cloning techniques
Clones of P.berghei MK65 were prepared according to the 
method used by Carter and Walliker (1975). Five CBA mice 
were- infected from two capillaries of LUMP 1150. When the 
parasitaemia was still below 2* one donor mouse was chosen 
in which at least 90$ of the infected red cells contained 
single parasites. The blood was diluted in solution A(Lumsden 
et al., 1973 ) until there was an average of 5-7 parasites
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per ml. of diluent. 0-1 ml aliquots were then injected 
intravenously into 10 CBA mice. The mice were examined 
daily until some of them became parasitaemic. The dilution 
and inoculation process was repeated and: blood was 
then stabilated in a large number of capillaries (150).
b. Cryopreservation
CBA mice with parasitaemia levels of 10-20# were bled 
by cardiac puncture into a 2 ml sterile syringe containing 
5 units of heparin.. The blood was then mixed with glycerol 
to a final concentration of 7.5# and was distributed with 
a 1 ml syringe into sterile capillaries. Both ends of 
each capillary were flame sealed, and the tubes were placed 
in a labelled holder and kept overnight in a deep freeze at 
-70°C. Next morning the stabilate was transferred to a liquid 
nitrogen container for permanent storage.
4. Infection and monitoring of parasitaemia 
a. Preparation and staining of blood-films
Two thin films of tail blood were made on each 76 x 25mm 
microscope glass slide. The films were dried quickly by 
means of a fan, fixed with methanol and stained with a 10# 
solution of Gierasa (Hopkin and Williams Ltd.) in buffered 
distilled water of pH 7.2 (16.716 Na2HP0^#2H20 + 2»72g KI^PO^ 
in one litre of distilled water) for 40-50 min in perspex 
staining plates (Lumsden et al..L973). The slides were then 
washed under tap water and allowed to dry.
b. Parasite counting
The stained blood film was examined under the oil 
immersion (x 100) objective of a Wild M20 microscope. The 
average number of red blood cells in each microscope field 
with a uniform covering of cells was an estimated 400. The 
number of parasitised red cells seen in 20 fields or the 
number of fields in which 50 infected cells were found, 
whichever was reached first, was determined and the result 
was expressed as a percentage of the total number of RBC 
scanned.
c. Red blood cell counting
The blood to be examined was diluted 1:200 with 
formol-citrate solution (1$ formalin + 3-3 g/1 trisodium 
citrate solution) in a red cell pipette. The diluent was 
then introduced into a counting chamber with an improved 
Neubauer ruling. The number of erythrocytes was expressed 
in millions per ml of blood.
d. Preparation of infective inocula
The contents of one capillary of the required stabilate 
was mixed with 0.6 ml of chilled solution A and injected 
intrapsritoneally in 0.2 ml aliquots into 3 donor mice.
When the parasitaemia reached 10—20?», the mice were bled 
from the heart into a syringe containing 4 units of heparin 
for each mouse. The blood was pooled and the parasitaemia 
and red cell counts were made. The blood was then diluted 
accordingly with solution A to provide the number of 
infected cells required for infection^ Lumsden et al.,1973).
e. Reticulocyte counting
blood films were prepared on cleaned glass slides 
coated with 0.3% brilliant cresyl blue in 95# ethyl alcohol 
They were air—dried and then incubated in a moist chamber 
for 5-10 minutes, air-dried again, fixed with methanol and 
stained in Giemsa solution (Viens et al.,1971) . With this 
method, malaria parasites together with reticulocytes can 
be seen and counted. Reticulocytes were recorded as a 
percentage of the total number of red blood cells.
f. Concomitant infections
To lessen the chances of bacterial infections, the 
CBA/lac mice were given aureomycin (Cyanaraid, England) in 
their drinking water (0.02# solution of powder) until they 
were weaned. To ensure that the animals were free from
Eperythrozoon coccoides or Haemobartonella murls, random 
samples from new stock mice were splenectomised and their 
blood films were stained with Giemsa and examined on 
alternate days for two weeks. Malaria infected control 
groups of mice were also examined for evidence of undue 
scattering of their parasitaemias which might reflect a 
concurrent infection.
No evidence of Eperythrozoon or
Detection of subpatent parasitaemias
(i) Splenectomy
The mouse was anaesthetised with ether and the left side 
l! marginal area was shaved. The mouse was positioned
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e . Reticulocyte counting
Thin blood films were prepared on cleaned glass slides 
coated with 0.3$s, brilliant cresyl blue in 95$ ethyl alcohol. 
They were air—dried and then incubated in a moist chamber 
for 5—10 minutes, air—dried again, fixed with methanol and 
stained in Giemsa solution (Viens et al.,1971) . With this 
method, malaria parasites together with reticulocytes can 
be seen and counted. Reticulocytes were recorded as a 
percentage of the total number of red blood cells.
f. Concomitant infections
To lessen the chances of bacterial infections, the 
CBA/lac mice were given aureomycin (Cyanamid, England) in 
their drinking water (0.02$ solution of powder) until they 
were weaned. To ensure that the animals were free from 
Eperythrozoon coccoides or Haemobartonella muris, random 
samples from new stock mice were splenectomised and their 
blood films were stained with Giemsa and examined on 
alternate days for two weeks. Malaria infected control 
groups of mice were also examined for evidence of undue 
scattering of their parasitaemias which might reflect a 
concurrent infection.
' No evidence of Eperythrozoon or Haemobartonella infections 
was ever seen.
g. Detection of subpatent parasitaemias 
(i) Splenectomy
The mouse was anaesthetised with ether and the left side 
costal marginal area was shaved. The mouse was positioned
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on a cork board with its left flank uppermost. The front 
limbs were held together with one paper clamp and hind 
limbs with another. Both clamps were attached to rubber 
bands which were secured by pins. After cleaning the shaved 
area with 70$ alcohol an incision of 1 cm in length was 
made over the spleen, which was visible through the body wall. 
The spleen was held with blunt forceps and its vessels 
ligated with cat gut. The spleen was removed after cutting 
the stalk and the peritoneum and abdominal skin were closed 
with suture clips.
(ii) Blood and tissue passage
The mouse to be tested for the subpatent parasitaemia 
was deeply anaesthetized with ether and pinned down on a 
cork board. Through the anterior approach, the thoracic 
cavity was cut open and the blood was sucked from the left 
ventricle into a two ml syringe containing 5 units of heparin 
in 0.1 ml of PBS. Depending on the size of the mouse 1 ml 
to 2 ml of blood was obtained in this way and was injected 
into two young mice.
The spleen, kidneys and liver were also removed. The 
cells were collected by crushing the individual organ in a 
fine wire mesh with the help of a small test tube and were 
flushed through the sieve with chilled TC 199 (10$) solution. 
The cells collected from each organ were injected into two 
uninfected young mice as before. Blood films were taken 
twice a week from the mice for at least 2 weeks and were 
examined for the presence of malaria infection.
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B. T-cell deprivation of mice
. Two methods were used. Dr E. Leuchars, Chester Beatty 
Research Institute, introduced me to the method of adult 
thymectomy, irradiation and syngeneic hone marrow 
reconstitution. This method produces excellent T—cell 
deprivation. (Davies, 19691 Doenhoff et al.,1970: and Parrott 
at al.,1970). In later experiments T-cell deprivation was 
carried out by adult thymectomy and antithymocyte serum (ATS) 
treatment. Since an irradiation source was not readily 
available and because this method also provides good T-cell 
deprivation (Lance 1970; Doenhoff, unpublished data) it 
was used in most of the experiments.
1. Thymectomy
The method of adult (6-8 weeks) thymectomy is used 
routinely in the Immunology Laboratory of the Edna McConnell 
Clark Schistosomiasis Research Unit at Winches Farm and is 
based on that of Kaplan (1950), Killer (I960) and Leuchars 
( 1966) .
The mouse was anaesthetised with ether and stretched 
out ventral side uppermost on a cork board with its limbs 
attached to paper clamps, connected to rubber bands. The 
neck was also stretched by a wire loop hooking over the 
upper incisors and pinned down. A bandage roll of 2 x 4  cm 
was placed under the shoulders. After swabbing with 70# 
alcohol a mid-line incision was made in the skin from 1 cm 
below the chin to approximately the level of the third rib.
small blunt forceps, the salivary glands wereUsing two
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separated from the median fissure until the trachea and its 
fascia was exposed. A wedge shape incision, 3-4 nun long 
was made on the manubrium sterni with small blunt scissors 
and was removed carefully. Then the fascia overlying the 
trachea was pinched and cut out as a rectangular piece 
about 3 mm wide and extending as far down the thoracic 
opening as possible.
Slight pressure was applied below the diaphragm, to 
bring up the thymus and to minimise the pneumothorax.
Using a Pasteur pipette with a diameter of 2-3 nun (i.e. 
slightly smaller than a lobe of the thymus) and connected 
to a negative pressure vacuum pump with a pressure of 
600 mm Hg, the thymic lobes were sucked out one at a time. 
The front limbs were freed, the roller bandage removed and 
the incision was closed with No 7 Michel clips by means of 
an Auto—clip applier (Clay—Adams, Inc. N.Y.).
The mortality rate was les6 than 5$. deaths being due 
to over anaesthesia, pneumothorax and haemorrhages.
Sham thymectomy was carried out in a similar way but 
without removing the thymus.
2. Anti-thymocyte serum (ATS)t preparation and use
ATS was prepared in albino rabbits by injection of 
thymocytes from 3-4 week old CBA/lac mice (Levy and Kedewar
1966).
Twelve 3-4 week old CBA/lac mice were killed by 
cervical dislocation. The thoracic cavity was cut open
A
109
through the anterior approach. Without rupturing the 
auricles, lobes of each thymus were dissected out by means 
of forceps. The thymi were then rinsed and freed from 
blood and other tissues in a petri-dish containing chilled 
TC199 (10/) solution.
Thymus cells were pooled by crushing the thymus glands 
in a fine wire mesh with the help of a small test tube and 
were flushed through the sieve with chilled TC199 (10/) 
solution. The cells collected were washed three times in 
10 ml of TC199 (150 g x 10 min), then injected i.v. into 
a rabbit after resuspending in 10 ml of TC199 (10/0 solution. 
The whole process was repeated after two weeks. One week 
later, the rabbit was killed and bled from the heart. The 
serum obtained was inactivated at 56°C for 30 min and then 
stored in a deep freeze at —20°C in 5 ml vials. A single 
bleeding from a rabbit ensured greater homogeneity in the 
potency of ATS than multiple bleeding and yielded about 
80 ml serum.
The ATS was given subcutaneously in two schedules.
In some experiments ATS was given as 0.2 ml doses on three 
occasions within the 10-12 days after thymectomy (ATSX 
treatment). In other experiments, ATS was given as 0.25 ml 
doses on 4 occasions within a similar period (ATSg treatment).
3, irradiation and bone marrow reconstitution
Irradiation was carried out one week after thymectomy 
with the use of a Marconi type TK 4574 B irradiation unit 
(Middlesex Hospital Medical School). The thymectomized and
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sham-ape rated mice were housed in perspex boxes and were 
exposed to 55 rads/min for a total of 850 rads delivered 
unfiltered at a distance of 100 cm at 230 kV and 15 mA.
Bone marrow obtained from a syngeneic mouse was used 
for the reconstitution of irradiated mice. The donor mouse 
was killed by cervical dislocation and pinned down dorsally. 
After swabbing with 70# alcohol, an incision was made on 
both sides of the thigh from the knee to the middle of the 
lumbar vertebra. The muscle attachments were then freed 
with curved scissors. The femur was held with Michel clip 
forceps and the upper extremity of the bone was dissected 
out; the joint at the lower extremity could then be 
dislocated easily. The bones were placed in pairs in a 
petri dish containing a sterile filter paper soaked with 
TC 199.
A number 25 needle and a two ml. syringe filled with 
TC 199 was used to flush the marrow down from the cut 
trochanter end of the femur. The procedure was repeated 
twice or more until the bone was devoid of marrow. The 
same 2 mg of TC 199 was used for a pair of bones thus giving 
1.25 x 107 cells/ml. The bone marrow lumps were broken up 
by aspiration into a syringe using a number 25c needle. 
Irradiated mice were injected instantly with 0.4 ml of the 
cell suspension (5 x 106 cells/mouse). They were all kept 
on sterile water for 14 days and a standard diet supplemented 
with sunflower seeds. Mortality was less than 10#. The 
mice prepared were used 30 days after the irradiation.
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4* Tests for the effectiveness of the T-cell deprivation
a. Skin grafting
CBA/lac mice were T—cell deprived by thymectomy and 
ATSg treatment. They were then grafted with skin from 
Parke's mice as described by Billinghan and Medcuwar (1961). 
In the intact control mice (10)t graft rejection began at 
15 days and was complete by 19 days s median skin graft 
survival time was 18 days. In the thymectomy and ATS- 
treated group the minimum skin graft rejection time was 
34 days and the median rejection time was 46 days. Grafts 
survived in 4 out of 9 mice for up to 1-J- years (see fig 2 
P 112 )•
b. SRBC antibody response
Intravenous injections of 0.2 ml of 2tf> SRBC were given 
to the intact control and the T-cell deprived groups. The 
mice were bled from the retro-orbital plexus bi-weekly and 
the agglutination titre, haemolysin titre, 2-mercaptoethanol 
resistant titre (IgG) and 2-mercaptoethanol sensitive titre 
(IgM) were determined. As shown in Pig 1, the total 
agglutination titre, haemolysin titre and 2-mercaptoethanol 
resistant titre (IgG) were very much depressed in the 
T—cell deprived group of mice compared with those of the 
intact controls, (see fig 3 P "3 >• (Experiments 4a and b 
were performed by Mr. R. Musallam).
iFIGURE 2 The percentage of  AKR sk in-graf ts  surviv ing on T-cel l -depr1ved and in ta c t  
control mice
D A Y S  A F T E R  S K I N  G R A F T I N G
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C. Diet preparation and treatment
1. Diet preparation
Low protein calorie diet (4# protein and its control 
of normal protein diet (21# protein) were prepared 
according to the methods used in the Chester Beatty 
Research Institute and the Immunology Laboratory at the 
Winches Farm Field Station. The contents of the diets 
were as shown in the table below.
INGREDIENTS
Casein
NORMAL PROTEIN 
(21#) DIET
420 g (21#)
Dextrin Technical Yellow (BDH)
Corn Flour
Baato Agar (DIFCO)
Salt Mixture 
XIV (ICN)
Total Vitamin supplement (United States Biochemical 
Corporation)
C o m  Oil
Water
500 g (25#)
800 g (40#)
80 g (4#) 
80 g (4#)
40 g (2#)
100 mis (4#) 
2 litres
LOW PROTEIN 
(4#) DIET
80 g (4#) 
640 g (32#)
1000 g (50#)
80 g (4#) 
80 g (4#)
40 g (2#)
100 mis (4#) 
2 litres
The diet to be prepared was weighed out according to 
the above formulae in separate containers. The agar was 
dissolved in 1 litre of water in a container heated on an 
electric plate with continuous stirring. Casein, dextrin, 
c o m  flour and salts were mixed thoroughly in a bowl and 
again after adding 1 litre of water. The mixture was then 
added to the dissolved agar. This was stirred continuously
for about 10-15 mins until a paste was formed. The oil 
was then added and stirred until thoroughly mixed. Stirring 
was continued while the diet was allowed to cool down.
The vitamin supplement was added and mixed at 68°C as 
some are heat labile.
The diet was spread evenly on a shallow pan to a depth 
of about 1 to l£ inches and stored at 4°C overnight. The 
next morning it was cut into 2 x 2 ^  inch cakes and stored 
at -20°C until used.
2. Feeding schedules
CBA/lac female mice were randomly assigned to the diet 
groups as soon as they were weaned at 21 - 3 days (16-17g) 
after birth. PABA (Sigma) (0.05$) was added to the water 
to ensure that the mice were not deficient in PABA. The 
diets and water were given ad lib. The mice were fed on 
the diets and the water for 4 weeks before the experiments 
began.
The mice receiving 4# protein diet consumed less food 
than the mice on the 21$ protein diet. The reduction in 
the overall calorie intake in addition to protein restriction 
caused a significant weight loss in the experimental groups 
(Malave and Layrise,.1976).
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D. Drugs 116
1. Preparation and use
The three drugs used, chloroquine, quinine and 
pyrimethamine were all administered intraperitoneally (i.p.) 
using a 1 ml syringe and 25G- needle.
a. Chloroauine
Chloroquine was used as chloroquine sulphate injection 
form, commercially prepared as Nivaquine (May and Baker).
One ml contains 40 mg base. This was diluted with 
normal saline to give the dose required in 0.1 ml/10 g of 
mouse and was stored at 4°C.
b. Quinine
Quinine hydrochloride (BDH) was used. It was not 
easily soluble in water and so was dissolved in absolute 
ethyl alcohol (lg base in 0.8 ml). Distilled water was 
then added to give the required amount of the base of the 
drug in 0.1 ml/10 g body weight of mouse, and was then 
put on the magnetic stirrer until fully dissolved. Fresh 
solution was prepared for every experiment.
c. Pyrimethamine
Pyrimethamine BP 120U powder (Wellcome) v/as used.
This failed to form a stable suspension either in normal 
saline or in water even with the aid of Tween 80. A stock 
solution of pyrimethamine 25 mg/ml was prepared by 
homogenising with 0.55& methylcellulose and then was 
ultrasonicated for about 5 seconds twice and was stored 
at 4°C (Peters, 1975). The required working dilution
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was obtained by diluting the stock solution with methyl 
cellulose (0.5/i) to a dilution of the required dosage in 
0.1 ml/10 g of mouse. Since each mouse weighed 20 —3 g 
at the time of treatment it received the drug in 0.2 -0.03 ml.
2. Drug testing
a. Therapeutic tests
Therapeutic inoculations were given i.p. as daily doses 
for 4—14 days. Full details are included as part of the 
procedure for each experiment.
b. Suppressive tests
A 4-day suppressive test (Peters 1965a»b) was used to 
determine suitable dosages during initial experiments and 
to retest the drug sensitivity of relapse populations 
isolated after courses of treatment.
7Male TO mice were inoculated i.p. with 1 x 10 
infected erythrocytes of the required parasite and were then 
grouped randomly into 5 groups of 6 mice each. One group 
was kept as an untreated control group, the others were 
treated with different dose levels of a drug daily for 4 
days starting 3-5 hrs (day 0) after inoculation of the 
parasites. The drug dosages used were worked out from the 
50^ and 90fi effective dosages (ED^q , EDg0) previous 
work done by Peters (1967a, 1975).
The blood films were taken on day 4 and the mean 
erythrocyte infection rate of each group of mice was 
measured.
c. Calculations
i. Effective doses
The mean parasitaemia' of each treated group was 
expressed as a percentage of that of the control group.
The data were plotted on log-probit paper, the Y axis 
being the probit of suppression of parasitaemia and the 
X axis the total log dose of the drug used for 4 days.
Prom that, the drug dosages that reduced the parasitaemia 
by 5055 (ED^q ) and 9055 (EDgQ) were worked out and were 
expressed as a single daily dose in mg/kg.
ii. Index of resistance
When comparisons of drug resistance of parent and 
relapse strains were made, the 4-day suppressive test was 
carried out with both strains and an index of resistance 
(Ij-0 and I^q ) worked out according to the following 
formula (Peters, 1975) •
ED^q of drug against relapse strain
Index of resistance = -----------------------------------(I5Q) ED^q of druS against parent strain
iii. Mean survival time
Mean survival time Is calculated by dividing the total 
survival time in days by the number of experimental animals.
total survival time in days
Mean survival time * ---- - ------ -no. of mice
However the percentage increased survival time is 
calculated according to the following formula (Ott, 1969)»
•f. Increased / ~ ..survival time (days) _ijx 100
survival time "(mean survival time of controls (days)
E. Schistosoma mansoni infections
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1. Maintenance in the snails
Schistosoma mansoni (Puerto Rican strain) was 
maintained in Biomohalaria glabrata in the Schistosomiasis 
unit of Winches Farm Field Station. The infected snails 
were kept in glass aquaria at 24-26°C and in darkness to 
prevent shedding of cercariae. When required, the infected 
snails were stimulated to shed their cercariae by putting 
them into a beaker at 30°C and under a light source. The 
cercariae obtained were used within two hours. Single sex 
cercariae were obtained from snails infected with single 
miracidia. The sex of the worm was checked previously by 
infecting some mice and perfusing them.
2. Infection of mice with cercariae
Gercariae were concentrated in a millipore apparatus 
(XX1004704) using a filter of 8 ILm pore size. When the 
cercarial suspension was introduced into the apparatus, 
the cercariae migrated into the top 1 cm layer of water 
under the influence of an artificial light and the excess 
water was removed from below by means of a vacuum pump.
Mice were anaesthetized with 54 mg kg"1 of veterinary 
Nembutal (May and Baker 60 mg ml 1 diluted with normal saline). 
The abdomens were shaved and the mice placed on their 
backs between wooden strips, fixed to a base board. Nickel- 
plated brass rings (4- inch diameter by 3/8 inch high and 
H .5 g in weight) were positioned and secured with 1 inch 
wide cellotape on the abdomen. The cercarial suspension 
was stirred vigorously and pipetted into each ring. Twenty
\
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minutes was allowed for the cercariae to penetrate and the 
unahsorbed water was sucked out, the animals were returned 
to cages and revived under warm conditions.
3. Recovery of adult worms
The adult worms were recovered from the hepatic portal 
system and the liver by perfusion with heparinised citrate 
saline (sodium citrate 1.57*. sodium chloride 0.88$, heparin 
2 unit/ml) by a modification of the method described by 
Smithers and Terry 1965 (James and Taylor, 1976).
Each mouse was killed by intraperitoneal injection of 
about 10 mg of Nembutal (60 mg/ml containing 25 unit/ml of 
heparin) . This caused all the worms to lose hold on the 
walls of the blood vessels (Smithers and Terry 1965). The 
mouse was skinned, its abdomen and thoracic cavity were 
opened and the rib cage was removed.
The mouse was stretched on a vertical sheet of perspex 
by means of the two spring clips attached onto one hind and 
one fore limb.
The hepatic portal vein was cut, the perfusion needle 
(19G) was placed in the left ventricle of the heart and, 
by means of a 50 ml syringe, 20 ml of the perfusion fluid 
was injected forcefully and steadily. The perfused blood 
and fluid was collected in a 25 ml universal tube, allowed 
to settle for 10 min and the supernatent removed leaving 
the sediment of about 1 ml. The red cells were lysed with 
2—3 drops of saponin (2.5#)» "the fluid decanted into a 
Sedgewick-Rafter chamber, and the worms were counted under 
a dissecting microscope.
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P. Serology
1. Haemagglutination test
a. Antigen
Sheep red blood cells (SRBC) were obtained in sterile 
Alsevers solution in 25 ml bottles (Tissue Culture Services, 
Slough, Bucks) and were kept at 4°C and used within 14 days. 
The required amount of cell suspension was washed 3 times 
with 1 in 10 normal saline (0.9#) by centrifugation (lOOOg 
x 10 min).
b. Immunization of mice
• The red cells obtained after washing were resuspended 
in normal saline to give a 20# suspension. Mice given 
single immunization doses were inoculated i.p. with 0.2 ml 
of this suspension ( l x  10^ SRBC). Hyperimmunized mice were 
given the same initial inoculum; single doses were given on 
6 further occasions at intervals of 2 weeks.
c. Collection of anti-SRBC serum samples from mice
i. Bleeding from the retro-orbital plexus
Blood samples were obtained as described by Jay- 
awardena (1975). Each mouse v/as lightly anaesthetised with 
ether and its head was firmly fixed between the thumb and 
the fore-finger of the left hand, stretching back the skin 
to make the eye-ball protrude. The tip of a pasteur pipette 
was introduced to 1 or 2 mm depth into the medial canthus 
of the eye at an angle of 45°. The pipette was rotated 
slightly to puncture the venous plexus and then withdrav/n
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slightly to allow blood to flow into it.
The blood samples obtained were transferred to small 
disposable plastic tubes (3*5 x 0.5 cm). The serum was 
separated by keeping the blood at 37°C for 30 min and then 
at 4°C for 5 min. The clots formed were removed and the 
tubes were centrifuged at 1000g for 10 min.
The serum was sucked into capillary tubes, inactivated 
at 56°C for 30 min in a water bath and stored at - 20°C 
in labelled small test tubes until used.
ii. Heart puncture
Mice hyperimmunised with SRBC were killed and bled from 
the. heart. Serum was prepared from this and treated as 
described above.
d. Determination of agglutinin titres
The method used is as described by Scott and Gershon 
(1970). Doubling dilutions of 20>tl of each serum were 
made with normal saline in a haemagglutination plate.
The dilution and application of fluids were carried out 
with tl.e use of a compu-pet 100 machine (Div. Warner- 
Lambert Co.). 20 >¿¿1 of a 2* suspension of washed SRBC
in saline was added to all wells including controls 
containing normal saline alone. The suspensions were 
thoroughly mixed on a whirl mixer at moderate speed for 
30 sec.
The tray was covered with a transparent plastic oover 
and was incubated at 37°C for 1 to 2 hrs. The agglutination
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titre was read under a dissecting microscope. The end point 
was taken as the last well where there was visible 
agglutination. 20 1 of freshly prepared 0.82$ solution of
2-mercaptoethanol in normal saline was then added to each 
well and the suspensions mixed thoroughly by placing the 
tray over the whirl mixer. The tray was left overnight at 
room-temperature and re-read on the following morning. 
2-mercaptoethanol breaks the disulphide bond holding the poly­
meric units of the IgM together. The titre of 2-mercaptoethanol 
resistant antibody is due mainly to agglutination by IgG 
and the difference between titres obtained before and after 
treatment with 2-mercaptoethanol is a measure of 
agglutination due to IgM antibody.
2. Haemolysin test
a. Complement
Fresh complement was obtained by bleeding normal guinea- 
pigs from the heart without killing them. Two guinea-pigs 
were kept in stock and were bled alternately. The animal 
to be bled was anaesthetised with ether just enough to 
allow it to be handled. A 190 needle fitted to a 10 ml 
syringe was introduced into the right side of the heart 
through the right 3rd intercostal space and 10 ml of blood 
was withdrawn. Serum was prepared by allowing the blood to 
clot at 37°C. It was stored at -20°C and always used 
within a week. The serum was used as a 10$ solution in
normal saline
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b. D e t e r m i n a t i o n  of h a e m o l y s i n  titres
The serum to be titrated was inactivated as before at 
56°C and doubling dilutions were prepared in a haemagglutin- 
ation tray as described above. 20 of the fresh
complement (10$ guinea-pig serum) was added to all wells 
including the wells containing saline. 20JU,\ aliquots of 
a freshly prepared 2$ suspension of SRBC was added to the 
wells. The tray was covered and was shaken on a whirl mixer. 
After incubation at 37°C for 1 to 2 hrs, the titres were 
determined by examining the plate against a white background. 
The end point was taken when there was 50$ lysis of the SRBC.
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IV. EXPERIMENTAL PROCEDURES AND RESULTS 
A. Patterns of infection
1. P.chabaudi
&• Infections in different strains of mice
CBA/lac and Swiss TO mice were used in the experiments, 
i. CBA/lac mice
These have been used extensively throughout this 
study. A standard inoculum of 1 x 10^ infected red blood 
cells in 0.2 ml was given intraperitoneally. The parasitaemia 
followed a characteristic and reproducible pattern (fig 4a).
The infection is very synchronous and the parasites show 
a preference for the mature red blood cells and single 
infections of the host cells predominate, except in late 
infection. Both single and double chromatin dot nuclei 
are seen. The parasites appeared first in the blood on 
the first day of the infection. The parasitaemia then 
increased rapidly until daje 5-7 reaching a peak with 
30-50# of the red blood cells infected. It fell sharply 
between days 6-7 and the blood became aparasitaemic by 
blood film examination between days 17-20. Gametocytes 
became more frequent after the peak of infection, approximately 
10 days after the infection.
A second peak of parasitaemia was seen on days 26-27 
which lasted 2-3 days but reached a peak of less than 
0.5#. A further recrudescence of parasitaemia occurred 
between days 56-60 with the highest parasitaemia being
0.05#. Between these peaks, the parasitaemia 
was not demonstrable by blood film examination,
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fJ.G.u.RE .4b Mean percentage parasitaemias in TO mice after 
inoculation with 1 x 10^ P. chabaudi infected 
erythrocytes
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FIGURE 5 Mean percentage parasitaemias of male and female 
CBA mice after injection of 1 x 107 P. chabaudi 
infected erythrocytes
but infection c ould be obtained by sub-inoculation of 
blood to u n i n f e c t e d  mice. The parasites could be found 
by this m ethod up to one week after the last peak of 
parasitaemia.
ii. TO mice
A s  stated above S w i s s  Albino TO mice v/ere u s e d  only 
for the drug s e n s i t i v i t y  test i n g  (4 day test). The pattern 
of p a r a s i t a e m i a  in TO mic e  (fig 4b) was similar to those of 
CBA mice ( f i g 4 a  ).
b. Sex of mice
Most of the experiments were carried out on CBA/lac 
female mice but there were some experiments where male 
CBA mice were used. Parasitaemia in male and female mice 
were compared and were found to be similar (fig 5 ).
c. Size of inoculum
Groups of 5 CBA female mice were inoculated with 
serial ten-fold dilutions of erythrocytes infected with
A OP.chabaudi ranging from 10^ to 10 infected RBC and the 
parasitaemias were followed.
The latent period (pre-2# parasitaemia) was measured 
graphically (fig 6a) according to the method of Warhurst 
and Polwell (1968). When plotted again on a semilog scale 
(fig 6b) the relationship of the latent period and the 
inoculum was found to be linear, with an approximate slope 
of - 1.2 (i.e. a ten fold dilution of the inoculum 
prolonged the latent period by 1.2 days). The parasite 
increased ten fold in approximately 1.2 days and so

Table I Mean percentage parasitaemia and standard deviation of the data in Pig 6q(different inocula of P.chabaudi
infection used)
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FIGURE 6b P. chabaudi - relationship between the number 
of parasites inoculated and the latent period 
of infection
133
the growth rate in hours was 1/26.8 hours (Warhurst and 
and Polwell ,1968).
Apart from the delay in the latent period of the 
parasitaemia, the general patterns of the infection were 
the same in all the groups. The duration of the first 
peak of the infection was also similar though with the 
lower inocula parasitaemias tended to come down earlier 
to a lower level. There was no mortality in any of the 
groups.
d. Para-aminobenzoic acid (PABA) supplement in w a t e r
Dixon 86 diet was used for the mice throughout the 
experiments. To find out whether there was a requirement 
for PABA in the diet, two groups of mice were each inoculated 
with 1 x 107 infected erythrocytes of P>chabaudi and 
were kept one with 0.05# PABA in the drinking water and the 
other without PABA, and the parasitaemias were followed.
The group w i t h  PABA showed a more regular d i stribution of 
parasitaemia. There was no significant difference in the 
peak of the parasitaemias and the general patterns of 
p a rasitaemia were similar (fig 7 ). The parasitaemia  
tended to remain patent in between the first and second
peaks in the PABA supplemented group compared w i t h  the 
group without PABA.
This experiment showed that for most experiments the 
standard diet was adequate for the P.chabaudi infection 
without P A B A  supplementation.
134
Mean percentage parasitaemias in CBA mice 
inoculated with 1 x 10^ infected erythrocytes 
and given a standard diet with or without a 
supplement of PABA

Table II Statistical analysis of the data in Fig 8 a. (n=6)
s£ay
Group 1 2 3 5 7 9 12 16 19 22 24 26 29 35 41 47 50 53 57 61
Deprived Mean 0.2 0.7 4.4 47.0 33.0 10.0 17.0 27.0 24.0 34.0 22.0 25.0 21.0 30.0 33.0 21.0 2 3 .0 31.0 24.0 23.0
infected 3D - 0.1 0.4 1.8 12.0 10.1 2.5 5.1 6.2 3.5 4.6 7.8 5.2 4.3 2.8 3.8 4.1 3.1 5.1 6.2 7.0
Intact Mean 0 .16 C.8 5.6 4 0 .0 28.0 2.4 0.22 0.03 0.01 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.02 0.07 0.0
infected SD - 0.08 0.4 2.1 9.2 6 .4 1.1 0.1 0.02 0.01 • • 0.1 0.2 - - 0.01 0.03 0.0
Simifieanci
________ LP <
NS NS NS NS IIS 0.001 0.0C1 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001
*significance between the means of intact and deprived groups 
using student T test.
NS = not significant
FIGURE 8a P. chabaudi - mean percentage parasitaemias in T-cel1-deprived and intact control CBA mice
FIGURE 8a P. chabaudl - mean percentage parasitaemias in T-cell-deprived and intact control CCA mice
Deprived (Thymectomy + ALS)
Intact control
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e . Infection in intact and T-coll deprived mice
T-cell deprivation by thymectomy and ALS treatment
T-cell deprivation in this experiment was done by
adult thymectomy and ALS (2) treatment (stated pp. log
P .chabaudi infection was compared, in intact, sham-
deprived and T-cell deprived mice after the inoculation 
7of 1 x 10 erythrocytes.
In all groups (intact, sham and deprived) parasites 
were first detected in the peripheral blood on day 1 after 
infection (fig 8a). The early stages of the infection 
(prepatent period and growth) in deprived mice were 
comparable with those in both control and sham-deprived 
mice. After days 5-6 after infection the intact and sham 
groups of mice began to resolve their infections but the 
deprived group remained parasitaemic at a level of 20—30fî.
No deaths were recorded in any of the groups up to 120 
days after infection.
Ü .  T-cell deprivation by thymectomy, irradiation and bone 
marrow reconstitution
T-cell deprivation was done by thymectomy, irradiation 
and bone marrow reconstitution as stated and sham 
deprivation was done by sham thymectomy, irradiation and 
bone marrow reconstitution.
Parasitaemia patterns in the normal and sham groups 
were similar to the previous experiment. In T-cell 
deprived mice, tho parasitaemia increased very slowly and 
reached the maximum parasitaemia level of 52?t at day 32(fig )

Table III Statistical analysis of the data in Pip: 8b.- (n=6)
Group Dat^ v, 2 5 7 12 20 24 28 32 41 48 54 58 66
Deprived Mean 0.7 10.5 12.5 2 9 .0 38.0 4 0 .0 44.0 5 2 .0 12.0 13.2 23.0 38.0 29.0
infected SD 1 0.4 4.3 6.7 3.4 9.8 7.1 8.5 17.0 3.2 2.1 5.2 11.0 8.5
Intact Mean 0.8 26.0 38.0 0.5 0.0 0.0 0.05 0.0 0.0 0.0 0.0 0.02 0.0
infected SD - 0.3 V_* • CD 7.2 0.2 0.0 0.0 0.02 0.0 0.0 0.0 0.0 0.01 0.0
Sisnificance P irs 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001
Shaa Kean 0.85 20.0 31.0 0.2 0.0 0.0 0.09 0.0 0.0 0.0 0.04 0 .03 0.0
infected 3D - 0.5 7.2 5.4 0.1 0.0 0.0 0.03 0.0 0.0 0.0 0.02 0.02 0.0
Intact Mean 0.8 26.0 38.0 0.5 0.0 0.0 0.05 0.0 0.0 0.0 0.0 0.02 0.0
infected SD - 0.2 3.2 7.3 0.2 0.0 c.o 0.02 0.0 0.0 0.0 0.0 0.01 0.0
Significance P < KS IIS NS 0.01 NS NS NS IIS NS NS 0.001 NS NS
* see table II
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Though the parasitaemia resolved in the intact control group 
on day 19 the infection remained at above the 125* parasitaemia 
level in the deprived group. On days 5 and 7 the infection 
in the T-cell deprived mice was significantly (P 40.001) 
lower than in the normal and the sham groups. There was no 
mortality recorded up to day 120 of the infection.
2. Parasitaemia pattern of P.berghei
Much has been published on the infections of mice with 
P.berghei. Jayawardena (1975) has given a detailed account 
of P.berghei infection in CBA mice and TO mice, so I did 
not attempt to repeat this.
a. Infection pattern in intact and T-cell deprived mice 
i. T-cell deprivation by thymectomy and ALSg treatment
In intact CBA mice inoculated with 1 x 10' P.berghei 
parasitized erythrocytes, parasites were detected in the 
peripheral blood by day 1. Thereafter the parasitaemia 
kept increasing and proved uniformly fatal between days 
9-25. Terminal parasitaemia ranged from 50-65# (fig 9a).
In the T-cell deprived mice (adult thymectomy and ALS (1) 
treatment), the parasitaemia showed a broadly similar 
pattern of development but the mean survival time was 
25.8 ± 3.5 days, which was significantly (P 40.001) longer 
than that of the intact group (18.1 - 6.4 days). The 
parasitaemia in the sham deprived group (ALS treatment with­
out thymectomy). followed the same pattern as the intact 
group with a mean survival time of 20.4 - 2.-7 days (fig 9&2).

Table IVA Statistical analysis of the data in Fig S A* • (n=8)
Group Datsi'v 1 3 7 10 14 17 19
r*"\C\J 27
Deprived Kean 0 .6 3.0 1 7 .0 13.0 25.O 2 9 .0 50.0 6 0 .0 52.0
infected SD - 0 .2 1 .8 3.1 3-7 8 .2 6.3 5.7 3.5 1.5
Intact Mean 1.1 3.4 20.0 19.0 38.0 35.0 56.0 57.0 -
infected SD - 0.2 0.8 3.1 4.0 9.0 8.6 4.2 3.5
Significance P< 0.001 B NS 0.01 0.01 NS NS NS
Shan Mean 0.8 4.5 15.0 17.0 33.0 3 2 .0 59.0 6 1 .0
infected SD - 0.3 1.1 5.3 3.9 12.8 10.8 1 9 .0 5.2
Intact Kean 1.1 3.4 20.0 19.0 38.0 35.0 56.0 57.0
infected SD - 0.2 0.8 3.1 4.0 9.0 8.6 4.2 3.5
Significance P< 0.05. 0.01 0.05 NS KS NS NS NS
*see table II
FIGURE 9al P. berghei - mean percentage parasitaemias m  
T-cell-deprived, sham deprived and intact 
control CBA mice inoculated with 1 x 10
m
FIGURE 9a2 P. berghei - niortalities of intact, shain and T-cell-deprived mice inoculated with 1 x 10 
infected RBC
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FIGure 9b2 P. berghel - mortalities of intact, sham and T-cel1-deprived mice inoculated with 1 x 10 
infected RBC
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ü  • T—cell deprivation by thymectomy, irradiation and 
bone marrow reconstitution
The parasitaemia patterns in all groups (normal, 
sham, T-cell deprived groups) followed similar patterns of 
infection and reached a parasitaemia level of 18-25$ on 
day. 12. Then the parasitaemia level in the sham and intact 
groups kept on increasing until all the mice died. The 
terminal parasitaemias ranged from 50-60$. The parasitaemia 
in the deprived group leveled out after day 12 and remained 
below 30$ (fig 9\).
The mean survival time of the T-cell deprived group 
was 37.2 - 4.2 days which was significantly (P < 0.001) 
higher than that of the sham group (18.4 - 5.6 days) and 
the intact group (15.2 - 6.7 days) (fig9hg).
b. Infection patterns in intact and thymectomised mice
This experiment was designed to find out the effects 
of adult thymectomy alone on P .berghei infections in CBA 
mice. 8 week old mice were thymectomised or sham 
thymectomised and P.berghei infection was given 4 days 
after the thymectomy together with the intact control 
group.
The parasitaemia patterns in the thymectomised, sham 
and intact control groups were all similar and were 
comparable. But there seemed to be a slight increase 
(2.3$ and 1.9$) in mean survival time in the thymectomised 
group, 21 - 3.1 compared with the sham, 17.2 - 5.4, and 
intact control groups 17.8- 5«1 days but was not significant.

Table V Statistical analysis of the data in Pig 10a,.(n=12)
Group Dalitv. 2 4 6 9 12 16 19
Thymectcnised Mean 1.7 11.8 13.2 12.8 30.2 48.4 54.0
infected SD t 0.5 6.6 4.3 2.6 4.6 8.5 8.5
Intact Mean 1.3 12.6 14.8 11.7 32.0 42.3 60.3
infected SD - 0.6 3.9 6.5 0.6 7.0 4.9 0.7
Significance P < NS NS NS NS NS IIS NS
Sham Mean 1.4 9.8 16.4 15.7 35.3 50.0 56.0
infected SD - 0.5 3.6 6.0 3.1 6.8 3-0 11.3
Intact Mean 1.3 12.6 14.8 11.7 32.0 4?.3 60.3
infected SD - 0.6 3.9 6.5 0.6 7.0 4.9 0.7
Significance P < NS NS NS NS NS NS NS
■ ■ ■ ■ M M
FIGURE 10a P. berghei -  mean percentage parasitaemias
in th y m e cto m is e d , sh a m -th y m e cto m ise d , 
in tact control CBA mice inoculated with 
1 x 1 0 ^  in fected  RBC
— A—  = th y m e cto m ise d
m — s  sh a m -th ym ectom ised  . ,
—# —  = in ta ct control
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FIGURE 10b Mortality curves for mice in Fig. 10a
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DISCUSSION 
1. P.chabaudi
There are some widely differing views on the virulence 
of P.chabaudi in mice. Peters (1967a), Ott (1969) and 
Carter and Walliker (1975) reported that P .chabaudi is 
virulent and often kills mice. Cox and Voller (1966) 
found that P .chabaudi-infected white mice usually recover, 
but there may be some deaths (Cox, 1970), and up to 20# 
mortality was recorded in mice by Nussenzweig et al.. (1966). 
In my experiments, P.chabaudi in 6-8 week old C3A mice 
invariably gave rise to a self-resolving infection. In 
3—4 .week old weaning CBA mice 70-80# of the mice died with 
high parasitaemia.
The virulence of rodent malaria infections is very 
unstable. A benign strain can become a virulent one by 
rapid blood passage of the infection (Cox and Voller, 1966; 
Garnham, 1966). Factors such as strains of mice (Peters, 
1967a), age and sex of mice, temperature, humidity (Garnham, 
1966), PABA content of the diet (Peters, 1970e$ protein and 
and vitamin A content of the diet (Krishnan et al.,1976), 
concomitant infections, (Ott and Stauber,1967) and 
preparation and dosage of inoculum (Ott, 1969) can be major 
determinants of virulence of the infections. The 17X strain 
of P.yoelii has been observed to undergo a spontaneous
shift to a virulent state in which 100# of mice may die with 
overwhelming parasitaemias within a week or 10 days (Yoeli
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and Hargreaves, 1974).
To standardise the infections as far as possible 
clones were prepared and stabilated in large numbers. 
CBA/lac inbred strains of mice were used because they give 
a reproducible pattern of infection with both P.chabaudi 
P «berghei infections and because they have been used 
extensively by other workers for their immunological 
studies (Jayawardena et_al.,1975, 1977; and Whitmore, 1974)
P »chabaudi in CBA mice gives rise to a characteristic 
reproducible chronic type of infection which persists for 
about 60 days. The parasite produces a synchronous type 
of infection, has no preference for reticulocytes and makes 
a good experimental model for human malaria caused by 
P.falciparum (Rosario, 1976). The parasite was not seen by 
blood examination in the intervals between the peaks of 
parasitaeraia. It could be demonstrated, however, by blood 
passaging into uninfected recipient mice. The parasite 
was obtained in this way up to 6 days after the last peak 
of patency. Injection of kidney, spleen or liver tissue 
did not improve any positives revealed by blood passage. 
However, Jayawardena et al. (1977) showed that P.yoelii 
infections persist in about 60ÇÎ of mice in their kidneys 
for about 4 weeks after disappearance of parasitaemia from 
the blood. Sometimes blood collected between the 2nd and 
3rd peaks did not produce infections in recipients. This 
could mean that the parasitaemia is very low and that 
parasites occur outside the circulation.
Nussenzweig et al. (1966) showed that 60?« P » chabaudi
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infected CF1 mice produced a chronic infection with three peaks 
of parasitaemia. The first peak was between 8 to 12 days 
with 10—40# parasitaemia. The second t>eak at the 3rd to 
4th week with 10# parasitaeaia and the third peak in the 
6th week with 30# parasitaemia. According to the authors, 
the majority of the mice died at the third peak of 
parasitaemia because of a sudden high parasitaemia.
Use of inocula of different sizes did not affect the
outcome of the infection. Even with a higher inoculum
8(10 infected erythrocytes), there was no mortality. The 
time to the first appearance of the parasite (pre 2# latent 
period differed but apart from that the general pattern of 
the infection was similar.
Sengers _ e-t al . (1971b) have also shown that there
was no correlation between the log inoculum and the number 
of deaths in P.berghei infections in Swiss mice.
Graphically calculated (Warhurst and Folwell, 1968) the 
pre 2# latent period was found to be 1*2 days (26*8 hrs)
(fig 6a ). Carter and Walliker (1975) gave a latent 
period of 24 hours in P . Wrghai infections in mice. The 
difference in latent period may be due to the different 
laboratory conditions, strains of mice and lines of parasites 
or may be because their figure was an approximate one.
It has been shown by several workers that the malaria 
parasite requires PABA for normal growth (Hawking, 1953l 
Kretschmar, 1965). Carter (1972) showed that chloroquine 
resistance in P.yoelii is dependent on the concentration 
of PABA in the diet. Also Kirakosyan (1970) demonstrated 
that choroquine was more effective against P .berghei in
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roice when PABA was absent from the host.
T-cell deprivation by adult thymectomy, irradiation and
syngeneic bone marrow reconstitution, (Killer, Doak and
Cross, 1963) has been used for experiments on P.berghei
and P.yoelii infections in nice (Jayawardena et al.,1977) .
Although leaving a residual 10?! T-cell population
(Doenhoff et al., 1970) this technique has the advantages
of ease of performance, reliability in results and
avoidance of the major inconvenience of •wasting' in long
term experiments (Davies, 1969). This method was used for
some experiments initially but had to be abandoned because
of the lack of a convenient irradiation source. T-cell
deprivation by adult thymectomy and ALS treatment was used
extensively in my experiments. Lance (1970) has presented
♦
the evidence to indicate that anti-lymphocyte serum (which 
is often synonymous with anti-thymocyte serum) acted by 
selectively depleting the recirculating lymphocyte pool. 
Doenhoff and Leuchars (1977) showed that the cytotoxic 
action of ATS is directed mainly against the recirculating 
thymus derived T-cell since it depletes the blood borne 
PHA-responsive cell pool. The action of ATS on antigen- 
reactive thymus—derived cells has been demonstrated 
directly by the use of chromosomally-marked lymphocyte 
subpopulations (Leuchars, Wallis and Davies, 1966). Intact 
mice treated with ATS eventually reconstitute their T-cell 
pool (PHA responsive cells) after 100 days. But in 
thymectomised and ATS treated mice recovery of PHA responses  ^
is only marginal and takes 400 days (Doenhoff and Leuchars,
1977). The fact that thymectomy followed by ATS treatment 
resulted in good immunodenression is shown by the experiments
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on p 111 . The skin graft rejection was delayed in 4 out 
oi1 1*9 niice for more than l-§- years and levels of agglutination, 
haemoglobin and IgG titres were suppressed in the deprived 
group in comparison with those of the controls.
The immune response of CBA mice to g .chabaudi infection 
is thymus dependent. P .chabaudi infection in the 
immunologically intact mouse is a resolving and then chronic 
type of infection. In nice T— cell deprived by thymectomy 
and ATS treatment the parasitaemia was the same as .that of 
the normal controls until day 7 of the infection but then 
instead of resolving it remained relatively constant. 
Generally the parasitamia rose to about 50£ but then came 
down and formed a plateau at a level of 12—30#. The mice 
survived for more than 120 days.
The T lymphocytes appear to perform two major roles in 
the induction of the immune response to plasmodia. One 
role is the helper function in initiating the events in 
the B-cells which lead to antibody secretion, the other 
role is to secrete lymphokines which bring about activation 
of the macrophages (Kreier, 1976)• Brown (1974) has 
suggested that T-cells might be important as helpers in 
establishing variant-transcending immunity. He suggested 
that during malarial infection, T-cells become primed to a 
determinant common to all plasmodial variants characteristic 
of the strain producing the infection.
P.yoelii infection in CBA mice is also T-cell 
dependent. In normal mice the first wave of parasitaemia 
resolves in 15-17 days but in T-cell decrived mice the
155
infection resulted in a progressive parasitaenia and proved 
fatal in 35-40 days (Jayawardena et al., 1977). A similar 
slow increase of parasitaenia to that with P.chabandi was 
shown in thymectomised, irradiated and cone marrow 
reconstituted mice infected with ?.yoelii (Jayawardena et al., 
1977)• This might be due to the effect of irradiation in 
the rapidly dividing cells of the gastro-intestinal tract 
causing reduced absorbtion of nutrients like PA3A, but 
this has not been proved.
It has been shown that the haematocrit level correlates 
very well with the parasitaenia level of ? .yoelii infections 
in mice (Lwin, 1975; Jayawardena et al., 1977); again 
the reticulocytosis is correlated with the haenatocrit 
value (Jayawardena et al., 1977). The higher the parasitaemia 
the lower the haematocrit level and as a result the higher 
the relative reticulocyte count. Since P.yoelii has a 
great preference for reticulocytes and because of lack of 
T-cell response, the decrease in haenatocrit value and 
increase of reticulocytes forms a vicious circle until the 
mouse dies of anaemia, p.chabaudi infection has no 
predilection for reticulocytes and this might be why a 
plateau is established and the mice survive.
2. P.berghei
p.berghel infections in mice are invariably fatal. 
(Greenberg et al., 1953). The parasitaemia levels of 
P .borghei in mice deprived by both methods were similar to 
that of infected intact controls (figs 9»1 & 9bl) . However,
the mean survival time for the group T-cell deprived by
156
thymectomy, irradiation and bone marrow reconstitution was 
36.2 ±3 days w h ich wa s  significantly (p <  0.001) longer 
than that of the normal and sham control mice. The group 
T-cell deprived by thymectomy and ALS treatment had a mean 
survival time of 25.8 —3*5 days w h i c h  was again significantly 
longer (P <  0.05) tha n  that of the intact and sham controls.
This may be due to the differing effects of ATS and 
irradiation. ATS selectively depletes the circulating 
T-cells (Lance, 1970) but irradiation affects the T cells, 
(PHA responsive cells) and B cells (LPS responsive cells) 
(Doenhoff and Leuchars, 1977) as well as the rapid dividing 
cells of the body like gastro-intestinal cells. Experiments 
were also done at two separate times with different sexes 
of.mice; male mice were used for the thymectomy, irradiation 
and bone m arrow reconstitution experiments and female mice 
for the other. These factors might play a role in the 
difference in mean survival times.
Jayawardena et al. (1975') have shown the increased 
mean survival time in T— cell deprived mice infected with 
P.berghei. Adult thymectomy alone did not alter the 
infection nor the survival rate very much.
This shows that the thymus has no direct influence through 
hormones on the infection (Trainin, 1974). Wright (1968) 
and Wright et a l . (1971) have shown that either neonatal 
thymectomy or ALS treatment in hamsters infected with 
P. b e r g h e i  prolonged the survival time. According to them, 
the depo s i t i o n  of antigen-antibody complexes on the brain 
vessels in the intact mice shortened the survival time.
But the effect of suppressor T-cells on the immune response 
of the host in the intact animal must also be considered.
Jayawardena and Waksman (1977) demonstrated the presence 
of T-suppressor cells in a T.brucei infection by showing
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the suporessive effects of mitogenic responses due to 
c o n  A and phytohaemagglutinin ( P H A ) , lipopolysaccharide 
(LPS) and allogenic cells in v itro by the T .brucei infected 
spleen cells. Since P .berghei produ c e d  a fatal infection 
in mice like T . b r u c e i , T-suppressor cells might play a 
r o l e .
The two plasmodia, P.chabaudi and P.berghei behave 
t otally differently imm u n o l o g i c a l l y . P.chabaudi does not 
resolve in T — cell deprived mice though it does in the intact 
mouse. Conversely T — cell deprived mice survived longer than 
no r m a l  mice whe n  infected with P . b e r g h e i . The two 
contrasting parasite-host relationship systems thus formed 
good models for subsequent studies.
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B '. Inaunodenr ossive effects of P.chabaudi infection
Since no work has been done on the immunodepressive
effects of P .c h a b a u d i . I intended to find out its effects
on SRBC. All the experimental mice received an inoculum 
7
of 1 x 10 P .chabaudi infected erythrocytes on day 0.
0. 2 m.1 of 20# SRBC (1 x 10^) was given intraperitoneally 
to both the experimental and the control groups of mice 
at various intervals during the infections according to 
the experiment. Sera were obtained from the retro-orbital 
plexus of mice at various intervals after SRBC injection 
and the agglutination titre, lysin titre, 2-mercaptoethanol 
resistant and sensitive titres were determined.
1. The effect of P.chabaudi infection on the primary immune 
response of mice to SRBC
The experiments were designed to find out the immuno— 
depressive effects of P.chabaudi on the primary immune response 
to SRBC given at the following levels of parasitaemia.
a. SRBC given at peak parasitaemia
SRBC were given on day 5 (peak) of P.chabaudi infection 
to both the experimental and the control groups. The 
results are shown in fig 11 and table VI.
The agglutination titre was between log2 9.4 (±0.9) and 
10.5 (±0.6) from days 11-28 and declined to log2 6 (±0.8) on 
day 63 in the uninfected control group. In the P.chabaudi 
infected mice the mean agglutination titre was comparable to 
that of the control group initially on day 8 but from day 11

Table VI Statistical analysis of the data in Fig 11 (n=5)
Test Group \jjayDatSf1 e 1 1 14 18 22 25 28 32 46 63
co
•H Control Mean 5.4 9.4 10.2 10.0 10.5 10.0 10.3 8.5 7.3 6.0-p
cd o SD - 0.9 0.9 0.8 1.4 0.6 0.8 0.6 1 . 0 1.3 0.8c u
•H -P Malaria Mean 4.8 5.8 5.8 4.8 3.8 4.6 4.8 4.6 3.8 3.6
3  -p infected SD - 0.5 0.5 0.5 0.5 0.8 0.6 0.8 0.6 oTJ 0.6
8c Significance P < NS 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0.001
Control Mean 4.8 9.4 9.4 9.5 8.5 7.3 8.5 8.0 6.3 3.3SD - 0.5 0.6 1.1 1 . 0 0.6 0.5 0.6 0.8 1.3 0.5
C O Malaria Mean 4.4 4.8 4.6 3.8 3.6 3.8 3.2 4.4 3.6 2.4>> *H 
,_q -p infected SD- 0.6 0.5 0.6 0.5 0.6 0.5 0.8 0.6 1.1 0.6
Significance P < IIS 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0.05
-p
C Control Mean _+ 0.2 8.8 10.0 10.0 8.8 10.0 10.3 7.5 6.8 6.0
-p SD - 0.5 0.8 0.7 1 . 0 0.5 0.8 o.5 0.6 1.5 0.8co a
•H P Malaria Mean 0.2 5.2 5.2 4.8 3.2 4.0 3.6 3.2 3.4 3.4
C *H 
4» infected SD - 0.5 0.8 0.5 0.5 0.5 0.5 0.9 0.5 0.6 0.6
Significance P < NS 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1 0 . 0 0 1
Control Kean 5.2 0.6 0.2 0 . 0 1.8 0 . 0 0 . 0 1 . 0 0.5 0 . 0Q)
> SD - 1.1 0.9 0.5 0 . 0 0.5 0 . 0 0 . 0 0.8 0.6 0 . 0
-P Malaria Mean 4-4 0 . 6 0 . 6 0 . 0 0.6 0 . 6 1.2 1.4 0.4 0.2
CO
C -P infected SD - 0 . 6 0.6 0.6 0 . 0 0.6 0.6 o.5 0.6 0.6 0.5
07 *H 
CQ -P Significance P < NS ns NS NS 0 . 0 1 NS 0 . 0 0 1 NS NS nsa
"Significance between 
the means of control 
and experimental 
group using student 
T test.
NS - not significant
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FIGURE 11 Log2  antibody titres to sheep red-blood 
cells given at the peak of P. chabaudi 
infection
(2MER/2MES titres=2-mercaptoethanol resitant/sensitive
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onwards the agglutination titres were significantly lower 
(P < 0.001) and never exceeded log 2 5.8 (± 0.5).
Anti SRBC haemolysin titres of the uninfected control 
group reached a maximum titre of log2 9.3 (± 1) to 9.4 (± 1.1) 
between days 11-18. But haenolysin titres in the malaria 
infected group were significantly lower (P < 0.001) 
and never rose above log2 4.8 (± 0.5).
2- mercaptoethanol resistant (2I>1ER) IgG titres were 
also depressed in the P.chabaudi infected group. The 
maximum 2MER titre was log2 5.2 (- 0.8) compared with a 
maximum for the controls of log2 10.3 (- 0.5) and the titres 
were significantly different (P <  0.001) from each 
other throughout the experiment.
The 2-mercaptoethanol sensitive (2MES) IgM titres 
were similar in both groups.
b. SRBC given early in the infection
SRBC were given on day 1 after the inoculation of 
P.chabaudi when the parasitaemia was 1.97»(- 0.4).
The maximal agglutination, haemolysin and 2HER titres 
for the uninfected controls were log2 10.2 (— 1.3)« log2 9.8 
(± 0.8), log2 9.3 (± 1.5) and for the infected group were 
log2 8.6 (± 1.5), log2 7.8 (± 1.2) and log2 8.4 (± 0.9) 
respectively. (fig 12 and table VII ).
Though there were slight depressions of agglutination, 
haemolysin and 2KER titres as a result of malaria infection, 
they were not as significantly different as the previous 
experiment.

r - s s -  — —  r w
Table VII Statistical analysis of the data in iig 12 (n=5)
*65 w Group Dath- 4 8 11 14 18 22 25 28
CNJ
K\ 46 63
Control Kean 5.2 9.3 8.8 10.2 9.8 8.8 8.6 9.3 6.7 6.3 4.8G
O
•H
SDÌ 0.5 0.7 0.5 1.3 1.1 1.1 1.1 1.5 1.3 0.6 0.8
-P
Ci GG ^ rial aria Kean 5.6 8.6 8.6 8.0 7.6 7.2 7.0 7.0 6.4 5.6 3.8•H -P -P -H infected SD - 0.6 0.9 1.5 1 . 0 1.1 1.3 1 . 0 0.7 1.1 1.9 0.6
n
<
Significance P < 0.02 IIS NS 0.02 0.02 NS 0.05 0.02 NS NS NS
Control Mean 7.2 9.8 7.2 7.0 8.0 7.8 8.0 7.0 6.5 5.6 3.2SD - 0.8 0.8 0.5 2.0 1 . 0 1.3 1.2 1.4 1.3 0.6 0 .5
G <T
■H U Malaria Kean 5.0 7.8 8.0 5.8 6 .4 5.8 5.4 5.6 5.4 5 0 2.803 -P
>5 *H►J -P infected SD - 1 . 0 1.9 1.2 0.8 1.1 0.8 0.9 0.9 1.1 1.2 0.6
Significance P < 0.01 NS NS NS 0.05 0.02 0.01 NS NS NS NS
-P Control Mean 0 . 0 8.8 7.8 9.0 8.0 8.0 8.6 9.3 5.5 6.0 4.63 SD - 0 . 0 0.8 1.3 1.9 1 . 0 0.7 1.1 1.5 0.6 0 . 0 0.9
CG 0  
•H G 
a -p Malaria Keen 0 . 0 8.4 7.2 8.2 7.6 6.6 7.0 6.6 4.8 5.4 3.8
C -P
-p infected SD - 0 . 0 0.9 1.3 3.1 1.1 1.1 1 . 0 1.1 1.5 1.1 0 .6
g Significance P < 0 . 0 NS NS NS NS 0.05 0.05 0.02 NS NS HS
Control Kean 5.2 0.6 1.0 1.2 0 . 0 0.8 0 . 0 0 . 0 1.3 0.3 0.2G> SD - 0.5 0.8 1 . 0 1.1 0 . 0 0.5 0 . 0 0 . 0 1 . 0 0.6 0.5
-P•H G Malaria Mean 3.6 0.2 1.4 0.8 0 . 0 0.6 0 . 0 0.4 1.6 0.2 0 . 0
a n c +> infected SD - 0.6 0.5 0.6 1.3 0 . 0 0.6 0 . 0 0.6 0.6 .5 0.0
CS -P Significance P < a  o i NS NS NS NS NS NS !<S NS NS NSSE
^Significance between the 
means of control and 
experimental group uring 
student T test.
NS «• not significant
P
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FIGURE 12 Lc^'antibody titres to sheep red-blood cells 
given at day 1 of P. chabaudi infection
SRBC

"able Vili Statistical analysis of the data in Fig 13 (n=5)
Test Group Datâ^v 55 56 59 65 67 71 82 101
co
■H
-P(d a c
•H -P
Control Mean SD Ì
5-2
0.5
7.6
1.1
9.2
0.5
9.0
0.7
8.8
0.8
9.0
1.2
9.8
0.5
7.2
0.8
Malaria Mean 5.2 6.6 8.8 7.8 8.0 7.8 9.5 5-3-P  *H infected 3 D - 0.5 1.5 0.5 0.5 0.8 0.5 1 . 0 1 . 0
' g
c
Significance P < 113 IIS NS 0.02 NS NS NS 0.05
Control Kean 4.0 7.8 7.6 8.0 8.0 8 .4 8.0 5.6SD - 0 . 0 0.8 0.6 0.7 0.7 0.6 0.7 0.6c (D
•H Î i 
(0 -P Malaria Kean 4.0 8.0 7.8 7.0 7.0 5.8 7.0 4.8
>> *H
-P infected SD - 0 . 0 1.2 1 . 0 0 . 0 0 . 8 5.5 0.8 1 . 0
Significance P < NS NS 0.02 NS No NS NS NS
•P Control Kean 0 . 0 7.6 8.8 8.6 8.2 7.0 8.8 6.0c3 SD - 0 . 0 1.1 0.8 0.6 0.5 2.7 0.8 1.0
OJ c
•H | ITalaria Mean 0.4 6.6 8.8 7.0 7.5 7.8 7.0 5.8a -p a) -p b -p infected SD - 0.9 1.5 0.5 1.4 1 . 0 0.5 1.4 1 . 0
s Significance P < s IIS NS NS US NS 0.05 NS
Control Mean 5.2 0 . 0 0.4 0.4 0.6 1 . 0 1 . 0 1.20)> SD - 0.5 0 . 0 0.6 0.9 0.6 0.7 0.7 0.5
«P
•H C Malaria Kean 
SD -
5.2 0 . 0 0 . 0 0.8 0.5 0 . 0 2.0 0.5
09
C  -P infection 0.5 0 . 0 0 . 0 1 . 0 0.6 0 . 0 0.5 0.5
GJ »riCO +> Significance P < NS NS NS NS NS 0.01 NS “ 0755
g
*8ee table VI
MEt ITRE LYSIN HIRE
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FIGURE 13 Log2 antibody titres to sheep red-blood cells 
given during the chronic phase of P. chabaudi 
infection
. SRBC
The 2MES titre was too low in both the groups to 
po -^ut out any significant difference between the groups.
c. SRBC inoculation during the chronic phase of P.chabaudi 
infection
SRBC were inoculated into the experimental group of 
mice on day 51 of the infection during the third peak of 
parasitaemia (0.05£ parasitaemia) together with the control 
group.
Antibody titres were similar to those obtained by 
inoculation early in the infection (fig 13 and table VIII).
2. The effect of P.chabaudi infection on the secondary and 
tertiary responses of mice to SRBC
These experiments were designed to find out the effects 
of repeated inoculations of SRBC following the primary dose 
of SRBC given at the following levels of parasitaemia.
a. Primary immunizing dose of SRBC given at peak parasitaemia
The primary dose of SRBC was given to the experimental 
group on day 5 of the first peak of the infection. The 
second dose was given on day 29, at the second peak and 
the third on day 51 at the third peak of the parasitaemia.
The same dose of SRBC was given to the uninfected control 
group at each time.
The primary responses against SRBC were similar to 
those of the previous experiment (Exp B. la) i.e. there
1 6 6

Table IX Statistical analysis of the data in Fig 14 Q.(n«6)
Test Croup DayData S 12 15 18 22 26 31 35 38 42 . 46 49 53 56 60 64 67 71 82 1C1
Mean 7.2 9.8 10.0 8.4 8.8 9.0 8.0 12.5 12.0 13.0 13.0 12.0 10.3 11.8 14.0 13.5 12.5 13.0 12.3 12.3
o A SD • 0.8 1.3 0 .0 0.6 0.8 0 .0 0 .0 0.6 2.0 0.0 C.O 0 .0 1.3 0.5 1.0 C.6 0.6 0.8 1.0 0.5
s oC t. -« ♦» Mean 5.8 7.7 4.3 1.8 2.7 3.4 5.2 10.4 11.8 9.6 8.8 8.3 7.8 9.5 11.0 10.5 1C.0 9.3 10.9 s.e
3 ♦*H
B SD - 0.8 2.3 1 .0 1 .0 1.4 1.5 1.8 1.8 1.6 2.2 1.7 2.2 1.7 1.7 1.4 1.3 1.9 2.5 1.7 2.3
< Significance P< 0.02 VS 0.001 0.001 0.001 0.001 0.01 0.05 NS 0.01 0.001 0.01 0.02 0.01 0.01 0.001 0.02 C.01 KS c.r.
Mean n.o 12.0 7.0 5.e 7.2 10.0 9.0 12.0 12.3 13.0 13.0 12.0 10.0 11.0 12.0 12.9 12.0 12.5 12.0 11.0A su - 0.6 0.0 0 .0 0.8 0.5 1.4 1 .0 0 .0 0.5 0 0 0 .0 0 .0 0 .0 C.8 0 .0 0.5 0 .0 0.5 C 8 1 .0
= c Mean 8.J 8.2 3.5 1.8 1.0 2.0 5.0 8.2 9.2 0.2 8.8 8.0 6.5 9.5 11.0 9.5 9.5 9.5 9.0 *\5
>»•* »4 «•
3 SD - 0.8 1.2 0.6 0.8 1.6 0.5 1.2 2.2 2.3 2.3 2.5 1.6 1.7 1.7 1.6 1.7 2.4 2.4 2.7 1.5
Significance ? < 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.01 0.01 0.01 • 0.01 0.001 0.001 NS RS 0.01 0.05 0.02 O.C5 O.COl
Heu 2.0 9.8 10.0 6.4 8.0 8.0 8.0 11.2 12.0 15.0 13.0 11.5 10.0 10.5 14.0 13.5 11.5 12.5 12. C 11.5
♦» * SD t 0.7 1.3 0 .0 0.6 0 .0 0.8 c.o 0.8 2.0 0.0 0 .0 0.6 0.8 0.6 1.0 0.6 0.6 0.6 o.s 0.6
C 'lean 0.6 6.5 4.2 1.8 1.7 2.2 3-8 9.6 10.4 9.0 8.3 7.5 6.5 9.0 10.8 10.0 9.3 9-3 9.S 7.3« i. Bcc «* SJ - 0.6 0.8 1.2 10 1.2 1.1 1.9 1.5 2.1 a. 21 2.4 . 1.3 0.8 1 .0 1.8 1.5 2.5 2.2 1.5
a Sl{Elflcane* ? < 0.01 0.001 0.001 0.001 0.001 0.001 0.001 0.05 83 0.001 0.001 0.01 0.001 0.01 0.001 0.001 0.02 rs r>2 c.c$ C.C31
Kean 5.2 0 .0 0 .0 2.0 0.8 1.0 0 .0 1.2 0 .0 0 .0 0 .0 0.5 0.3 1.3 0 .0 0 .0 1 .0 0.3 0.3 C.P6 A SD - 0.5 0 .0 0 .0 1 .0 0.8 0.8 0 .0 1.1 0 .0 0 .0 0 .0 0.6 0.5 0.5 0 .0 0 .0 1.2 0.5 r .c 0.5
**««* • Mean 5.3 1.2 C.2 0 .0 1 .0 1.2 1.4 0.8 1.4 0.6 0.5 0.8 1.3 e. c C.2 9.3 l.C C.P 1 .0 \ .a
C -» B& —a *» SD - 0.8 2.0 0.5 0 .0 0.6 0.8 0.9 1.3 1.5 0.6 C.6 0.5 1 .0 1.9 0.5 0.5 c.s o.c 1.4 1.3
| ffgnlflcancc p < ns VS VS O.eo\ MS MS ns K3 oojr ES I!S IIS ns NS K3 rs S3 VS rs
so» table VI
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FIGURE 14a Log2 antibody titres to challenge doses of 
sheep red-blood cells when priming was done 
at the peak of P. chabaudi infection
1st SRBC 2nd SRBC 3rd SRBC
1 G9
was significant deoression of agglutination titres, 
haemolysin titres and 2LIER titres in the infected group 
(P < 0.001) especially between days 15-26 after malaria 
infection (fig 14aand table IX ).
After the second immunizing dose of SRBC, the 
agglutination titres and 2I.R2R titres were comparable in 
the experimental and control groups on day 38. This was 
followed by depression of titres in the infected group 
reaching a maximum difference from the control group of 
log2 3-4 (P 4. 0.001) .
After the third immunizing dose of SRBC, the gap 
between the experimental and control groups in terms of 
agglutination, haemolysin and 2I.ÍER titres was reduced 
again on days 56 and 60 of the infection. The gap 
widened again after that to differences of log23-4.
Throughout the experiment the 2KES antibody titres 
were too low to interpret the significance in between 
the groups.
b. Primary immunizing dose of SRBC given during the
second patent period of narasitaemia (low oarasitaerria)
The primary immunizing dose of SR3C was given on day 
29 of the malaria infection and the second dose on day 51.
The orimary response was comparable to that of the 
previous experiments (see B. lb,c and figs 12 and 13 )•
The agglutination, haemolysin and 2MER titres in the control 
and the experimental groups were not different on days 31 
and 35 (figHb and table X ). Later these titres

'able X Statistical analysis of the data in Fig 14b (n=6)
Test Group Dat&s 31 35 VX C
D 42 46 49 53 56 60 64 67 71 82 101
c Control Mean SD -
2 .8 9 .0 1 0 .4 9 -6 9 .0 7 .6 8 .5 9 .8 1 2 .0 1 1 .6 1 1 .4 11.4 11.8 1 0 .8
• H
P 0 .5 1 .0 0 .9 0 .6 0 .7 0 .6 1 .0 0 .8 0 .5 1 .1 1 .1 1 .3 1.0 1.0
£u C  
C . lialaria ¡•lean 3 .5 8 .0 8 .8 7 .5 8 .0 6 .5 7 .6 9 .7 1 2 .0 1 0 .7 9 .3 9 .8 1 0 .0 8.2
- P  - H  
P  - P infected SD - 1 .2 1 .3 1 .3 0 .8 0 .9 0 .6 0 .6 0 .5 0.0 0 .3 1 .2 1 .2 0 .7 0 .6
i<
Significance P < US NS 0 . 0 5 0 .0 0 1 NS 0 .0 2 IIS Ii3 KS NS 0 .0 5 NS . 0 .0 1 0.001
Control Kean 5 .8 9 .0 9 .2 8 .8 8 .2 7 .8 7 .0 9 .2 1 1 .0 1 1 .4 1 0 .4 1 1 .2 1 1 .2 7 .3SD - 0 .5 0 .0 0 .8 0 .8 0 .8 0 .5 1 .4 0 .5 0 .8 0 .9 0 .9 0 .8 0 .8 1.0
c  p•Ha -p Ilalaria Mean 5 .5 8 .5 7 .4 7 .0 6 .8 6 .0 7 .2 9 .0 1 1 .0 1 0 .7 8 .8 8 .8 8 .2 6.4
> J  * H  
h 3 * P infected SD - 1 .4 1 .1 1 .1 0 .6 0 .8 0 .6 0 .8 0 .6 0 .8 1 .4 1 .2 0 .8 1 .3 0.9
Significance P < NS IIS 0 .0 2 0 .0 1 0 .0 2 0.001 NS NS NS NS 0 .0 5 0.001 0.001 0.05
•pc Control Ifean 0.0 8 .6 1 0 .7 9 .4 8 .8 7 .6 8.5 9 .4 1 2 .0 1 1 .4 1 1 .2 1 0 .8 1 1 .8 1 0 .0d•p SD - 0.0 0 .6 0 .8 0 .6 0 .8 0 .6 1.0 0 .6 0.0 0 .9 C.8 1 .1 1.0 0 .8
C l Q•p ua -p Malaria Kean 0 .2 7 .8 8 .6 7 .3 7 .0 6 .3 6 .6 9 .3 1 2 .0 8 .8 9 .2 9 .2 9 .4 7 .2c *H -p infected SD - 0 .4 1 .2 1 .5 1.0 0 .6 0 .8 0 .6 0 .8 0.0 0 .8 1 .5 1.0 1 .3 0.8g Significance P < NS NS 0 .0 2 0 .0 1 0 .0 1 0 .0 2 0 .0 1 NS NS 0.001 0 .0 2 0 .0 5 0 .0 1 C.001
o
> Control Kean 2 .8 0 .4 0 .2 0 .2 0 .2 0.0 0.0 0 .4 0.0 0 .2 0 .2 0 .6 0.0 0 .8•H
-P S3 - 0 .5 0 .6 0 .5 0 .6 0 .5 0.0 0.0 0 .6 0.0 0 .5 0 .5 0 .6 0.0 0 .5
c -P Malaria Kean 3 .3 0 .2 0 .2 0 .2 1.0 0 .2 1.0 0 .2 0.0 1 .8 0 .5 0 .7 0 .6 1.0C *H B -P infected SD - 0 .8 0 .6 0 .6 0 .6 0 .6 0 .4 0 .0 0 .4 0.0 1 .3 0 .6 0 .5 0.9 0 .7
g Significance P < KS NS NS NS NS KS 0 .0 0 1 NS NS 0 .0 2 KS NS NS ITS
* see table VI
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FIGURE 14b Log^ antibody titres to a challenge dose of sheep 
red-blood cells when priming was done at l o w  
P .  chabaudi paras 1 taemia s
1st SR8C 2nd SRBC
-él
17
reduced more in the infected group and became significantly 
different from the control group on day 49 (P < 0.02 - 0.001).
After the second immunizing dose the antibody titres 
in the two groups were almost identical on days 56 and 60 
but starting from day 71-101 the agglutination, haemolysin 
and 2MER antibody titres were significantly different from 
each other (P < 0.05 - 0.001).
3• Catabolism of immunoglobulins in mice infected with 
P.chabaudi
The results of the above experiments 2a and 2b (figs 14a 
andl4t) showed that 7-10 days after each immunizing dose 
the experimental groups and the control groups were 
comparable in terms of the anti-SRBC agglutination titres, 
lysin titres and 2MER antibody titres. Significant 
differences in titres were seen only 10 days or more after 
the immunizing dose. Consequently I investigated whether 
there is any increased catabolism of immunoglobulins as a 
result of P.chabaudi infection.
1 ml of hyperimmune anti-SRBC serum of log2 18 
agglutination titre was injected intravenously on day 4 of 
the malaria infection. Serum was collected from the retro- 
orbitsLl plexus at different intervals and the agglutination, 
haemolysin, 2MER and 2MES antibody titres were determined.
The agllutination titre, haemolysin titre and 2KER (IgG) titres 
seemed to have significantly more catabolic effect on the 
infected grout) compared to the control on days 11, 14 and 19 
(P < 0.05-0.001) (fig 15 and table XI).

Table XI Statistical analysis of the data in Fig 15 (n=6)
Test Group DatS'-v 0 2 6 11 14 19 22 33 40
Cc Control I5«3? 13.5 13.2 10.5 10.7 9.2 7.7 7.3 3.0 2.7p SD - 0.5 1.0 0.8 0.5 1.0 0.5 0.5 0.6 0.5
c uP P Malaria liean 13.0 13.2 11.0 8.8 7.2 6.3 6.3 2.5 1.8p p 3 p infected SD - 0.7 0.4 0.6 0.4 1.0 0.5 0.5 0.5 0.2
B< Significance F < NS NS NS 0.001 0.01 0.01 0.01 NS 0.01
Control Mean 12.2 11.4 9.8 8.7 6.5 5.4 4.3 2.8 2.0SD - 0.8 0.6 0.4 0.6 0.6 0.6 0.5 0.5 0.0p p02 P Malaria Mean 12.4 11.4 9.4 7.8 5.3 4.3 3.8 2.0 1.8>i P P infected SD - 0.9 0.6 0.6 0.4 0.5 0.5 0.2 0.6 0.8
Significance P < KS HS HS 0 .05 0.01 0.02 NS NS NS
P Control Mean 12.8 12.8 10.3 10.5 • 8.8 7.7 6.7 2.8 2.0CC SD - 0.4 0.8 0.5 0.6 1.0 0.5 0.8 0.5 0.0&: o p k Malaria Mean 12.8 12.7 11.3 8.8 7.2 6.2 4.8 2.2 1.5C3 P C P infected SD - 0.5 0.5 0.8 0.4 1.0 0.4 0.8 0.5 0.6
a Significance P < NS NS NS 0.05 0 .0 5 0.05 0.01 NS NS
0 Control Mean 0.5 0.3 0.5 0.2 0.3 0.0 .7 0.3 0.5P SD - 0*6 0.5 0.6 0.4 0.8 0.0 0.6 0.5 0.6P ok U 
C p O P(C P
Malaria
infected
Mean 
SD -
0.2
0.5
0.5
0.6
0.0
0.0 0.70.5
0.0
0.0
0.2
0.4
1.5
0.6
0.3
0.5
0.3
0.5
g Significance r < MS KS NS NS NS NS °*05 NS NS
* see table VI
r~ ' ~ - .
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FIGURE 15 The effect of P. chabaudi infection on the 
catabolism of passively transferred antibody to 
SR3C injected on day 4 of P. chabaudi .infection 
(titres expressed as log,,)
Hyperimmune
serum
I
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DISCUSSION
Antibody production is the result of the co-operation 
of T-cells, B-cells and macrophages. Any depletion, 
damage or inhibition of these cells or of their co-operation 
will bring about reduced production of antibody. Many 
mechanisms of immunodépression in parasitic infections 
have been proposed (see pages 38 to 42 ) but the exact
cause of immunodépression is still unknown. Terry (1978) 
has made an extensive review of immunodépression in parasitic 
infections. According to him antigenic competition accounts 
for at least some of the depression associated with parasitic 
infections. Also parasite or host derived mitogens, 
lymphocytotoxic factors and lymphocytic suppressive factors 
may all play a role (see fig. 16 page 176),
The immunodépression in malaria depends on several 
factors| strain of parasite, type of antigen, time of 
inoculation of antigen and the method used for estimation.
The degree of immunodépression is correlated with the level 
of parasitaemia (Wedderburn,1974) and so the strain of 
parasite which produces higher levels of parasitaemia will 
have a more pronounced immunosuppressive effect than a 
benign strain. The immune response also depends on the 
type of antigen; when antigens like SRBC, aggregated human 
gammaglobulin or tetanus toxoid were injected into 
malaria infected mice there was a depressed response but 
antigens like bacteriophage or human serum albumin given 
intraperitoneally together with pertussis vaccine induced 
a normal response (review by Wedderburnjl974)• The time of 
inoculation of the antigen in relation to the parasitaemia
16 Possible mechanisms of parasite-associated 
immunodépression (Terry, 1978)
LYMPHOCYTE
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level of the malaria, infection played a major role in 
depression of the level of the immune response (Whitmore,
1974)» SRBC given in the early part of the malaria infection 
enhanced the PFC response rather than depressing it and 
then the switch from enhancement to depression occurred 
rapidly (Poels and Van Niekerk, 1977). The spleen ulaoue 
assay method was used by the majority of workers (Salaman 
et al.t 1969; Wedderburn, 1974; and Whitmore, 1974).
Weidanz and Rank (1975) demonstrated a severely depressed 
splenic antibody response to SRBC and that this had little 
effect on antibody formation in the lymph nodes during 
P.yoelii infection in mice. The spleen plaque assay thus 
does not seem to reflect the degree of immunity elsewhere in 
the body. In my experiments, the method of estimation of 
the immunodepressive effects of P .chabaudi infection was 
by measurement of agglutination and haemolysin titres to 
SRBC. 2-mercaptoethanol was added after recording the 
endpoints of the agglutination titre, and resuspending the 
agglutinated cells. A comparison of this method, with 
existing procedures in which sera are pretreated with 
mercaptoethanol, has been shown to produce no significant 
differences in the MR-resistant titres of the haemagglutination 
response to several antigens (Scott and Gershon, 1970).
The same method has been applied in the determination of 
the response to SRBC in P.yoelii infected mice by Greenwood 
et al. (1971a).
The immunodepressive effects of P.chabaudi infection on 
the primary immune response to SRBC gave the expected 
results. The degree of suppression depended on the time 
when antigen was injected relative to infection, the time
at which the response was measured and the class of 
antibody estimated as discussed earlier. When antigen 
(SRBC) was given at the height of the parasitaemia 
(expt.B la p 1 5 8 ), there was a significant depression 
of agglutination, haemolysin and 2 ME-resistant (IgG) 
titres, and this depression was still present 70 days after 
infection. The titres of malaria infected and control 
groups were very significantly different 15-35 days after 
infection, but less so between days 35 and 70 (fig 11 ).
When SRBC were given at periods of low parasitaemia 
either early or during the chronic phase of the infection, 
the agglutination, haemolysin and 2-ME-resistant titres 
were generally lower in the infected group than in the 
controls (figs 12 and 13 ), though they were not reduced to 
the same extent as when SRBC were given during periods of 
high parasitaemia (fig 11 p *160). I found no enhancement 
of IgA (ME sensitive) titres in the early stages of malaria 
infection like Poels and Niekerk (1977) who demonstrated 
increased splenic plaques at this stage. Also my result 
differed from that of Hudson et al. (1976) who found 
increased IgM splenic PFCs in early T.brucei infections 
in mice. The method I used may not have been sufficiently 
sensitive to detect such differences. The background 
agglutination and haemolysin titres of unchallenged and 
uninfected as well as malaria infected groups were very 
low (log20-log2l) throughout the experiment and so were 
taken as 0.
The effect of P.chabaudi infection on the secondary 
and tertiary responses of mice to SRBC depended on the
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timing of "the initial priming. When the priming with 
SRBC was done at the peak of parasitaemia (5 days after 
infection), the primary response was markedly suppressed 
( fig 14 a P 1 6 B ) ,  but when another challenge of SRBG 
(secondary) was given, the>_initial antibody response was 
comparable with that of the controls for 7-10 days. Immuno­
dépression became pronounced only after 10 days (fig 14 a 
p IBB ) . Tertiary responses to a further challenge were 
similar. When priming was done at a low level of parasitaemia 
and was followed by a secondary challenge during the chronic 
stage of malaria, the secondary response in the infected 
group again matched that of the normal group for 7-10 days.
A minor degree of immunodépression was then seen (fig 14 b
P 1 7 1  ) .
Salaman et al. (1969) have shown that mice in which 
the primary response was much depressed, by giving SRBC 
at the peak of P.yoelii infection, responded vigorously to 
a second dose of SRBC (estimated by the 4 day spleen plaque 
assay). This result agreed with my result for the period 
between 7-10 days after the second or third challenge.
Subsequent immunodépression following 10 days after the 
secondary response was comparable with that of Whitmore
(1974) who showed that the suppression of IgG and IgM 
splenic PPCs of the primary response to SRBC by mice 
previously infected with P .berghei resulted in a diminished 
response to subseauent challenge with this antigen.
Greenwood et al. (1971a) also primed mice infected with 
P.yoelii infection at the peak of parasitaemia and followed 
with a secondary dose of SRBC one month later and found 
a depressed primary type of response with high IgM (ME sensitive
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titres). They interpreted the results by measuring the 
SRBC antibody titres only at one point, 7 days after the 
SRBC injection. According to their results the total 
agglutination titres differed by log2 5.2 in the primary 
response and by only log2 2 in the secondary responses 
between the malaria infected groups and the uninfected 
Controls. These results agree with my data (fig 14 api6 8  ). 
This shows that memory to the primary infection was not 
impaired.
Initially comparable levels of antibody occurred 
against SRBC after the primary or secondary challenges in 
both infected and control mice, but subsequent lower levels 
in the infected group made me suspect that there was increased 
catabolism of SRBC antibodies associated with malaria 
infection (fig 14 a p 168). But this was not clearly shown 
in a preliminary passive transfer of hyperimmune serum 
against SRBC from uninfected donor mice to recipient mice 
5 days after infection with malaria. However this should 
be clarified by further passive transfer experiments 
transferring the hyperimmune serum to such mice at various 
times after malaria infection. In addition hyperimmune 
serum against SRBC raised in malaria infected and uninfected 
mice could be passively transferred to uninfected recipients 
and the relative rates of catabolism assessed as shown in 
expt B 3 p 10O , in order to assess avidity.

See table VI
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FIGURE 17 The effect of chloroquine on the antibody
response to SRBC (titres expressed as log2 )
c • The effects of antimalarial drurcs on the immune response 
of mice to SRBC
These experiments were designed to find out whether 
the antimalarial drugs, chloroquine, quinine and pyrimethamine, 
have any immunodepressive or immunostimulatory effect on 
the responses of mice to SRBC.
1. Chloroquine
Chloroquine was given intraperitoneally in two different 
doses to two groups of mice. One received 5 mg kg-1 and 
another 50 mg kg-1. The control group received 0.2 ml of 
distilled water. The mice were challenged intraperitoneally 
with 0.2 ml of 20$ SRBC 5 hours after the drug treatment. The 
agglutination, haemolysin, 2MER and 2MES titres were determined 
at 3-4 day intervals in all three groups. The responses in 
the experimental group receiving 5 mg kg-1 were comparable with 
those of the control. But the group receiving 50 mg kg-1 of 
chloroquine showed a significant difference (P<0.05 to 0.01) j 
in agglutination titre and 2ME resistant (IgG) titres on days 
11 f 151 and 18 though haemolysin titres and 2ME sensitive 
titres were similar to those of the control (fig 17).
2. Quinine
Quinine was also given in two different doses. One 
group received a single dose of 15 mg kg and another 
150 mg kg"1 i.p. The control group received 0.2 ml of 
distilled water as before. SRBC were given 5 hours after 
the drug treatments. Results differed little between 
groups (fig 18).

Table H I U  Statistical analysis of the data in Pig 18 (n=5)
Test Group Datä'v 4  7 11 14 18
G
0•H
P
fj Oc u•H P P **H G P H
ft
<
Control
Quinine . 
1 5 0  mg kg"
Significance
Mean 
SD -
¡lean 
S3 -
? <
4.5 7.8 9.2 8 . 6  9.6 
0 . 6  0 . 8  0 . 8  0.9 0.9
5.4 7.8 11.0 8 . 8  9.8 
0.9 0.5 1.4 2 . 2 1.5
NS NS 0.05 NS NS
Ly
si
n
ti
tr
e
Control
Quinine  ^
1 5 0  mg kg" 1
Significance
Mean 
S3 -
Mean 
S3 -
P <
5.0 7.6 9.4 0.0 7.8 
0.7 0.9 1.7 0 . 0  1.9
5.8 7.6 10.6 9.0 9.8 
0 . 8  0.9 1.5 0 . 8  1.5
NS NS NS 0.05 NS
P
G
P
C G •H G CO P G -H
U P
a
Control
Quinine . 
1 5 0  mg kg~i
Significance
Mean 
3D -
Mean 
3D -
P <
0 . 6  7 . 4  8 . 4  8 . 2  9 . 0  
0.9 0.9 1.1 0 . 8  1 . 2
0 . 2  7 . 2  1 1 . 0  8 . 8  10.3 
0.5 0 . 8  1.4 2 . 2  1.3
NS NS 0.02 NS NS
»>•HP
«H Oa G 
G p 
G P 00 P
Control
Quinine . 
1 5 0  mg kg"A
Significance
; ean 
SD -
Mean 
SD -
P<
4 . 0  0 . 4  0 . 8  0 . 8  0 . 6  
0 . 7  0 . 6  0 . 8  0 . 8  0 . 6
5 . 2  0 . 6  0 . 0  0 . 0  0 . 0  
1 . 1  0 . 6  0 . 0  0 . 0  0 . 0
NS NS NS NS NS
*  see
h
Table XIIIB Statistical analysis of the data in Fig 18 (n=5)
Test Group
•v j ) a y
Datîtv 4 7 11 14 18
G
0
•H Control Kean 4.5 7.8 9.2 8.6 9.6
- P
Cti 0> SD - 0.6 0 . 8 0.8 0.9 0.9
c  u
• H - P Quinine^ Mean 4.6 7.4 9.4 8.2 9.4
r H
15 mg kg 1 SD - 0.9 0.9 1.1 1.1 1.1
**>
8
<
Significance P < WS NS NS NS NS
Control Kean 5.0 7.6 9.4 8.0 7.8
G d>
• H G SD - 0.7 0.9 1.7 0 . 0 1.9
0Q - P
> S *H
h J  * P Quinine  ^
15 mg kg-i
Mean 
SD -
4.8
1.6
8.0
0.7
8.0
1 . 0
7.6
0.6
7.8
0.5
Significance P < NS NS NS NS NS
• P
S
* P
Control Mean 0.6 7.4 8.4 8.2 9.0SD - 0.9 0.9 1.1 0.8 1.2
63 Q  
* H  G Quinine . Mean 0.4 7.2 8.6 8.0 8.8
<I> *H  
- P
15 mg kg” SD - 0.9 0.8 1.1 1 . 0 0.8
g Significance P < IIS NS NS NS NS
<D Control Mean 4.0 0.4 0.8 0.8 0.6>
•H
SD - 0.7 0.6 0.8 0.8 0.6
- P
•HO/ Quinine 1 Mean 4.2 0.2 0.8 0.2 0.6
G -P 15 ng kg"1 SD - 1.5 0.4 0.4 0.5 0.6
r
Significance P < NS NS NS NS NS
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Ta'cle XI7A Statistical analysis of the data, in Fig 19(n=5)
Test Group Dat3> 4 7 11 14 18
co•H•P
£ 0 c u•H -P •P *H3 -p HVr.
«■4
Control
Pyrinethanine
2.5 ng kg ~L 
Significance
Mean 
SD -
Mean 
SD -
P<
4.5 7.8 9.2 8.6 9.6 
0.6 0.8 0.8 0.9 0.9
4.8 8.0 9.0 9.0 9.4 
1.1 0.7 0.7 0.7 0.7
ITS NS NS NS NS
Ly
ni
n
ti
tr
e Control
Pyrinethaainfi 
2.5 ng kg ”
Significance
Mean 
SD -
Mean 
SD -
P<
5.0 7.6 9.4 8.0 7.8 
0.7 0.9 1.7 0.0 1.9
4.8 8.2 9.2 7.4 7.8 0.5 0.5 0.8 0 6 0.5
NS NS NS NS NS
ME
 r
on
in
tan
t 
ti
tr
e
Control
Pyrinethanine 
2.5 ng kg”1
Significance
Mean 
SD -
Mean 
SD -
P<
0.6 7.4 8.4 8.2 9.0 
0.9 0.9 1.1 0.8 1.2
0.0 7.6 8.2 9.0 9.0 
0.0 0.6 0.8 0.7 0.7
NS NS NS NS NS
ME
 e
en
si
ti
ve
 
ti
tr
e
Control
Pyrimethamine 
2.5 eg kg
Significance
Mean 
SD -
Mean 
SD -
P<
4.0 0.4 0.8 0.8 0.6
0.7 0.6 0.8 0.8 0.6
4.8 0.4 0.8 0.0 0.4 
1.1 0.6 0.5 0.0 0.6
NS NS NS NS NS
* s<
TableXlVB Statistical analysis of the data in Fig 19(n=5)
Test Group XljayDath'-v 4 7 11 14 18
q0
•H
« P
d 0q u
• H - P  
- P  -H  
3  - P  
r H
to•<
Control
Pyrimethamine 
0 .2 5 mg kg “
Significance
Mean 
SD -
Mean 
SD -
P<
4.5 7.8 9.2 8.6 9.6 
0.6 0.8 0.8 0.9 0.9
4.8 0.0 9.6 8.2 9.2
2.6 1.0 1.1 0.8 1.3
NS NS NS NS NS
Ly
si
n
ti
tr
e Control
Pyrimethamine 
0 .2 5 mg kg-1
Significance
Kean 
SD -
Mean 
SD I
P<
5.0 7.6 9.4 8.0 7.8 
0.7 0.9 1.7 0.0 1.9
4.8 6.8 9.4 8.2 8.0 
0.5 0.8 1.8 0.5 1.2
HS NS NS NS NS
MS
 r
es
is
ta
nt
 
ti
tr
e
Control
Pyrimethamine 
0 .2 5 mg kg“1
Significance
Mean 
SD -
Mean 
SD -
P<
0 .6 7 .4 8 .4 8 .2 9 .0
0.9 0.9 1.1 0.8 1.2
0.3 7.0 8.8 8.0 8.4 
0.5 1.0 0.8 1.2 0.9
NS NS NS NS NS
ME
 s
en
si
ti
ve
 
ti
tr
e
Control
Pyrimethamine 
0 .2 5 mg kg“1
Significance
Mean 
SD -
Mean 
SD -
P<
4.0 0.4 0.8 0.8 0.6
0.7 0.6 0.8 0.8 0.6
4.5 1.0 0.0 0.2 0.8 
2.5 0.7 0.8 0.5 0.8
NS NS NS NS NS
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FIGURE 19 The effect of pyrimethamine in the antibody 
response to SRBC (titres expressed at 1og2)
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3. Pyrimethamine
Pyrimethamine was given intraperitoneally as a single 
dose at two dose levels to two groups of mice. One group 
received 0.25 mg kg-1 and another 2.5 mg kg-"1-. The normal 
control group received 0.2 ml of 2£ carboxymethylcellulose. 
Differences in the agglutination, haemolysin, 2KER and 2MES 
titres were again not detectable (fig 19 ).
DISCUSSION
Chloroquine is not just an antimalarial but has been 
used effectively in the treatment of collagen diseases such 
as rheumatoid arthritis (Bagnall,1957; Scull, 1962). It 
was also claimed to be a useful drug in the treatment of 
discoid lupus erythematosus, in polymorphic light eruption 
(Cahn et al., 1954; Epstein I960*, Merwin and Winkelraannj 1962) 
and in solar urticaria (Brunsting and Epstein,1957).
Peters (1970a), in his review on the direct effect of 
antimalarialdrugs on immunity, suggested that chloroquine, 
related 4-aminoquinolines, mepacrine and pyrimethamine 
produce immunosuppression of the host. Hurvitz and 
Hirschhorn (1965) showed that chloroquine in high 
concentrations suppressed the in vitro lymphocyte response 
to phytohaemagglutinin and to streptolysin 0 antigen, but 
with low doses (10-2 mg ml-1) the suppressive effect could 
bo seen only if the drug was added early to the culture.
The authors proposed that the action of chloroquine is due 
to the stabilization of lysosomal membranes and orevention 
of release of enzymes reauired during the initiation of 
depression of lymphocytes.'
A c c o r d i n g  "to P e t e r s  (1970a), the erythrocytic parasitaemia 
w i t h  c h l o r o q u i n e  r e s istant strains of P.berghei reached 
h i g h e r  le v e l s  in mice t reated w i t h  hig h  doses of chlorocuine 
o r  quinine than in anim a l s  that had received lower doses 
o f  drugs. This effect, a c c ording to him, w a s  due to the 
i m m u n o s u p p r e s s i v e  effect of the drugs, w h i c h  could not be 
e l i c i t e d  w i t h  a  dru g  sensitive st r a i n  of p l a s m o d i u m  infection.
In the experiment IV C.l, chloroquine did not show any 
sign of immunodépression of SRBC antibody titre at a dose 
level of 5 mg kg-1, but with the high dosage of 50 mg kg-1 
there was significant depression of agglutination titres 
on days 11, 15, 18 and also in the ME resistant titre (IgG) 
on days 15 and 18. 50 mg kg“1 dose of chloroquine is much 
higher than that of the human oral dosage of 1500-1800 mg 
given over 4 days and equivalent to 20-26 mg kg 1 (Ross 
Institute, 1975). One cannot be sure whether such a dose 
given over 4 days would produce pronounced immunosuppression 
or not.
Whitehouse and Bostrom (1965) referring to other workers 
stated that chloroquine has no effect on the immune response 
of the rabbit and guinea pig. Thompson and Bartholomew 
(1964) (reported by Sams, 1967) tested the ability of 
rabbits to produce circulating antibody to typhoid 0 and 
H antigens and to bovine serum albumin. It was found that 
chloroquine had absolutely no effect on this ability.
Kalmanson and Guze (1965) demonstrated that hydroxychloroquine 
had no effect on either the primary or the secondary anti­
body response to diptheria toxoid or on the delayed tuberculin
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hypersensitivity reaction in guinea pigs.
Pyrimethamine is an antimetabolite and its effect on 
plasmodium is by inhibiting some metabolic process like 
dihydrofolate reductase function for synthesis of tetra— 
hydrofolate co-factors (see page 5a ). Other anti-folic 
acid substances like methotrexate have marked immuno­
suppressive properties (Aisenberg, 1970) which might 
therefore be a feature of chemotherapy with drugs like 
pyrimethamine.
Experiments using either the high or the low dosages 
of quinine and pyrimethamine had no significant effect on 
the antibody titres to SRBC in mice. Chloroquine at 50 mg kg" 
and quinine at 150 mg kg“1 i.p. are the highest dose levels 
that can be given to CBA mice without killing them. Also 
pyrimethamine at 2.5 mg kg“1 is much higher than the human 
therapeutic dosage of 50 mg i.e. 0.08 mg kg“1 (Ross Institute,
1975).
Immunosuppression depends to a considerable extent on 
the appropriate timing of drug and antigen. Aisenberg (1967) 
investigated the suppression in mice of the response to a 
nonreplicating antigen (SRBC) with the alkylating agent 
cyclophosphamide. According to him cyclophosphamide must 
be given simultaneously with the antigen or within the 
proceeding 24 hours to achieve complete suppression at a 
low drug dosage (165 mg kg"1), while at higher drug levels 
(330 mg kg"1) the agent can be given up to 48 hours before 
or after the antigen. With a replicating antigen, the 
immunosuppressant must be delayed to allow the antigen to 
build up to the necessary level (Aisenberg, 1970). In my
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experiments, the drugs were given 5 hours before the non 
replicating antigen (SR3C) and were of both high and low 
dosages. So if the drugs have an immunosuppressive effect 
it should be detected because the dose of the drugs and the 
timing met the criteria put up by Aisenberg (1970).
Chloroa.uine at a dose of 50 mg kg-'*' produces some 
immunodépression in mice but 5 mg kg-1 does not. It is 
doubtful whether normal therapeutic doses of chloroquine in 
man are immunosuppressive, but it is wise to look for it 
especially when this is given in high doses against the 
chloroquine resistant strains of P ♦falciparum. Otherwise 
chloroquine might produce an increased drug resistant strain. 
It has been shown that reduction of the immune response of 
the host facilitates the emergence of drug resistant 
strains of parasites (Peters 1970a) and also the occurrence 
of a selection of resistant mutants under drug pressure (Peters 
1970b). So chloroquine might act both ways by suppressing 
the immune response of the host and by a constant drug
pressure
. *
D. Resistance to reinfection after drug 
treatment of P .chabaudi infections
1 9 2
These experiments were designed to find out whether 
supnressive or curative treatment that would still allow 
the development of a strong immunity was possible.
1. Resistance to reinfection
The experimental group of 12 mice was infected by
7inoculation of 1 x 10 P.chabaudi from two donor mice.
The control group was injected with 0.2 ml of PBS per mouse. 
The parasitaemia is shown in fig 20 . Challenge infections 
were made on day 66 of the infection on the assumption that 
there were no more parasites in mice of the test group.
(see experiment IVAla p 125 )• The challenge inoculum was 
1 x 107 infected erythrocytes obtained from.two donors 
infected with the original stabilate (LUMP 1156).
The experimental group showed a solid immunity to 
reinfection while the uninfected challenge control group 
of mice gave a normal pattern of parasitaemia with a peak 
parasitaemia of 32$. (fig 20).
2. Suppressive chemotherapy and immunity to reinfection
Preliminary experiments established that i.p. injections 
of chloroquine of 10 mg kg“1 .or more for 7 days cured .
P .chabaudi infections in CBA mice and the maximal dose of
a single i.p. injection which would not kill the mouse was 
50 mg kg-1.

Table XVA Statistical analysis of the data in Pig 20
Group No. of 
mice
N^y
DaWs 1 4 7 9 15
18 21 25 28
CMK\ 35 66 0 3 8 12 18 20 jo reduction paras i?aem.ia
Chloroauine , 
40ag kg“ aay L 
from -1 to +3
8
Mean 
SD -
0.01 0.0 
0.01
0.0 0.0 0.4 13.0 
0.1 2.8
7.5
3.5
0.0 0.0 0.0 0.0 0.0 0.0 1.5
0.9
0.01
0.01
0.0 0.0 0.0 95/-
Chloro^ine  ^
10m.“ kg day 
from -1 to +3
8
Kean 
SD I
0.02 0.0 
0.02
0.0 0.0 4.5
2.2
5.9
4.0
0.0 0.0 0.0 0.0 0.0 0.0 0.0O
&
0)
0.3
0.4
0.01
0.01
0.08
0.2
0.0 0.0
99^
Jhloro,iu|ne 
10 mg Yg eay-l 
from -1 to +5
8
Mean 
SD -
0.C5 0 .0  
0.8
0.0 0 .0 0.0 0.3
0 .6
3.2
7.2
0.0 0.0 0.0 0.0 0.0 £ 0.0o
0)CK
0.7
0.3
8.0
7.2
0.2
0.02
0.0 0.0
Ghlorouuine . 
10mg kg”1day“1 
from -1 to +7
8
Kean 
SD -
0 .0 3 o.o 
0.04
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3
0.2
2 3 . 0
12.0
0.4
0.3
0.02 0.0 
0.04
28Jt
Infected control 12 Kean 1.3 13.0 27.0 11.0 0.07 0.0 0.0 0.3 0.02 0.0 0.0 0.0 0.0 0.0 c.o 0.0 0.0 ioo£SD - 0.8 7.0 12.0 5.1 0 .0 3 0.2 0.01
Challenge
control
8 Kean SD -
- - - - - - - - - - - 0.0 0.5
0.3
3 2 . 0
18.0
7.0
3.2
0.08 0.01 
0 . 0 3  0 . 0 1
-
- the percentage reduction (r) of parasitaemia (maximal) in the experimental groups relative to the mean percentage psrasit'-enia 
(maximal) of the control group was calculated by r = 100 - f  experimental group x 100\
\challenge control group /
- the percentage reduction (r) of pnrasitaemia (maximal) in the experimental groups relative to the near, percentage perasit'-emia 
(maximal) of the control group was calculated by r = 100 - f  experimental group x 100\
\challenge control group /
i ■ ■ ■ ■4  8 c  o
m n / a £ C L. A A
Ul i i t l t
.. „ . . f w i t h  P. Chabaudi after suppressive chemotherapy of the primary 
FIGURE 20 Resistance to reinfection wit ------------
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a * Effets of high doses of suppressive chemotheruny with 
chloroquine
The standard inoculum of P.chabaudi infection was 
given to two groups of 8 mice. One grout) was kept as 
controls and the other received an i.p. injection of 
chloroquine at 40 mg kg-1 from days -1 to 3. A third 
grouD of challenge control mice received only 0.2ml of PBS.
Fig 20 shows the parasitaemia patterns. In the 
experimental group, the parasitaemia was below 0.015# on 
day 1 and was then undetectable in blood films. Parasitaemia 
was then detectable again on day 15 with a mean parasitaemia 
of 0.4# and a maximum of 13# on day 18 of the infection.
After rechallenging on day 66 of the infection, there was 
a very low parasitaemia (1.5#) in the experimental group 
compared to 32# in the challenge control group.
b. Effects of moderate doses of sutmressive chemotherapy 
y/ith chloroquine
One group 00 of 8 mice received 10 mg kg 1 of 
chloroquine i.p. from days —1 to 3 of the infection^ 
another group 0$ the same dose per mouse from days -1 to 5* 
and C from days -1 to 7•
The parasitaemias obtained are shovm in fig 20 •
A H  the groups of treated mice had very low levels of 
parasitaemia (0.02-0.05#) on day 1 v/hich then became negative. 
The infection remained negative for more than 5 days in 
group A mice and for more than 10 days in group B. The 
maximal mean parasitaemias were of 5.9# and 3.2# respectively 
Group C remained negative throughout.

Table XVB Statistical analysis of the data in Pig 21
Group No. of mice
V^ay
DaN 2 5 10 15 19 22 26 29 33 36 66 0 3 8 11 17 20 r reduction of parasitaemia
Chloroquine . 
2 re kg’1 day’
12
Mear: 0.4 0.3 0 .01 0.09 0.09 O.OJ 0.5 1.3 0.4 0 .0 0 .0 Oc
aJrza 0 .0 0 .0 0 .0 0 .0 0 ,0 IOO5:fron -1 to + 19 3D - 0.3 0.01 0 .01 0 .2 0 .0 2 0 .6 2 .2 0.4 0.3 m • H • m «» m mdays
Challenr* 8 Mean
5
o4>«
0 .0 0.5 32.0 7.0 0.08 0 .01
control 0.3 1 2 .0 3.2 0 .0 3 0 .01
- see table XVA for the oaloulation of reduction of paraaitaemia.
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On reinfection, the group treated for 7 days (group B) 
had significantly higher mean (p <  0.001) peak paracitaemias 
(7/°) than those treated for 5 days (group A) with mean peak 
at 0.3$. Both were,however*significantly lower (P <  0.001) 
than the challenge controls of mean parasitaemia 32$.
Group C mean peak parasitaemia (23$) was not significantly 
different from the controls.
c. Effect of low dose suppressive chemotherapy with 
chloroquine
The experimental group consisted of 12 mice each treated 
with chloroquine at a dose rate of 2 mg kg- "^ daily from 
days -1 to 20 of the infection. The mice remained 
parasitaemic but below a mean level of 0.4$ (see fig 21 ).
The maximum mean parasitaemia went up to 1.3$ after 
treatment and the duration of the period of patent infection 
was 36 days.
When reinfected on day 66 with the standard inoculum, 
the mice remained uninfected by blood film examination.
3. Therapeutic chemotherapy and immunity to reinfection
a. Effects of curative treatment
Though treatment with 10 mg kg ^ of chloroquine for
7 days will cure a P « chabaudi infection attempts were made 
to find out the correlation between different doses of the 
drug and development of immunity to homologous challenge.
Three groups each of 10 mice, were inoculated with 
1 x IO* 7 P.chabaudi infected orythrocytos on day 0. The 
first group received 10 mg kg-1, the second 20 mg kg"1

Table XVI Statistical analysis of the data in Fig 22. (n»8)
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and the third 40 mg kg ^ daily. Controls were included 
as before and the challenge was given 68 days after the 
primary infection. All three treated groups were cured 
completely by the third day of the treatments (fig 22 ).
iVhen blood, spleen, kidneys and liver tissues v/ere sub- 
inoculated from mice of each group into uninfected mice on 
day 46 of the infection, no detectable infections were 
produced.
After challenge, the mean peak oarasitaemias in the 
treated groups were all below 6fl and were significantly 
different (P <  0.001) from the challenge control (34 - 3.2). 
Though the durations of the infections in these groups 
v.ere similar, they were also shorter than those of the 
challenge control group.
b. Effects of treatment at various stages of the infection
The experiment was designed to find the effect on 
development•of resistance to reinfection by curing mice 
at various stages of the infection. There were four 
experimental groups, each of 10 mice (fig 23 )• Treatment
was started on day 2, 4, 6, or 14 after infection with 
P.chabaudi. Chloroquine at 10 mg kg-1 was given daily to 
mice of each group for 7 days. Two control groups were 
included as in previous experiments. In all cases infections 
lasted 2-4 days after the onset of treatment. Subinoculation 
of blood, kidneys and liver from 2 mice of each experimental 
group into two uninfected mice was performed on day 52 of 
tho infection and all gave negative results.

rafcle X7TI Statistical analysis of the data in Pig. 23. (n=0)
Group SJfeyDa£Nv. 2 5 9 13 15 22 26 66 0 2 5 9 11 18 21
reduction
of
parasitacnia
Group treated Mean 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 5.9 2.1 11.5 0.0 0.0 cc
on cay 2 SD - 0.8 0.3 3-5 3.2 10.9 -
Group treated Mean+ 1.9 6.8 0.0 0.0 0.0 0.0 0.0 o.o 0u 0.0 0.2 2.5 5.7 3.8 0.0 0.0 ■v?COon day 4 SD - 0.2 1.6 G<L> 0.2 2.4 5.8 4.0
Group treated Mean 1.5 4 0 .0 0.02 0.0 0.0 0.0 0.0 0.0 | 0.0 0.4 6.0 0.6 6.5 0.0 0.0 Olid
on day 6 SD t 0.6 5.7 0.02 O0(S 0.13 4.7 1.0 03 • VJ1
Group treated Kean 1.5 42.2 10.0 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.03 0.0 0.0 0.0 0.0 9#on cay 14 SD - 0.6 4.7 5.3 0.9 0.5 0.02
Challenge Mean - - - - - - - - 0.0 0.7 36.0 1.0 0.5 0.2 0.0
control SD - 0.3 5.1 0.4 0.4 0.1 0.0
see table XVA for the calculation of /£ reduction of parasitaemia
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FIGURE 23
laci t.l I
The effect of curative chloroquine treatment (lOmg kg 1 day 
|p. Chaboudi infection in resistance to reinfection
x 7) of various stages of 
challenge
20 4
After challenge on day 66, there was not much 
difference between groups of mice treated from day 4 or 
from day 6 of the primary infection. Kice treated from 
day 2 had significantly higher (P < 0.001) mean peak 
parasitaemia (11#) than those treated from day 4 (3.8#) 
on day 6 (6#). The group in which treatment started on 
day 14 of the infection had a significantly low (p <  O.OOl) 
level of parasitaemia (peak 0.6#) and shorter duration of 
infection than the other experimental group.
The challenge control group showed a maximal mean 
•oarasitaemia of 36# and the normal infected group had a 
solid immunity to reinfection.
DISCUSSION
P.berghei is not a suitable parasite for studies on 
resistance to reinfection in mice because it is so virulent, 
and is therefore a poor model for human malaria (Brown et al.,
1976). P.chabaudi.on the other hand,produces a chronic 
pattern of infection in CBA mice resulting in solid immunity 
after resolution. It was suitable therefore for studies 
on the induction of antimalarial immunity and an analysis of 
the immune response. Where drug treatment was required in 
these experiments chloroquine was used since it is the most 
commonly used antimalarial drug and is effective against 
P .chabaudi infection.
Cox (1958) and Gilbertson et al. (1970) treated P.berghei 
infection in mice with 20 mg kg"1 of chloroquine daily for 
5 days but there was still 35-40# mortality. Sergent and Pone et 
(1956) treated the first attack of P . berghei^ in mice with
25 mg kg 1 of chloroquine, bat the infection recrudesced 
and the mice died. A single dose of drug given after malaria 
infection (the "Rane test") has been used by some workers 
for screening purposes. Peters (1970a) and Pinder (1973) 
in their reviews on the "Reme test", concluded that chloroquine 
is active against P .berghei but i6 not curative. In my 
experiments I managed to cure up to 50-75# of the mice with 
chloroquine (10 mg kg-'*') given for 14 days, and 13-38# with 
7 day treatment.
A solid immunity was demonstrated by challenge 66 days 
after infection (expiv D-1 p i g s  ). The immunity obtained on 
that day was likely to be sterile i.e. maintained in the 
absence of parasites, since blood, kidneys, spleen or liver tissue 
injected from the infected mice into recipient mice did not 
produce any infection. Cox (1970) has shown that 80# of 
the mice infected with P.chabaudi recovered and produced a 
solid acquired immunity. He also claimed that the immunity 
was of sterile type after 8 weeks of infection and lasted 
for over 5 months. The occurrence of a sterile immunity 
following malaria infections in mice has been reported for 
P .berghei (Y/eiss and De Giusti, 1966), for P . vlnckei (Cox, ( e.<K- 
1966.) and in P.yoelii (Barker, 1971). Corradetti (1963) 
also reported a sterile immunity of P.berghoi in rats. 
Jayawardena (1975) has demonstrated the persistence of 
P.yoelii infection in the kidneys of CBA mice 4 weeks after 
the regression of the parasitaemia.
So, though a sterile immunity is likely, the possibility 
of the parasite surviving somewhere in the body must be 
considered. On the other hand, drug-cured malaria infections
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25 nig kg of chloroquine, but the infection recrudesced 
and the mice died. A single dose of drug given after malaria 
infection (the "Rane test") has been used by some workers 
for screening purposes. Peters (1970a) and Pinder (1973) 
in their reviews on the "Rane test", concluded that chloroquine 
is active against P.berghei but is not curative. In my 
experiments I managed to cure up to 50-75# of the mice with 
chloroquine (10 mg kg-^) given for 14 days, and 13-38# with 
7 day treatment.
A solid immunity was demonstrated by challenge 66 days 
after infection (expiv D* pi a a ). The immunity obtained on 
that day was likely to be sterile i.e. maintained in the 
absence of parasites, since blood, kidneys, spleen or liver tissue 
injected from the infected mice into recipient mice did not 
produce any infection. Cox (1970) has shown that 80# of 
the mice infected with P.chabaudi recovered and produced a 
solid acquired immunity. He also claimed that the immunity 
was of sterile type after 8 weeks of infection and lasted 
for over 5 months. The occurrence of a sterile immunity 
following malaria infections in mice has been reported for 
P.berghei (Y/eiss and De Giusti, 1966), for P.vinckei (Cox, f e.Gx- 
1966.) and in P.voelli (Barker, 1971). Corradetti (1963) 
also reported a sterile immunity of P.berghei in rats. 
Jayawardena (1975) has demonstrated the persistence of 
P.yoelii infection in the kidneys of CBA mice 4 weeks after 
the regression of the parasitaemia.
So, though a sterile immunity is likely, the possibility 
of the parasite surviving somewhere in the body must be 
considered. On the other hand, drug-cured malaria infections
are a more sure way of showing the existence of a sterile 
immunity (Cox, 1966a). Chemotherapy from days -1 to 7 of 
infection suppressed the first wave of parasitaemia. Thera 
was no recrudescence of the parasitaemia and no immunity to 
challenge. There was resistance to reinfection when the. 
suppressive chemotherapy was followed by a recrudescence. 
Mice given suppressive chloroquine treatment (10 mg kg-"*") 
from days -1 to 3 recrudesced 5 days earlier and with higher 
parasitaemia than the group treated from days -1 to 5. On 
rechallenging, the first group had significantly lower 
parasitaemia than the second.
The results of the experiment D 3b (pa 0 1 )  supported 
the previous experiment in some ways by showing that immunity 
in malaria infection can be achieved by curative treatment 
early in the infection. The immunity obtained by treating 
the infected mice on days 1, 2, 4, or 6 was not significantly 
different (figs 22 and 23 ). The strongest immunity to 
challenge was obtained by treating the malaria infection 
on day 14 (fig 23 ).
(1966) have shown that, though
cross—resistance to x , vincKei inieuiiiuu uc nuum>
hours after a P.chabaudi infection, the maximal protective 
effect was seen only during the second week of the P.chabaudi
Jerusalem (197^ have also shown that 
n Swiss or C3H/ST2 mice produced maximal
infection
infection
parasites from the blood. They did get some immunity when 
treatment started on day 0 but, though their results could 
not be compared directly with mine, best protection was 
obtained by treatment at a comparable stage in the infection. 
When chloroquine was given at a dose rate of 40 mg kg-^ from 
days —1 to 3, recrudescent infections were not significantly 
different after treatment with 10 mg kg-1 for the same period 
of infection. On rechallenging also, the parasitaemia levels 
were not significantly different from each other.
Afridi and Rahim (1959*. 1962) have shown less effective 
protection against human malaria using a single high 
suppressive dose of pyrimethamine (50 mg) than a lower dose 
(25 mg). According to Eling and Jerusalem (1977), the degree 
of immunity is related to the number of surviving parasites 
in the host which is inversely proportional to the amount 
of drug administered. So effective drug treatment diminishes 
the number of parasites and the development of immunity.
This general assumption seems to apply in my experiments 
where complete suppression of parasitaemia with chloroquine 
from -1 to 7 days did not produce any immunity at all.
When the malaria infection was maintained at low levels 
for a long period of time by subcurative doses (chloroquine 
2 mg kg“’'*' daily) , the mouse acquired a solid immunity and was 
aparasitaemic after challenge. Carrescia and Arcoleo (1957) 
tried to prolong the parasitaemia of P « berghe i infection in 
mice by repeatedly treating them with 5 mg kg of chloroquine 
during the primary attack and during each relapse. They 
managed to demonstrate some immunity by this method.
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Gilbertson et_al. (1970) suppressed P .berghei infection in 
mice for 90 days with a PABA-deficient milk diet and were 
able to demonstrate immunity. According to them, a short 
high parasitaemia was not enough to promote measurable 
resistance and they concluded that the duration of a first 
infection was more important. However, this method of 
suppression by chemotherapy in the human situation might 
provoke the development of drug resistant strains if 
prolonged (Peters, 1970a).
Some resistance to reinfection was obtained by curing 
the infection from day 1. Upon rechallenge on day 68, the 
peak parasitaemia was below 6# compared with 33# in the 
challenge controls. This resistance to reinfection does 
not seem to depend on the dosage of curative drug used,
10 mg kg-1 daily for 7 days being as effective as 40 mg kg-1; 
That immunity develops within this short period of infection 
(24 hours) has been shown by Nussenzweig et al. (1966). 
According to them, 24 hours after P.chabaudi infection, mice 
were resistant to rechallenging with a virulent strain of 
P ♦vinckei. Though the authors could not prove that this 
was an immunological response they did show that resistance 
was not due to PABA deficiency.
In ray experiments the inoculum size was very high 
( l x  10^) and if these parasites died a great deal of antigen 
would be released to stimulate the immune response. Immunity 
to malaria infection has been induced by using parasitic 
fractions as immunogens (Zuckerraan et al., 1967; Jerusalem 
and Bling , 1969; D'Antonio et al., 1970; and Hamburger and
1976). Though chloroquine given at a dose ofZuckerman
2 0 9
10 mg kg is effective enough to bring down the parasitaemia,
40 mg kg for 4 days has also been shown to allow a relapse. ■
This means that though the parasite count in the peripheral 
blood became negative some parasites were still surviving 
to provoke the immunity.
On the other hand, the soluble antigens may be produced 
by the phagocytic cells after taking up the parasites (Seitz, 
1976). Soluble malarial antigens have been shown with different 
¡species of plasmodium infections(p.37).Seitz (1976) showed that 
antibodies directed against the soluble antigens are more 
reliable indicators of the immune status of the animals than 
the fluorescent antibody. He also demonstrated that 
plasmodial extracts prepared by breaking up parasite material 
by physical means contain less antigen than the supernatant 
of the macrophage cell culture or sera from the infected 
mice.
y.u>
Cox^( 1966v) has shown an immunogenic effect against 
P .berghei could be obtained in rats by the injection of soluble 
antigens extracted from the plasma of monkeys during acute 
P.knowlesi infection. So, we can assume that soluble antigens 
are produced during treatment and these antigens are necessary 
for the provoking of the immune response of the animal.
However, Collins et al. (1977) attempted to immunize monkeys 
against P.knowlesi infections by serum-soluble S—antigens. 
According to them the protection obtained by this method was 
incomplete and that the antibodies to the soluble antigens 
had only a limited role in protection of the host against
But it has been suggested by Wilson (1974)malarial infection.
that S-antigens are of host origin. According to him,
the soluble antigens circulate for a week after chemotherapy
and induced homologous antibody.
The exact mechanism of resistance to reinfection in 
malaria infection is not known. Rank and Weidanz (1976), 
have shown that after curative treatment of P . gallinaceum. 
bursaless chickens resisted a challenge infection with the 
same parasite and they suggested that non-sensitizing 
immunity is B-cell independent. Gravely and Kreier (1976) 
prepared T and B lymphocytes from spleens of rats immune to 
P.berghei and transferred the cells to non-immune rats to 
test their ability to control a challenge infection. According 
to them, a B-cell enriched fraction prepared on nylon wool 
columns was more protective than immune T-cells but less 
protective than a combined T and B cell population. They 
suggested that a differentiated B-type lymphocyte, which, 
lacked both theta antigen and the complement receptor, probably 
an antibody-producing cell, was responsible for 
conferring immunity to malaria.
Jayawardena (1975) showed that immune spleen cells were 
highly effective in transferring immunity to normal and T-cell 
deprived recipients. Treatment of these cells with anti-theta 
antiserum did not remove their protective effect, so they 
suggested that the effector cells in the immune spleen cell 
population were not T-cells.
McDonald and Phillips (1975) demonstrated that when 
unfractionated spleen cells from mice immune to P.chabaudi 
infection were transferred to donor mice, they conferred 
resistance to reinfection, T-cells alone were less effective
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and immune macrophages transferred little or no protection. 
According to them the resistance to reinfection was due to 
the co-operation of T-cells with other cells, probably 
radiosensitive cells. They were supported by the work of 
Brown et al. (1976) , who demonstrated that unfractionated 
spleen cells and T-cells from P .berghei-infected rats could 
transfer protection to syngenic recipients as early as 11 days 
after infection of cell donors. They also showed that 
protection conferred by T-cells increased with the duration 
of the infection in the donors, at least up to 100 days, and 
the additional presence of B-cells in transferred lymphocyte 
populations enhanced the protective capacity shown by T-cells 
alone. The authors suggested that the protective immunity 
is likely to be due to the T-cells exerting their protective 
action mainly through specific co-operation with B-cells. 
Roberts et al. (1977) also demonstrated by a series of 
experiments in Nu/Nu mice infected with P.yoelli that T-cells 
play a crucial role in the control of malaria infection by 
their helper function in the production of antibody. In my 
preliminary studies, the chloroquine cured P.chabaudi infected 
T-cell deprived mice were not as resistant to reinfection as 
intact treated controls. Probably this indicates that T-cells 
play a major role in the resistance to reinfection, though 
some other cells may play some part as well.
However, my experiments showed that duration of infection 
was as important as density of parasitaemia for development 
of immunity after chemotherapy.
£• Drug treatment of P .bergnei in intact 
and T-cell deprived mice.
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1• The effect of early treatment with chloroquine
a- Suppressive treatment with chloroquine for 4 days from 
the day of infection (day 0)
T-cell deprivation for this experiment was by adult 
thymectomy, irradiation and bone marrow reconstitution.
Three groups of mice, T-cell deprived, sham thymectomized 
and intact (normal), were infected with P.berghei and' 
treated with 10 mg kg-^ day'^of chloroquine on days 0-3 
inclusive. Control groups were infected but not drug 
treated.
The pattern of parasitaemia( table XVIIlBpf "the three 
untreated groups were similar. The parasitaemia was below 
1.5# on day 3 and rose to 18-25# on day 8. Terminal 
parasitaemia ranged from 30—65#, and intact and sham 
operated mice began to die on day 7, while the first death 
of the deprived control mice was on the 32nd day. The mean 
survival time for the intact group was 16.2 - 8.7 days, for 
the sham group was 16.2 - 5.5 days and for the deprived 
group was 36.2 - 3 days.
Mice in the treated groups remained aparasitaemic for at 
least 8 days on blood film examination, (fig 24< ). 5 out of 10
intact and treated mice became blood film positive and died 
with a mean survival time of 28.2 — 5.6 days. Only 2 out of
10 mice from each of the sham and T-cell deprived.
groups became parasitaemic and died with mean survival times

Table XVIIIA Statistical analysis of the data in Fig 24 (n»10)
r
Group Data"- 3 5 8 10 12 15 17 19 22 26 29 33 35 37 ..
Denrived Mean 0.0 0.0 0.0 0.02 6.9 9.3 14.1 18.4 14-5 14.3 2.1 24.8 15.3 12.0
treated SD - - - - 0.01 3.2 4.2 8.8 6.6 5.7 3.8 12.7 5.3 6.8 2.7
Intact Mean 0.0 0.0 0.0 0.01 0.7 11.5 3.7 4.0 20.7 2 4 .6 19.8 l.i 5.0 4.0
treated SD- - - - - 0.8 14.7 1.1 2.3 4.1 9.3 30.6 0.0 0.0 0.0
Significance P < NS NS NS NS 0.001 NS 0.01 0.001 0.05 0.02 NS 0.001 0.001 0.001
Deprived Kean 0.0 0.0 0.0 0.02 6.9 9.3 14.1 18.4 14.5 14.3 2.1 2 4 .8 15.3 i2.o : •
treated SD 1 - - - 0.01 3.2 4.2 8.8 6.6 5.7 3.8 12.7 5.3 6.8 2.7
Sham Mean 0.0 0.0 0.0 0.02 0.3 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
treated SD - - - - - 0.4 0.9 - - - - - - - -
Significance P< NS NS NS NS 0.001 NS 0.001 0.001 0.001 0.001 NS 0.001 0.001 0.001 . . .
The figures correspond to the nean percentage parasitaernia and SDs of the recrudescences (2 in both sham and 
deprived treated group and 5 in intact group).
For untreated controls see Table XVIIIB
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Table X7III3 Statistical analysis of the untreated infected controls for Table XVIIIA. (n=10)
*see table VI
of 17 days and 34.3 — 6.2 days respectively.
The recrudescent parasites were stabilated on day 
15 for drug sensitivity testing.
b. Treatment with chloroouine for 7 days from day 2 of 
infection
T-cell deprivation in this experiment was by adult 
thymectomy and ATS (1) treatment. Prom day 2, treatment 
with chloroquine at 10 mg kg-1 daily for 7 days was given 
to groups of deprived, sham deprived and intact mice. The 
parasitaemia was measured every 2-3 days (fig 25 ). The 
patterns of parasitaemia of the three untreated control 
groups were again similar. The parasitaemia was about 1# 
when treatment was started and reached 30-40# on the 14th 
day. Terminal parasitaemia was 50-65#. The deaths in the 
intact untreated group started on the 9th day and in the 
T-cell deprived animals on the 23rd day. The mean survival 
time for the intact group was 18.1 - 6.4 days, sham 20.4 -2*7 
and the deprived group 25.8 — 3.5 days. The treated groups 
became aparasitaemic after 3 days of treatment and remained 
so until day 16 of the infection in intact and day 18 in 
deprived and sham deprived mice. In the intact group, 7 
out of 8 mice showed a recrudescence of infection, and died 
with a mean survival time of 32 — 17*1 days. 4 out of 8 
in the T-cell deprived group showed a recrudescence starting 
from day 18 of the infection. Only 1 died from the T-cell 
deprived group on day 62 of the infection. The rest 
recovered. The parasites were stabilated on day 21 as 
before (fig 25' )«
¡mu***'
X
fTable XIXA Statistical analysis of the data In Fig 25a. (n»8)'
Croup <2ay 2 4 7 9 11 14 lé 18 21 23 25 31 33 37 41 43 48 52 55 60
*
Deprived Mean 1.4 0.01 0.0 0 . 0 0 . 0 0 . 0 0.6 0.03 0 .9 0.8 1.6 1 .6 1.2 0.2 0.4 0.2 0.1 1.0 0 .4 0 .4
treated 3D Î 1 . 0 0 . 1 - - - - 0.02 0.01 0 .5 0.3 0.8 0 .6 0.3 0 . 1 0.2 0.03 0.04 0 .0 3 0 .1 0.2
Intact .Kean 1 . 1 0.02 0.0 0.0 0.0 0.0 0.06 2.4 5 .8 4.2 9.0 2 7 .0 3 2 .0 2 9 .0 3 2 .0 54.0 15.0 28.0 3 2 .0 31.0
treated 3D - 0 . 3 5 0.02 - - - - 0.06 1.5 2.1 1.8 3.1 6 .1 7.1 3.8 9.8 12.0 6.2 10.5 1 3 .0 14.0
Signifi­
cance P< 123 - ¡25 1*3 M5 UZ ITS 0 .0 0 1 0 .0 0 1 0 .0 0 1 0 ,001 0 .0 0 1 0 ,0 0 1 0 .0 0 1 0 .00 1 0 .00 1 0 .0 0 1 0.001 0.001 01001
« see table XIXS for untreated controls and table VI for abbreviations
- The figures correspond to the mean parasitaemias of recrudescences only 
(7/8 + in intact, 4/® + in deprived mice after treatment.)
lCil FIGURE 25 P. berghei - mean percentage parasitaemiasin T-cell-deprived and intact control
RBC and treated with chloroquine 10 mg kg
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Table XIXB Statistical analysis of the untreated infected controls for Table XIXA. (n»3)
Group v^ay 2 4 7 9 11 14 16 18 21 23 25 27
Deprived
infected
control
Mean 1.0 6.0 10.0 6.3 13.0 34.0 43.5 43.4 53.0 63.0 65.0 62.0SD - 0.3 1.1 5.3 2.0 3.9 12.8 12.8 10.8 19.9 6.E 9.1 5.0
Intact
infected
control
Mean 0.7 4.03 9.5 8.0 18.0 36.0 56.0 5 2 .0 67.0 57.0 DSD - 0.2 2.7 3.2 1.7 3.1 8.2 6.3 5.7 4.6 3.5
Significance P < 0.05 NS WS NS 0.02 NS 0.05 NS ns 0.05 - -
Deprived
infected
control
Mean 1.0 6.0 10.0 6.3 13.0 34.0 43.5 43.4 53.0 63.0 65.0 62.0
SD - 0.3 1.1 5.3 2.0 3-9 12.8 12.8 10.8 19.9 6.8 9.1 5.0
Cham
infected
control
Mean 
SD -
0.8
0.2
5.0
0.8
7.0
1.7
6.0
1.6
15.0
3.1
37.0
9.0
53.08.6
61.0
4.2
63.0
4.2
D - -
Significance P< • NS NS NS WS •NS NS NS 0.001 NS - - -
-see table VI 
D - death


Table XX Statistical analysis of the data in Pig 26. (n=8)
Group s4£yDat^ v 2 4 •7 9 11 14 16 18 21 23 25 27 31 37 - Figures after day 16 correspond to mean
Deprived
treated
Mean 
SD -
0.8
0.2
0.02
0.01
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
percentage parasit- 
aenias of recrudes­
cences only.
(4/8 recrudesced in 
intact group).
Intact Kean 0.6 0.03 0.0 0.0 0.0 0.0 0.0 0.02 2.0 0.3 0.06 1.1 1.9 17.0 0.5
treated SD - 0.3 0.2 0.01 1.0 0.1 0.03 0.5 0.7 6.0 0.1
see table XIX3 for 
uninfected controls 
and table VI for
Significance P< WS NS NS NS NS NS NS 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001
Deprived Kean 0.8 0.02 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 abbreviations
treated SD - 0.4 0.01
Shan Kean 0.8 0.04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
treated SD - 0.4 0.02
Significance P< NS 0.05 NS ire NS NS NS NS NS NS NS NS NS NS NS
i i i i i i i n u i i i i  FIGURE 26 P. borghei Mean percentage parasitaemias in T-cel1-deprived;
sham-deprived and intact control CBA mice inoculated 
with 1 x 107 infected RBC and treated with chloroquine
(lOmg kg ”  ^ day  ^ x 14).
2 2 2
c. Treatment with chloroouine for 14 days from day 2 of 
infection
This experiment was similar to b (gibove) except the . 
period of treatment was from day 2 to day 15.
The treated intact and sham groups and deprived groups 
became aparasitaemic from day 3 of the infection. Pour out 
of 8 of the intact group became parasitaemic again on day 18 
of the infection and reached a maximum mean parasitaemia of 
17#. The infection resolved later and all the mice survived. 
The deprived and sham deprived treated groups remained 
aparasitaemic from day 4 of the infection throughout the 
experiment (fig 26 )•
2. The effects of late treatment with chloroquine
a. Treatment with chloroquine for 4 days from day 7 of infection
Three groups of treated and of control mice were used 
as before. The T-cell deprivation was done by thymectomy, 
irradiation and bone marrow reconstitution. The treatment 
was given from days 7—10 of the infectionifig 27).
The patterns of infection in the three untreated groups 
were almost the same as those in experiment E la. The mean 
survival time of the intact groups was 15.2 - 8.7 days, of 
the sham was 18.4 - 5.6 and of the deprived group was 37.2 ±4.2 
days. The increased survival time in the T—cell deprived 
group compared to that of the sham group was 101# and with 
that of the intact group was 145#.

Table XXIA Statistical analysis of the data in Fig 2 7 (n«10)
Group Data'' 3 5 8 10 12 15 17’ 19 22 26 29 33 35 37 39
Deprived Mean 0 .8 9.8 2 4 .0 0.4 0 .0 0 .0 0.9 11.5 2 2 .6 2 0 .6 25.7 18.2 15.0 18.0 25.0treated 3D - 0.4 2 .1 8 .1 0.4 - - 2.5 7.1 7 .0 2 8.2 4.0 1.5 2.2 1.1 7.0
Intact Kean 0.5 7.6 2 5 .0 1 .6 0 .0 0 .0 0 .0 2 3.0 7.0 0 .2 1 .0 2 .0 4.0 0 .0 0 .0treated SD - 0 .6 2.4 1 1 .6 4.0 - - 0 .0 1 1.9 3.7 0 .0 1 1 .0 0.9 4.0 - -
Significance P< NS 0.05 NS NS - - IIS 0 .01 0 .001 0 .001 0.001 0 .001 0 .001 0 .00 1 0 .001
Deprived Kean 0 .8 9.8 24.0 0.4 0 .0 0 .0 0.9 11.5 2 2 .6 2 0 .6 25.7 18.2 1 5 .0 18.0 2 5.ctreated SD I 0.4 2 .1 8 .1 0.4 - - 2.5 7.1 7.0 8.2 4.0 1.5 2.2 1.1 7.0
Sham Mean 0.7 8.9 1 6 .6 0 .1 0 .0 0 .0 0 .1 5.3 12.0 6.9 12.4 1 3 .0 10.0 7.0 14.0treated SD - 0 .2 1 .1 5.8 0 .1 - - 0 .1 1.5 2.4 5.0 4.0 3.0 - - -
Significance P< NS NS 0 .0 5 NS NS NS NS 0.02 0.001 0.001 0.001 0.001 - -
- for untreated controls see table XXIB 
*see table VI
FIGURE 27 P. berghei - mean percentage
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TpVle XXIB Statistical analysis of the untreated infected controls for table XXIA. (n«10)
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All the treated groujs became blood film negative after
4 days of treatment. The infections were patent again on 
day 17 and the parasitaemic patterns were all similar. The 
mean survival time in the treated deprived group was 36.4 —5 
days, in the sham deprived group 22.3 - 2.1 days and in the 
intact group was 20.8 — 5.2 days. The mean survival times 
were not significantly different from those of the 
corresponding untreated controls (table XXIB ).
The parasites were stabilated after recrudescence on 
day 22.
b. Treatment with chloroquine for 7 days from day 7 of the 
infection
Deprivation was done by thymectomy and ALS (1) treatment 
but grouping was done as before.
Mice of the experimental groups were treated on days 
7— 13 after infection at a dose rate of 10 mg kg”1 day-1.
All of the treated groups became aparasitaemic after 3 days 
of treatment, and infections started to recur on day 21.
5 out of 8 from both the deprived and intact groups 
recrudesced and 4 out of 8 from the sham group (fig 28 ). 
There was one death in the sham group on day 63 and one in 
the deprived group on day 31» otherwise the infections 
resolved. ( see tableXIXB for untreated controls).
o . Treatment with chloroquine for 14 days from day 7 of 
infection
Deprivation was done by thymectomy and ALS (1) treatment. 
The chloroquine treated groups became negative by blood film

Table XXII Statistical analysis of the data in Fig 28. (n=8)
Group vQay 2 4 7 9 11 14 1 6 18 21 23 25 27 31 33 37 41 43 48 5 2 55
deprived Mean 0.9 6.0 8.0 0.2 0.0 0.0 0.0 0.0 0.03 0.8 2.8 4.2 4 . 8 13.0 22.0 19.0 22.0 0.1 0.03 2.0
treated SD 0.3 2.0 3.2 0.1 0.1 0.5 0.7 2.0 3.3 6.1 7.2 2.3 4.1 0.02 0.01 1.0
I n t a c t Mpsn 0.6 4.3 6.0 1 . 1 0.0 0.0 0.0 0.0 0.03 0.4 2.6 1.6 5.0 1.5 0.6 3.4 3.5 0.2 C.08 0.4
treated SD - 0.3 2.1 3.1 0.03 0.01 0.02 1.3 0.5 1.2 0.3 0.2 1 . 2  0 . 0 0.1 0 . 0 3  0 . 1
Significance P < NS NS NS 0.001 NS NS NS NS NS 0.05 NS 0.01 NS 0.001 0-001 0.0010.001 0.02 0.02 0.01
Deprived ¡lean 0.9 6.0 8.0 0.2 0.0 0.0 0.0 0.0 0 . 0 3 0.8 2.8 4.2 4.8 1 3 . 0 22.0 1 9 . 0  2 2 . 0 0.1 0.03 2.0
treated SD - 0.3 2.0 3.2 0.1 0.01 0.5 0.7 2.0 3.3 6.1 7.2 2.3 4.1 0.02 0.01 L 0
Sham ¡•lean 0.5 4.7 7.2 0.6 0.0 0.0 0.0 0.0 0 . 0 4 2.0 2.7 3.0 12.0 17.0 8.0 4.0 3 2 . 0 28.0 29.0 20.1
treated 3D - 0.2 2.1 3.2 0.3 0.02 1.1 1.2 0.9 2.5 4.1 3.1 1.1 8.2 6 . 4 5.1 4.1
Significance P < 0 . 0 1 NS NS 0.01 NS NS NS NS NS 0.02 NS 0.001 0.001 NS 0.001 0.0010.01 0.001 0.01 0.0
see table XJXB for uninfected controls, and table VI for abbreviations
figures after day 18 correspond to the mean parasitaemia (- SD) of the recrudescences only 
(5 mice recrudesced in both intact and deprived groups, 4 mice in sham group).
tl
kd
H
IA
tt
 
CA
HA
 jl
l I
 M
IA
see table X1X3 for uninfected controls, and table VI for abbreviations
figures after day 18 correspond to the mean parasit a e n ia  (- SD) of the recrudescences only 
(5 nice recrudesced in both intact and deprived groups, 4 mice in sham group).
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Table XXIII Statistical analysis of the data in Fig 29. (n«8)
Group
sjjay
Dat£ 2 4 7 9 11 14 16 18 21 23 25 27 31 33 37 41 43 48 5 2 55 6 0
Deprived Mean 0.8 5.0 7.8 0 . 0 3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 l.G 1.2 4.5 2 . 1 3.0 4.5 3.0 0 . 3 0 . 3 1 . 5
treated SD - 0.5 1.0 2.0 0 . 0 1 0.6 0.7 1.3 0.3 1.0 1.3 0.9 0.1 0.1 0.6
Intact Kean 0.6 5.8 4.0 0.08 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.05 1.3 0 . 1 0 . 5 14.0 0.3 0.0 0.0 0.0 0.0
treated SD - 0.4 2.1 1.1 0.02 0.02 0.7 0 . 0 2 0 . 2 5.0 0.1
Significance P< NS NS 0.001 0.001 NS NS NS NS NS NS NS 0.001 NS 0.001 0 . 0 0 1 0001 0001 0001 0001 0001 00C1
Deprived Kean 0.8 5.0 7.8 0.03 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 4 . 5 2 . 1 3 . 0 4 . 5 3 . 0 0 . 3 0 . 5 1.5
treated SD - 0.3 1.0 2.0 0.01 0.6 0.7 1.3 0.3 1.0 1 . 3 0 . 9 0.1 0.1 0.6
Shan Kean 0.7 5.0 8.5 0.04 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AD
treated SD - 0.2 1.2 3.2 0.01
Significance P< NS NS NS NS NS NS NS NS NS NS NS
see table XIXB for untreated controls and table VI for abbreviations. AD» accidental death due to drowning
figures after day 25 correspond to the mean parasitaemias (- SD) of recrudescences only.
(2 nice recrudesced in both deprived and intact groups).
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iiüüülülli FIGURE 29 P. berghei -  mean percentage paras itaemi as in T -c e l l -  deprived and in ta c t  con trol CBA mice inoculated with 
1 x 107 infected RBC and treated with chloroquine
1G mg kg  ^ (days 7-20)
roto
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examination after the 3rd day of infection and remained so 
for 16 days. 2 out of 8 mice from both the deprived and 
the intact groups subsequently showed recrudescence of 
infection (fig 29 )• The controls were the same as S lb.
( table XIXB).
3. The effect of quinine treatment
Drug treated and untreated T-cell deprived (thymectomy 
and ALS2 treatment), sham and intact mice were included as 
in the preceeding experiments. Infection was initiated with
7an inoculum of 1 x 10' infected erythrocytes.
Quinine treatment at a daily dose of 100 mg kg ^ for 
7 days was started on day 1 when the parasitaemia was 
between 1?£ and 3$.
The mean survival time of the untreated intact group 
was 17.4 - 8.4 days and of the T-cell deprived mice was 
33.3 - 6.5 days.
In the quinine treated groups apart from a slight 
suppression of parasitaemia during the treatment period, 
the infection pattern was similar to that of corresponding 
controls (fig 30)
In the intact treated group, all the mice died with a 
mean survival time of 27*8 ~ 3.4 days. In the T—cell 
deprived treated group only 1 of 6 mice resolved on day 37. 
The five mice remaining died with a mean survival time of 
37.8 - 1 days.
t e
Table XXIV Statistical analysis of the data in Fig 30 and It's untreated Infected controls (n-6 )
%I1
Group vgay 1 2 3 7 1 0 1 2 14 17 2 1 ‘ 23 27 30 33 35 40 44 47 53 57
Deprived Mean 1.3 3.0 3.7 3.8 7.0 15.3 1 5 . 6 28.0 33.0 31.0 2 5 . 0 3 8 . 0 6 1 . 5 1.0 0.0 0.0 0.03 3.5 0.1
treated SD - 0 . 2 0.4 1.5 1.3 1.7 4.0 C. 6 11.3 5.1 2 7 . 0 3 0 . 0 34.0 4.9 0.3
Intact Mean 1 . 0 3.3 2 . 8 1.3 6 . 0 7.3 1 6 . 5 2 6 . 0 5 1 . 0 5 8 . 0 6 3 . 0 D
treated SD - 0.3 1 . 0 1 . 1 0.9 3.4 7.4 4.7 5.7 12.5 5.7 0.7
Si.-nific&nce P < NS NS NS 0 . 0 1 NS 0 . 0 5 NS NS 0 . 0 1 0 . 0 5 0 . 0 1 - - - - - - - -
Deprived Mean 0 . 6 1.4 3.0 5.5 1 3 . 0 1 5 . 0 19.3 1 9 . 0 2 9 . 0 47.0 57.0 49.0
infected _ _ +
control SD - 0.5 1.5 2.7 3.0 6 . 6 7.6 1 0 . 7 7.2 5.0 4.0 11.7 1 9 . 0
Intact Mean 1.07 3.4 6.7 2 3 . 6 2 2 . 0 2 1 . 0 15.0 2 3 . 0 5 1 . 0 6 2 . 0 D
infected _+
control SD - 0 . 6 2 . 2 1.9 23.7 1 2 . 0 14.0 3.5 5.3 2 1 . 0 •
Significance P < NS NS 0 . 0 2 NS NS NS NS NS 0.05 - - -
FIGURE 30 P. berghei - mean percentage parasit- 
aemiasin T-cell-deprived and intact 
control CBA mice inoculated with 
1 x 107 infected RBC and treated with 
quinine 100 mg kg  ^ day  ^ (day 1-7)
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4. The effect of pyrimethamine treatment -
T-cell deprivation was done by thymectomy and ALSg 
treatment and the mice were grouped as before. Pyrimethamine 
was given at a dose rate of 2 mg kg-1 daily for 7 days from 
day 2 when the parasitaemia was between 1.2# - 0.7 and 
1«5# — 0.4 • The parasitaemia was detectable up to day 3 
and then undetectable from day 7 onwards. In all cases 
subinoculation of blood from two mice of each group to 
uninfected mice did not produce a parasitaemia (fig 31).
5. Drug sensitivity of P.berghei after chemotherapy in intact 
and T-cell deprived mice
Drug sensitivity was performed by a 4 day suppressive 
test as described in chapter II (p 117 ) in male TO mice of 
20-25 g body weight. The results obtained were, plotted on 
a probit-activity log dose paper and the ED^q and EDgQ 
(90# suppression of parasitaemia) were worked out and 
expressed in terms of mg kg“'1' of body weight.
Drug sensitivity testing was carried out on all the 
stabilates of the recrudesced populations of experiments 
E la, lb, 2a, 2b, and 2c. The index of resistance of the 
T-cell deprived group was monitored in terms of the effective
doses of the recrudesced intact treated group.
There was no significant increase in the index of resistance 
of the T—cell deprived group compared to that of the parent 
line or the corresponding recrudescent intact treated group 
(see table XXV).
Table XXV Suppressive test of P.berghel infection using the recrudescent population after treatment 
of intact and T-cell deprived mice.
Stabilate tested Intact treated group Deprived treated group Index of resistance
E D ^ Î  SE ® 90 Î  SE ed 5 0 î  SE ED9 0  i SE
Oirv
IH
I 90
Original parasite 1 .6 2Î0 . 6 2.92Ì0.7 - - - -
Exp. E la (chloroquine 
1 0  mg kg-^ x 4  days) 1 .6  t o .4 2.9 -0.8 1.7 io.5
3 . 0  il.O 1 . 0 6 1 . 0 3
Exp. E lb (chloroquine 
10 mg kg-  ^x 7 days) 1 .8  i o . 2 3.2 Ì0.4 1.9 io.3
3.2 i o . 9 1.06 1.00
Exp. E 2a (chloroquine 
10 mg kg-1 x 4 days) 1.75^0.5 3.2 Ì0 . 3 1.8 io.3 3 . 1 io.8 I. 0 3 0.97
Exp. E 2b (chloroquine 
10 mg kg-1 x 7 days) 1.9 ÌO.5 3.1 Ì0 . 7 1.7 -0.5 3.3 ^0.7
0.89 1.06
Exp. E 2c (chloroquine 
10 ng kg~* x 14 days) I.8 7ÌO. 6 3.17^0.8 1.78Ì0.07 3 . 1 io.6 0.95 0.98
-all doses (mg kg”^) are single daily doses of chloroquine given on consecutive days. ED^ and ED^q are computed 
graphically as described. I (index of resistance) - BD,-^  or ED^ of deprived treated group
ED/ -50 or EDon of intact treated group
-SE was computed graphically as described by( Peters 19 6 5 b >. -'U
roC593
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The parasitaemias in the P. berghei infected intact, sham- 
and T-cell deprived mice were similar, the increased mean 
survival time in the T—cell deprived group being the main 
difference (Pig 9a and 9b ). Chemotherapy of P .berghei 
infections in mice has been much studied. Peters (1970a) 
has compiled details of the effective doses of different 
antimalarials for P .berghei but, according to him, factors 
like the strain of mouse used, sex, age, concomitant 
infections, environmental factors, strains of parasites and 
the technique used may all vary the effective dose. In 
carrying out experiments the size of the infective inoculum, 
the time spent in preparation of the inocula, the route of 
drug administration, the timing of the first drug dose, the 
frequency and duration of administration, timing of termination 
of experiments and the technique of reading blood films are 
important factors that must be studied. Different PABA 
concentrations in the diet can also change the drug dosage 
required to control the infection (Carter, 1972; Kirakosyan, 
1970).
In my experiments, I tried to minimize these variables 
by using the same diet, mice, inoculum and techniques for 
all experiments. There were slight variations of the 
temperature between 17°C-22°C and humidity between 42# to 
61#. The intraperitoneal route was chosen for the drug 
administration because it is easy and it is a more sure way 
of knowing that the drug is absorbed than the oral route. 
Thurston (1953) and Hawking (1966) used the intraperitoneal 
route for drug administration and Peters (1973) also used the
2 3 8
same route for his treatment with pyrimethamine.
In my preliminary studies on chloroquine treatment of 
P »berghei infection in mice, the duration of treatment was 
found to be more imuortant for curing all of the infected 
mice than using a high dose for a short time. Chloroquine 
given in high doses for a short time (40 mg kg-1 for 4 days) 
produced a higher reciridescence rate than when given at a 
lower level for a longer period (10 mg kg-^ x 14 days).
It is very difficult to get a 100# cure rate of P.berghei 
infection in mice with chloroquine. Box et al. (1954) used 
an average daily dose of 183.9 mg kg-^ of hydroxychloroquine 
in the diet given from days 3-6 of the P.berghei infection 
but failed to cure any mice.
Suppressive chloroquine given on days 0-3 was more 
effective than the therapeutic treatment from days 
7-10 in all groups of mice. Since chloroquine was given 
intraperitoneally, the same route as the infection, and 
because it was given within 3 hours of infection, the drug 
might have acted before the parasites had entered the blood 
stream. Also»the chloroquine may have killed a high proportion 
of parasites before they began to multiply. So after 
suppressive chemotherapy, there were fewer recrudescences and 
less mortality in the intact, sham and deprived groups than 
after therapeutic treatment.
When early chloroquine treatment of P.berghei was 
compared among the infected intact, sham and T—cell deprived 
groups, the drug seemed to be more effective in the T—cell 
deprived group. In suppressive chloroquine chemotherapy 
(treated 0-3 days) only 2 mice relapsed and died in the
23
T-cell deprived group though 5 relapsed and died in the 
intact control group. When treated with chloroquine for 
7 days (days 2—7)» 2 out of 8 mice relapsed with one death 
in the deprived group but 5 out of 8 mice relapsed and 
died in the intact group. Also when treated with chloroquine 
for 14 days (days 2-15) 4 out of 8 mice recrudesced in the 
intact group and none relapsed in the T-cell deprived group. 
Though the numbers of animals used in each experiment were 
not very large, chloroquine was shown to be more effective 
in T-cell deprived groups them the intact controls in all 
the experiments.
Also, when comparing late treatment of P.berghei among 
the intact control, sham and the T-cell deprived groups, 
the effect seemed to depend on the drug dosage schedule. 
Treatment with 10 mg kg“1 for either 7 or 14 days did not 
produce any significant difference in recrudescence rate or 
mortality in all the groups. However, when treated for 4 
days all mice showed a recrudescence but 4 deprived mice 
survived this. This shows that treatment with chloroquine 
can be effective in T-cell deprived and intact groups but, 
if a lower dose schedule of chemotherapy was given, T-cell 
deprived groups survived more than intact control groups.
These results are the opposite of those obtained with 
P.chabaudi (discussed on p S 7 S  )• There, chemotherapy
was shown to be more effective in the intact mice. The 
exact reason for why T-cell deprived treated mice survived 
better is not known. It is generally assumed and was shown 
with p.chabaudi that immune mechanisms are helpful in drug
treatment. But mice (Jayawardena et al., 1975) and hamsters
(Wright, 1968; Wright et al., 1971) survive P.berghei infection 
better if they are T-cell deprived. Though the exact mechanism 
is not known, Jayawardena (1975) tried to explain this in terms 
of the infection inducing T-suppressor cells which suppress 
the immune mechanisms and cause earlier deaths in intact 
animals. Wright (1968) and Wright et al. (1971) showed that 
the formation of immune complexes in P.berghei infected intact 
hamsters caused the animals to die earlier whereas in the 
ALS treated or neonutally thymectomised hamsters they 
survived longer. So if the treatment is not effective 
(chloroquine 10 mg kg- -^ for 4 days) and if the infection 
recrudesces, the deprived mice would be expected to be better 
off. There might be a better immune response in T-cell 
deprived mice because of the absence of T-suppressor cells.
The occurrence of any immune response in intact mice 
infected with P.berghei is a controversial matter. Since 
P.berghei invariably kills the mice, the immunity if present 
is not effective. But, on the other hand suppression of 
the parasitaemia in P.berghei infections by drugs or by 
using a milk diet in mice has been shown to induce some 
immunity (Gilbertson et al., 1970; Carrescia and Arcoleo,
1957). Jayawardena et al. (1975) have shown that P.berghei 
in mice elicits only limited T-cell activity (eg. to PHA) 
and a generalised failure of T-cell function (assayed on 
day 15). Also, Krettli and Nussenzweig (1974) have shown that 
T-cells (© positive cells) as well as B-cells (complement 
receptor positive cells) were reduced in numbers in P .berghei 
infection in mice but a third cell population, without 
comolement receptors or 0 antigen, increased in size from 
day 14 of the infection. According to Gravely and Kreior
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(1976) neither 0 positive T-cells nor complement receptor 
positive B-cells conferred immunity to P.berghei in 
passive transfer experiments in rats. According to them, 
the cells which lack both © antigen and complement receptor 
cells (probably antibody-producing cells,B-cells) were 
concerned with immunity. So, P.berghei infection in mice 
reduces the number as well as the activities of T-cells and 
of some B-cells (complement receptor positive) but induced 
the increased production of other B-cells which, in rats 
seem to be important in the development of immunity. However, 
Brown et al. (1976) showed that protective immunity to 
P.berghei in rats was due to T-cell activity through 
co-operation with B-cells. So if T-cell activities are 
necessary there may not be effective immunity in intact 
mice infected with P.berghei.
There is an indication that late treatment of P.berghei 
infection in intact mice leads to less recrudescence and 
lower mortality than early treatment. Since the number of 
animals (8 mice) used in these experiments was small, the 
experiments need to be repeated before definite conclusions 
can be drawn.
Quinine does not cure P.berghei infections of mice.
Hill (1950) and Thurston (1950) just managed to reduce the 
parasitaemia of P.berghei infection in mice by suppressive 
treatment. Peters (1970a) and Pinders (1973) in their 
reviews on the "Rane Test" reported that quinine has 
definite activity against P.berghei but there were no 
survivors even with the maximum dosage of the drug.
2 4 2
My preliminary experiments showed that quinine could 
be given intraperitoneally to CBA mice up to a maximum of 
150 mg kg“1 without killing them. A dose of 100 mg kg”1 
had no effect on the parasitaemia of a P.berghei infection 
in both intact and T—cell deprived mice, but mean survival 
time was increased from 17.4 - 8.4 to 27.8 - 3.4 days in the 
intact treated group. In the T-cell deprived treated group
1 out of 6 mice survived and the rest died with a mean 
survival time of 37.8 — 1 day
Pyrimethamine was found to be a very effective drug in 
curing P.berghei infection in CBA mice. Most et al. (1967) 
obtained a radical cure of P.berghei infection in mice by 
giving 3 mg kg“1 of pyrimethamine daily for 4 days
2 mg kg”1 daily for 7 days completely cured P.berghei 
infection in my experiments in both normal and T-cell 
deprived mice.
The recrudescences of the P .berghei or P .chabaudi 
(Exp.F pa44) infections in T-cell deprived mice after 
various dosages of drug treatment did not show any significant 
increase in drug resistance, compared with that of the 
recrudescences from intact treated mice or of the original 
line of parasite. Drug resistant strains of malaria parasites 
are easily produced in experimental conditions by suppressing 
or avoiding the immune response of the host (Peters, 1970a; 
Warhurst, 1965 5 and Hawking, 1966). Peters (1965a) 
succeeded in developing drug resistant lines of P .berghei 
by treating infected mice with increasing doses of 
chloroquine. Also Rosario (1976) succeeded in developing
a stable line of drug resistant P.chabaudi by treating with
2 4 3
chloroquine at 2 rag kg-1 for 5 days and passaging 5 times.
But the P.chabaudi resistant line was only resistant to 
6 daily doses of 3 mg kg“1 of chloroquine. In my experiments, 
since I used only one course of treatment, the resistance 
if it developed may be very low.
2 4 4
P. Drug treatment of P.chabaudi in 
intact and T-cell deprived mice
I. The effect of early treatment with chloroquine
a. Treatment with 2 mg kg ^ chloroquine for 7 days from day 
5 of the infection
Three groups of mice, intact, sham deprived and T-cell 
deprived (thymectomy and ALS1 treatment) were treated and 
there was a corresponding untreated control group for each.
71 x 10' P . chabaudi infected erythrocytes were inoculated on 
day 0. The chloroquine i.p. injections of 2 mg kg-1 daily 
were given to mice of the experimental group from days 5 to »
II. The parasitaemia was monitored at 3 to 4 day intervals, 
(fig 32a ).
The parasitaemia in the intact and sham-deprived 
treated groups went down from the initial mean' level of 
13 to 14# to 0 on day 11 and remained aparasitaemic until 
day 18 (intact mice) or day 23 (sham-deprived). After 
recrudescence,maximum parasitaemias were 0.8?» — 0.6 in 
the intact mice and 0.4# - 0.3 in the sham-deprived group. 
Parasitaemia in the T-cell deprived treated group was 
16«î± 0.3 at the onset of treatment and remained patent with 
a minimum mean parasitaemia of 0.1# — 0.1 on day 11 and a 
subsequent maximum parasitaemia of 20# — 10 on day 54»
Parasites from recrudescent infections of the treated 
groups were stabilated on day 23 for later drug sensitivity 
testings. In the untreated control groups of intact and 
sham deprived mice, the first wave of parasitaemia was 
resolved on days 15 and 18 respectively. The second peak
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Table XXVIA Statistical analysis of the data in Fig 32.01 (n=8)
Group
s*5ay
DatS> 5 7 11 13 15 16 23 26 29 33 36 40 43 46 52 54 58 61 71
Deprived l ie an 16.0 5.0 0.1 0.7 1.7 5.2 5.7 1.2 1.1 3.7 7.0 3.0 7.0 7.3 6.8 20.0 4.5 2 3 .8 9 .0
treated 3D i 0.3 4.0 0.1 1.1 4.7 4.7 5.7 2.1 1.7 4.7 8.0 0.4 1 6 .0 8 .4 7.4 10.0 1.3 1.2.0 3.0
Intact lie an ? 4.0 5.0 0.01 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
treated SD - 5.3 2.0 0.01 0.1 0.6
Significance P< u s KS 0 .0 5 KS NS 0.02 0.05 NS NS NS 0.05 0.001 NS 0.05 0.05 0.001 0.001 0.001 0 .001
Shan Iiean 1 3 .0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.01 0.0 0.05 0.0
treated SD - 6.0 0.3 0.1 0.3 0.5 0.01 0.01
Intact 1^9 an 14.0 5.0 0.01 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
treated SD - 5.3 2.0 0.01 0.1 0.6
Significance P< KS 0.001 0.02 IIS NS 0.001 0.02 0.01 NS NS MS NS NS NS NS 0.02 NS 0.001 NS
- for untreated control see table XXVIB and table VI for abbreviations
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Table XXVIB Statistical analysis of the data in Fig 32L. (n«8)
Group s^ teyDathv, 5 7 11 13 15 18 23 26 29 33 36 40 43 46 52 54 58 61 71
Deprived Mean 13.0 2 6 .0 5 .2 10.0 20.3 2.7 2 .7 1.7 1.4 2.9 2.0 1.4 0.5 9.0 4 .0 5.0 0.3 5.0 7.0
infected
control SD * 3 .8 3.9 4 .6 3 .6 19.6 1.6 3 .6 2.6 2.6 4.0 1.9 2.5 0.9 1.5 3 .3 3.8 0.2 3.5 2.4
Intact Kean 11.0 22.6 0 .6 0 .1 0.0 0.0 0.0 0.02 0.2 0.3 0.07 0.0 0.0 0.01 0 .0 5 0.0 0.0 0.0 0.0infected
control SD i 6.6 8.5 0 .3 0.1 0.01 0.03 0.2 0.07 0.01 0.04
Significance P < NS NS 0 .0 2 0.001 0.02 0.001 NS NS ire NS 0.02 NS NS 0.001 0.01 0.001 0.001 0.001 0.001
Sham Mean 15.0 21.0 1 .0 0.2 0.02 0.0 0.0 0.07 0.05 0.0 0.08 0.0 0.0 0 .0 3 0.05 0.0 0.0 0.0 0.0
infected
control SD - 5.4 5.3 1 .5 0.2 0.01 0.05 0.02 0.03 0 .0 4 0.03
Intact Mean U.O 22.6 0 .6 0.1 0.0 0.0 0.0 0.02 0.2 0.3 0.07 0.0 0.0 0.01 0.05 0.0 0.0 0.0 0.0infected
control SD * 6.6 8.5 0 .3 0.1 0.01 0.03 0.2 0.07 0.01 0.04
Significance P< US NS NS NS 0 .001 NS NS 0.02 0.001 0.001 NS NS NS NS NS NS NS NS NS
ysee table VI
►FIGURE 32b P. chabaudi - mean percentage parasitaemiasin T-cell-deprived (thymectomy and ALSj)
treatment), sham deprived and intact control CBA mice inoculated with 1 x 10 infected RBC
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of parasitaemia (0.3$ and 0.08$) was seen on days 33 and
36 and a third peak of 0.05$ in 5 out of 8 mice on day 52.
The deprived untreated group was parasitaemic throughout up to 
thenday 86 and/most of the mice became aparasitaemic after that.
b. Treatment with 4 mg kg"1 chloroquine for 7 days from 
day 3 of the infection
Two groups of mice, intact and T-cell deprived (thymectomy
and ALSg treatment) were drug treated and there was an
untreated control group for each. A P .chabaudi infection of 
n1 x 10 infected erythrocytes was given i.p. on day 0 to 
each mouse. Chloroquine at 4 mg kg-1 was given to the 
experimental groups from days 3 to 9. The initial parasitaemia 
was 3-4$.
In both experimental groups, the blood films became 
aparasitaemic on day 7. In the intact treated group the 
mice remained aparasitaemic and infections were not obtained 
in recipient mice when the blood, kidney or spleen was 
subinoculated on day 26 from each of two mice of the group.
In the deprived treated group, the infection became 
aparasitaemic but recrudesced on day 19 in all mice and 
remained parasitaemic above 7$ thereafter, (fig 33).
Infections in the untreated control groups were similar 
to those in the first experiment (P la p 252 ). The intact 
group reached a peak parasitaemia of 32 * 7-3$ on day 7 and 
the infections resolved by day 22. The second peak of 
parasitaemia was 0.4$ - 0.4 on day 30 and resolved again on 
day 41. The deprived untreated group had a patent parasitaemia 
throughout the experiment.

Table XXVII Statistical analysis of the data in Pig 33 • (n«6)
Croup ^ £ a yDatfrv 2 3 5 7 1 1 1 2 1 6 19 2 2 2 6 30 37 41
Deprived Mean 1 . 1 4.3 0.1 o.o 0.0 0.0 0.0 0.4 2 6 . 0 1 0 . 2 7.0 7.3 8 . 1
treated SD - 0 . 2 1.0 0.05 - - - - 0.1 6 . 2 7.2 2 . 8 4.9 6 . 0
Intact Mean 0.9 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
treated SD - 0.5 1.7 0 . 0 3 - - - - - - - - - -
Significance r < HS NS NS IIS NS NS NS 0.001 0.001 0 . 0 1 0.001 0 . 0 1 0 . 0 1
(for untreated controls see table XXXI p )
♦see table VI
FIGURE 33
P. chabaudi - mean percentage parasitaemiasin T-cell-deprived and intact control^CBA mice 
inoculated with 1 x 107 infected RBC and treated with chloroquine 4 mg kg day (days 3-9)
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c. Treatment with IQ mg kg chloroquine for 7 days from 
day 5 of the infection
T-cell deprivation in this experiment was the same as 
in the previous experiment. All of the experimental treated 
group had a parasitaemia of between 12# to 14# on the first 
day of treatment. They became aparasitaemic on day 11 and 
remained blood negati/e ¡when the blood, kidneys and spleen 
tissues were inoculated from two mice of each group into 
untreated recipients»only the deprived group gave a positive 
result. The untreated control groups developed infections 
similar to those already described (fig 34 )•
2. The effect of late treatment with chloroquine
a. Treatment with 2 mg kg"1 chloroquine for 7 days from 
day 13 of the infection
T-cell deprivation in this experiment was carried out 
by thymectomy and ALS^ treatment. The parasitaemia in 
intact andshara-deprived treated groups became zero by day 
15 and remained so throughout the experiment. Splenectomy 
of two mice from each group on day 36 did not induce a 
recrudescence of infection. The blood, spleen and kidneys 
from two mice of each group were subinoculated into 6 
uninfected mice but patent infections did not result. The 
deprived treated group remained patent throughout, though 
the infection went down to 0.09 - 0.1# on day 18 (fig 35 ).
The parasites from the T-cell deprived treated group were 
stabilated on day 33 for drug sensitivity testing.

Table XXVIII Statistical analysis of the data in Fig 35« (n=8)
Group Dat?t* 5 7 11 13 15 18 23
26 29 33 40 52 54 58 61 71
Deprived Hean 14.6 2 4 . 0 5.1 1.3 0.1 0.09 1.9 10.7 5.B 1.4 n.04 3.6 0.6 4.5 2.0 4.1
trea ted SD - 8.2 9.1 6.1 1.2 0.1 0.1 2.9 6.7 5.2 1.8 0.02 4.9 0.5 6.3 2.8 5.5
Intact Hean 1 4 . 0 2 5 . 0 3.1 0.01 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
treated SD - 3.4 5-3 0.2 0.01
Significance P < NS NS NS 0.01 0.02 0.05 NS 0.001 0.01 0.05 0.001 NS 0.01 NS NS NS
Sham Kean 9.4 18.3 1.5 0.02 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
treated SD - 7.6 6.6 1.6 0.01
Intact i’lean 14.0 2 5 . 0 0.3 0.01 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
treated SD - 3.4 5.3 0.2 0.01
Significance P < NS 0.05 NS NS -
*see table XXVI for untreated control and table VI for abbreviations
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Table XXIX Statistical analysis cf the data in Fiy 36. (n=8)
Group Datî>> 5 7 1 1 13 15
18 2*3 26 29 3 3 36 40 ’ 45 46
Deprived Mean 9.3 1 6 . 3 8 . 5 3 . 2 0 . 0 2 0.03 0.0 0.0 0.2 1 . 0 3.3 1.4 0.1 1.0
treated SD t ’ 9.1 3 . 4 1 . 5 0 . 8 0 . 0 1 0.01 0.2 0 . 5 5.8 2.4 0.2 , 1.4
Intact Mean 12.0 2 0 . 1 0 . 4 0 . 0 1 0 . 0 0.0 0.0 0.0 0.0 ’0 . 0 0.0 0.0 0.0 0.0
treated SD - 6.0 5 . 6 n.3 0 . 0 1
Sirr.ificnr.ee P < IS xs 0.001 O.COl 0 . 0 0 1 C.001 NS NS 0.02 0 . 0 0 1 HS TTC*¿IO NS NS
Shan Mean 10.0 1 5 . 4 1.9 0.01 0 . 0 0.0 0.0 0.0 0.0 0 . 0 0.0 0.0 0.0 0.0
treated SD - 3.9 5 . 6 1.7 0.01
Intact Mean IO A • J 20.1 0 . 4 0.01 0 . 0 0.0 0.0 0.0 0.0 0 . 0 0.0 0.0 0.0 0.0
treated SD * 6.0 5.6 .0.3 0.01
Significance ? < :;s ITS 0 . 0 5 i:s î:s IIS ITS NS ITS 13 NS ITS NS NS
♦see table XXVIB for untreated control and table VI for abbreviations
firures after day 26 correspond to the mean parasitaenias of the recrudescences (- SD) 
(4 / 8  recrudesced in the deprived (rroup)
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firures after day 26 correspond to the roan parasitaenias of the recrudescences (- SD) 
(4/8 recrudesced ir. the deprived yroup)
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firures after day 26 correspond to the mean parasitaenias of the recrudescences (- SD) 
(4/8 recrudesced ir. the deprived yroup)
‘see table XlVIii 1'ot untrea
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Treatment with 10 mg kg ^ chloroquine for 7 days from 
day 13 of the Infection
The design and T-cell deprivation of the experiment 
was the same as that for the previous experiment. The drug 
treated groups of intact and sham-deprived mice became blood 
film negative on day 15 and remained aparasitaemic to the 
end of the experiment. The T-cell deprived treated group 
became blood film negative on day 23 and then 4 out of 8 
mice showed a recrudescence of infection on day 29 with a 
parasitaemia level comparable to those of the untreated 
controls (fig 36 ). The recrudescent infection was
stabilated as in the previous experiment on day 33.
3. The effect of quinine treatment . -; .+■
f
T-cell deprivation in these experiments was done by 
adult thymectomy and ALS (2) treatment, and grouping of 
mice was done as in previous experiments.
a. Treatment with 20 mg kg“1 quinine for 7 days from day 1 
of the infection
Parasite inoculation given on day 0 was 1.5 x 10® 
infected erythrocytes. The normal pattern of infection 
in the control groups of mice was comparable with that of 
previous experiments. The parasitaemia on the first day of 
treatment was 5.1 1 1* in the intact group and 4.5 - 1.3* 
in the deprived group. The infection resolved by day 20 and 
recrudesced on day* 27 31 in the intact group. The
deprived group showed a continuous parasitaeinia (Pig 37 )

Table XXX Statistical analysis of the data in Fig 37 and its untreated infected controls. (n»6)
Group »^*Day Da'S1— 1 3 6 10 13 17 20 24 27 31 34 39 48
Deprived Mean 3.4 12.3 20.? 18.0 14.3 11.5 6.6 9.6 12.0 10.0 7.1 8.2 6.8
treated SR - 0.6 5.2 7.3 9.0 5.0 5.3 6.6 9.2 7.0 5.9 8.6 8.2 6.8
Intact Kean 4.3 14.5 13.0 6.8 1.3 0.0 0.0 0.05 0.4 3.0 0.0 0.03 0.0
treated SD - 0.5 7.1 6.9 2.4 1.3 - - 0.04 0.6 3.9 - 0.02 -
Significance P < 0.02 NS NS 0.05 0.001 0.001 0.05 0.05 0.01 0.05 NS 0.05 0.05
Deprived Kean 4.5 24.3 2 3 . 0 2.6 9.5 .7.4 7.0 6.8 3.0 6.3 7.5 - 11.5
controls SD - 1.3 0.6 7.3 2.7 2.5 5.5 4.8 5.4 4.4 4.9 5.0 0.7
Intact Mean 5.1 27.8 6.3 0.8 0.7 0.4 0.0 0.0 0.01 0.1 0.0 0.0 0.0
controls SD - 1.0 1.7 2.6 0.8 0.4 0.3 - - 0 . 0 3 0.01 - - -
Significance P < US NS 0.001 NS 0.001 0.02 0.01 0.02 NS 0.02 0.01 - 0.001
*see table VI
FIGURE 37 P. chabaudl -  mean percentage parasitaemiaain T -ce ll-d e p r iv e d  and In tact con trol ^  
'  CBA .I c e  inoculated with 1-5 x !0 8 in fected  R8C and treated with quinine 20 mg kg
(days 1 -7)
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In the ihtact drug treated group of mice the peak was 
seen on day 3 with a parasitaemia of 14.5 - 7.1# compared 
to that of the untreated intact control of 27.8 - 1.7#.
The infection became negative on day 17 and recrudesced on 
day 27» In the deprived treated group the maximum parasitaemia 
was 20.3 - 7.3# compared with that of the untreated deprived 
group of 24.3 - 8.65&. The infection persisted at a 
level above 2.6#inthe deprived control group. There were 
no deaths in any of the groups. All recrudescent parasites 
after drug treatment were stabilated for later drug 
sensitivity testing.
b . Treatment with 100 mg kg~^____quinine for 7 days from
day 1 of the infection
QThe heavy inoculum of 1.5 x 10 P.chabaudi infected 
erythrocytes was given as before. The intact treated group 
became aparasitaemic on day 10 from the initial level of 
3.5 - 1# then recrudesced to a level of 8.2 - 5.4#* whereas, . 
in the deprived treated group, the parasitaemia increased 
from 4.8 - 0.2# to a peak of 17.3 - 3.9# on day 10. This 
was not significantly different from that of the untreated 
deprived control (24.3 ± 8.6#) on day 3. The parasitaemia 
in the deprived group remained positive throughout the 
experiment and was comparable with that of the untreated 
deprived control. Recrudescent populations of parasites 
were stabilated on day 20 for drug sensitivity testing
(fig 38 )

Talils XXXI Statistical analysis of ’he data in Fie 38« (n=6)
Group 1 3 6 10 13 17 20 25 23 32 35 38 ' 48
Deprived Mean 4.8 7.9 1 2 .8 17.5 1 6 .0 7.4 13.5 11.7 4.5 9.5 6 .0 5.5 14.3
treated SD -■ 0 .2 4.9 13.7 3-9 3.2 6 .0 8 .8 9.0 5.8 9.5 5.4 1 .0 9.9
Intact Kean 3-5 4.1 0 .01 0 .0 0.08 8 .2 4.2 0 .0 0 .0 0 .0 0 .0 0 .0 0 .0
treated HD - 1 .0 1.5 0.01 0 .2 5.4 5.5
Significance P < 0 .01 I*S 0.05 0.001 0.001 NS 0 .05 0 .01 NS 0 .05 0.02 0.001 0.01
Deprived Kean 4.5 24.3 2 3 .0 2.6 9.5 7.4 7.0 6.8 3.0 6.3 7.5 - 11.5
infected
control SD t 1.3 8.6 7.3 2.7 2.5 5.5 4.8 5.4 4.4 4.9 5.0 0.7
Intact Kean 5.1 27.8 6.3 0.8 0.7 0.2 0.0 0.0 0.01 0.1 0.0 0.0 0.0
infected
control SD 1 1.0 1.7 2.6 0.8 0.4 0 .3 0 .0 3 0.05
Significance P < IS IIS- 0.001 US 0.001 0.01 0.01 0.01 XS 0.01 0.01 0.001
*see table VI
FIGURE 38 p chabaedi - —  P«n»1t— • - * »  T -ce ll-d e p r iv e d  and in ta c t  control
m ---------  ¿ T ^ o c u l a t e d  with 1 .5  »  108 in fected  RBC and treated « i t i ,  ,u ,n ,n e
100 mg kg'1 day'1 (days 1-7)
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Table m i l  Statistical analysis of the rata in Pis 39 and its untreated infected controls (n=6).
Group N w2at£>v. 2 4 5 7 11 12 16 19 22 26 30 37 41
deprived ;iea? 1.1 22.0 22.3 2.8 8 .0 e .6 27.0 12.3 21.0 10.2 10.8 17.0 0 .0
treated 5D - 0 .3 6.7 6 .2 3.6 6 .2 5.2 4 .5 2.7 7 .0 5*5 5.2 2.1 0.0
Intact ilean 1.1 16.0 14.4 0.5 0.1 0 .0 6 0 .1 0 .2 0 .5 0.1 0 .0 0.0 0.0
t'“Ctrd SB i 0.3 3.4 3.4 0.1 0.1 0 .0 5 0.1 0 .2 0 .5 0 .3 - - e .o
5f.raifiear.C9 P < us I T ?. . O 0 .0 3 ES 0.02 0.01 0.C01 0.001 0.CC1 0.001 0.001 0.001 ES
Deprived i-ear. 0 .3 15.8 33.e 44.6 10.0 18 .0 12 .0 12.3 13 .0 8 .2 6 .2 6 .5 6 .7
inf ectrd 4.
control S3 - 0.4 7 .5 9.8 7.7 4.2 1 .6 5 .0 1 .5 1 .5 2 .3 4 .5 0.7 1 .2
in'eat-d
control
.'I?an 
53 I
0 .9
0 .3
11.3
4 .6
26.0
3.8
32.0
7.3
1 .2
0 .7
0 .3
0 .3
0 .1
0.1
0.04
0.02
0.0 0 .2
0 .2
0.4
0.4
0.02
0.04
0.0
Significance p < K3 K3 u s 0.02 0.001 0.0C1 0.001 0.C01 0.001 0.001 0.02 0.001 0.001
*see- table VI
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c . Treatment with 100 mg kg quinine for 7 days starting 
from day 4 of the infection
id
A. P «chabaudi infection of 1 x 10^ infected erythrocytes 
was given on day 0. The intact and the T-cell deprived 
untreated group showed a parasitaemia of 0.8 ± 0.4$ and 
0.9 ±0.3$ on day 2 and a peak of 44.6 ± 7.7# and 32 ± 7.3$ 
respectively on day 7. The blood films from the intact 
group became negative on day 22 and a second parasitaemia 
period occurred on days 26-37 with a maximal parasitaemia 
of 0.4 ± 0.4$. In the drug treated intact group of mice 
the parasitaemia fell from the initial level of 16 ± 3.4$ 
on day 3 to a level of 0.06 ± 0.05# on day 11 and remained 
positive between 0.1# and 0.5# up to day 22. The T-cell 
deprived treated group of mice showed an initial parasitaemia 
of 22 ± 6.7# which fell after treatment but the lowest 
parasitaemia was 2.8 ± 3.6# and the parasitaemia remained 
throughout the experiment. Apart from day 7, the 
parasitaemias in the drug treated groups were significantly 
different from each other (P ^ 0.05-0.001) (fig 39- )•
There was no mortality during the experiment.
4. The effect of pyrimethamine treatment • !"
T-cell deprivation in these experiments was done by 
adult thymectomy and ALS (2) treatment and grouping of 
mice was done as before.

Table XXXIII Statistical analysis of the data in Fig 40. (n=6)
Group DayData 1 3 6 10 13 17 20 24 27 31 34 38 48
Deprived Mean 4.0 0 .04 0.0 0.0 0.01 28.5 13.3 7.5 10.5 7.0 3.5 18.5 6 .6tree ted SD - 2.7 0.1 “ - 0.01 9.2 1 6 .6 6 .4 2 .2 1.4 0.7 10 .6 7.7
Intact Mean 3.7 0.0 0.0 0.0 0.3 1 .2 0.0 0.0 o.o3 0.0 0.0 0.4 0.0treated SD - 0.9
'
* • • 0.0
(for untreated controls see table XX. X p 2 5 9 )
The figure 
•see table
corresponds to the mean of the recrudescences only. (3 recrudesced in deprived group and 1 in 
yj intact group).
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a. Treatment with 0.2
1»5 x 10 P ,chabaudi-infected erythrocytes were 
inoculated on day 0. Infections in the untreated intact 
and T—cell deprived mice were like those already described 
for earlier experiments. Both the treated groups remained 
blood negative starting from the 3rd day after treatment. 
However, in the T-cell deprived treated group, 3 out of 6 
mice recrudesced on day 13 and remained parasitaemic 
throughout (fig 40 ). In the intact treated group only 1 
mouse became, blood film positive (with 0.39» paraaitaemia) 
on day 13 and again on day 27.
A heavy inoculum of 1.5 x 10 infected erythrocytes 
was given on day 0 and treatment was started when the 
parasitaemia was between 4»2 —5.65*. The infection became 
blood negative on day 3 in both the intact and T-cell 
deprived treated groups. The intact treated group remained 
blood negative throughout the experiment but in the deprived 
treated group 4 out of 6 mice showed a recrudescence on day 
17 and remained patent after that (fig 41 ).
pyrimethamine for 7 day3c. Treatment with 2 mg kg
A p.chabaudi infection of 1 x lo' infected erythrocytes 
riven on day 0 and pyrimethamine treatment was started

Table .1XXI7 Statistical analysis of the data in Pic 41. (n=6)
1 *y 6 10 13 17 20 24 27 31 34 CO 4e
i deprived Hoar - / b.o 0.0 0.0 0.0 0.0 10.0 16.0 5.0 11.7 3-5 0.9 9.7 ' 7.5
j treated S3 - 1.1 - - - - 1.1 14.5' 6*1 10.4 5.6 1.4 6.0 2.1
Intact Kean 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
treated S3 - 1.3 - - - - - - - - - - - -
j Significance ? < HZ £3 NS NS HS 0.001 0.02 NS 0.02 NS NS 0.01 0.001
(for untreated controls see table XX X p S 5 9  )
In the deprived group, the figures correspond to the mean pf 3 recrudescences (after treatment)

FIGURE 4.1 P. chabaudi - mean percentage parasitaemias 
in T-cell-deprived and intact control CBA 
mice inoculated with 1.5 x 10® infected 
RBC and treated with pyrimethamine 
2 mg kg 1 (days 1-7)
r ~ *
Deprived
Intact control
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FIGUT._ - P. chabaudi - mean percentage parasitaemias in CBA mice infected witr. 
" 7 -1 — 11 x 10 infected HBC and treated with pyramethamine 2 mg kg day
(days 2-8).
I
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Parasitaemia in both the treated groups became negative 
on day 6 and remained as such throughout the experiment 
(fig 42 ). The blood, spleen and kidney tissues from two 
mice of each group injected into 6 clean mice did not produce 
any patent infection.
The control groups were the same as those in experiment 
3c (p 266). There was no mortality recorded during the 
experiment.
5. Drug sensitivity of P.chabaudi after chemotherapy in intact 
and T-cell deprived mice
Drug sensitivity testing was performed on all the 
stabilates of the recrudesced populations of experiments 
P la, lb, 2a, 2b, 3a, 3c, 4a and 4a including the original 
stabilate.
The 4 day suppressive test (p H T  ) was used for the 
drug sensitivity testing. The index of resistance of the 
T—cell deprived group was monitored in terms of the effective 
doses of the recrudesced intact treated group.
There was no significant increase in the index of 
resistance of the T—cell deprived group compared to that of 
the parent line or the corresponding intact treated group 
(Table XXXV).
T a b l e  X X X V  S u p p r e s s i v e  t e s t  o f  P . c h a b a u d i  i n f e c t i o n  u s i n g  
o f  i n t a c t  a n d  T - c e l l  d e p r i v e d  m i c e .
t h e  r e c r u d e s c e n t  p o p u l a t i o n  a f t e r  t r e a t m e n t
Drug Stabilate tested Intact treated group Deprived treated group Index of resistance
tested ED^q - SE E D ^ i s E ED50 ± SE ED90 ± SE X50 J90
Original stabilate 1.6 t 0.4 2.5 - 0.8 - - - -
©£
Exp. F la (chloroquine 
2 mg kg"1 x 7 days) 1.5 - 0.5
2.73- 1.2 1.5 - 0.7 2.4 ± 0.8 1.0 0 . 8 8
£
c*
o
u
Exp. F lb^(chloroquine 
10 mg kg x 7 days) -
- 2.1 ± 0.3 2.9 - 0.9 - -
cH
£O
Exp. F 2a (chloroquine 
2 mg kg"1 x 7 days) 1.4 - 0.3
2.3 - 0.6 1.75- 0.7 3.04^ 0.4 I. 2 5 1 . 3 2
•*
Exp. F 2 K (chloroquine 
10 mg kg x 7 days)
- - 1.4 - 0 . 4 2.4 ± 0.5 -
Original stabilate 39.0 t 7.0 68.0 -18.0 - - - -
©£•H
£«H
Exp. F 3a,(quinine 
20 mg k g "1 x 7 days) 38.0 - 8.0 7 2 .O -2 1 . 0 O•
+ 1O 77.0 -18.0 1.03 1 . 0 7
£ Exp. F 3c (quinine 
100 mg vg~L x 7 days) 4 2 . 0  ±12.0 75.0 ±17.0
38.0 ± 9.0 83.0 ±25.0 0.9 l.ll
Original stabilate 0 0 2 5 ^.0 . 0 1 0035- 0.02 - - - -
© Exp. F ¿a (pyrimethamine 
0.2 mg kg'* x 7 days)
0028± 0.01 Q042Î 0.02 0.02- 0.01 0 .0 5 Ì O.O3 0.71 1.19
Ë
Exp. F 4b (pyrimethamine 
2 mg kg"1 x 7 days) -
- 0 .0 3 ± 0.02 0045- 0.02 - -
s e e  t a b l e  X X V
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DISCUSSION
The line of P .chabaudi used in "the experiments is 
sensitive to chloroquine and pyrimethamine (Walliker, personal 
communication). According to Rosario (1976), infection in 
C^/Black mice is sensitive to 6 daily oral doses of 3 mg kg“^ 
of chloroquine. In my preliminary tests, intraperitoneal 
injections of 7 daily doses of 4 mg kg-^ of chloroquine 
was found to cure 100# of CBA mice without recrudescence.
When 7 daily doses of 2 mg kg-'1' of chloroquine were given 
to the P .chabaudi infected mice, 100# recrudescence occurred.
I used 3 different drug regimes against P .chabaudi, 2 mg kg- "^ 
(subcurative dose), 4 mg kg-^ (minimum curative dose) and
10 mg kg-1 (above curative dose), with the drug dosages 
given intraperitoneally for 7 days.
Chemotherapy of blood induced P .chabaudi infection in 
intact mice depends not only on the drug dosage but also on 
the time of treatment. This effect can be clearly seen with 
a low drug dosage (2 mg kg-^) schedule. When given from 
days -1 to 20, the parasitaemia was maintained at a low level 
(0.4$) but went up to 1.3# after treatment. The infection 
lasted for 36 days. However, when administered on days 5 to
II the mice became aparasitaemic by day 11. The infection 
recrudesced 5 days earlier than the control group with a 
slightly higher parasitaemia of 0.8# — 0.6. V/hen the same 
dose of chloroquine was given on days 13—19# the infection 
resolved completely. This indicates that a drug dose which 
is subcurative when given early in the infection was more 
effective when used in the later part of the infection.
When a higher dose of chloroquine (10 mg kg 1) was used all
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of the mice were cured whether treatment was started early 
or late. In these respects the chemotherapeutic effect 
of chloroquine against P.chabaudi infection is comparable 
with that against P.berghei infection.
However, early chloroquine treatment of P.chabaudi 
infected T—cell deprived mice was more effective than late 
treatment, though not with low doses of chloroquine. In 
both the early and late treatment, 7 daily doses of chloroquine 
at 2 mg kg-'*' just reduced the parasitaemia to about the 1i» 
level but this rose again to the original level as soon as 
the chemotherapy was stopped. However, early institution of
7 daily doses of chloroquine at 10 mg kg- "^ cleared parasites 
from the blood of the T-cell deprived group, though 4 out of
8 mice recrudesced. The reason why chloroquine is less 
effective in late treatment of T-cell deprived mice is not 
known but the results agree with those obtained with treat­
ment of P.berghei in T-cell deprived mice. A similar result 
has also been obtained by Smith and Wood (1965a) in 
treatment of pneumococcal infection with penicillin in intact 
and irradiated (650 rads) mice. According to these authors 
penicillin was equally effective when given 9 hours after 
infection but less effective in the irradiated mice when the 
treatment was delayed until 24 hours. These authors found 
penicillin was more effective when the organisms were 
rapidly multiplying (9 hours) but less so when the infection 
was established. They proposed that at that stage the 
curative action was not due to the bactericidal action of 
penicillin alone but a combined effect with the cellular 
defences of the host. The reason why chloroquine acts more 
effectively early in the infection in T-cell deprived mice
is not known. In chemotherapy 3 major factors are involved, 
drug, host and parasite (Whiteside, 1962).
The drug chloroquine has been shown to be effective 
independently without the requirement of the immune response 
of the host (Elko and Cantrell, 1970), and this was confirmed 
in my experiments where early treatment of T-cell deprived 
mice led to a 100# cure. But, when treated late, though the 
parasitaemia was reduced to zero as effectively as in the early 
treated group, 50# of the mice recrudesced. So this effect 
was unlikely to be due to that of drug alone. Jayawardena 
et al. (1977) have shown the persistence of P.yoelii infection 
in the kidneys of mice up to one month after patency. If 
something similar occurred with P.chabaudi it might explain 
the recrudescence after chemotherapy late in the infection 
as proposed by Jennings et al. (1977) for T.brucei. In the 
immunologically intact mice, the immune response would remove 
these parasites but this might not occur in immune deprived 
mice, where T-cells are absent.
The recrudescent population of P .chabaudi from the drug 
treated T-cell deprived mice did not show any significant 
increase of drug resistance when tested with the 4 day 
suppressive test and compared with the original stock. It 
may be that the 4 day suppressive test is not sensitive 
enough to show slight variations in drug resistance of the 
parasite because chloroquine resistant strains of P .chabaudi 
have been obtained by treating infected mice with oral doses 
of chloroquine (2 mg kg-1 daily for 5 days) and by passaging 
the infection and repeating the treatment 5 times (Rosario, 
1976). However, before drawing any conclusions, it will be
necessary to repeat the same type of experiments with other 
antimalarials to test the drug sensitivity with other 
available methods like the Rane test and the 2# bioassay 
test.
The treatment of P .chabaudi in immunologically intact 
mice is more effective than that in T-cell deprived mice.
This effect is the same for both early and late treatments.
In early treatment with chloroquine (2 mg kg-1 for 7 days) 
the parasitaemia in the T-cell deprived group stayed above 
the 0.1# level, though the intact and sham-treated groups 
fell to zero. The difference was more pronounced after 
treatment with 4 mg kg-1 for 7 days, when all the infected 
intact mice were cured totally but all the T-cell deprived 
mice recrudesced. All of the mice in the infected intact 
group were cured by treatment with 2 mg kg 1 for 7 days while 
the parasitaemia in the T-cell deprived group was reduced 
only to 0.9# - 0.1. Using 10 mg kg“1 daily doses of chloro­
quine for 7 days the parasitaemia in both the groups went 
down to zero, 50# of the mice recrudesced in the T-cell 
deprived group. This showed that with subcurative doses of 
chloroquine, an effective immune response (T-cell probably) 
was necessary to bring down the parasitaemia to zero. Also, 
when an effective dose of chloroquine was given (40 or 10 mg 
kg"1 for 7 days) an intact immune response was required for 
the prevention of recrudescence. Roberts et al. (1977) 
have also shown that clindamycin treatment of P.yoelii 
infection in Nu/Nu mice resulted in recrudescences, though . 
the same treatment gave a curative effect in the intact mice.
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Taliaferro (1948), Taliaferro and Kelsey (1948) and 
Taliaferro and Taliaferro (1949) have shown that quinine 
was more effective in the intact control than the splenectomised 
chickens infected with P «gallinaceum. Also in other protozoal 
infections, Jancso and Jancso (1934) and Kolpikow (1926) 
showed that chemotherapy of T.brucei infection in intact 
mice was better than in the splenectomised mice. Muntui 
et al. (1961) have shown that neoarsphenamine was not as 
effective in lethally irradiated rats infected with T.brucei 
as in the intact controls. They used a lethal dosage of 
irradiation which killed the rats in 8-17 days. Irradiation 
affects the rapidly dividing cells of the body like haemopoietic 
cells and gastro-intestinal cells together with the lymphoid 
cells. Though the effects of other factors like lack of 
nutrients required for the parasite and anaemia etc, might 
play some role as well, one can see the important role of 
the immune mechanism in drug treatment.
Quinine treatment of P.chabaudi infection was also more 
effective in intact mice than in T-cell deprived mice. Though 
quinine chemotherapy (100 mg kg ^ for 7 days) in P .chabaudi 
infection is not curative, the parasitaemia went down to 
zero in the intact group but invariable recrudesced after the 
treatment. However, the same dose of quinine did not bring 
down the parasitaemia as low in any of the experiments with 
T-cell deprived mice. When quinine treatment was given on
Qday 1 after a heavy inoculum (1.5 x 10 ) the parasitaemia did
not fall at all. It fell to zero in the intact group (fig 38 ).7However, quinine treatment after an inoculum of 1 x 10 
infected erythrocytes reduced the parasitaemia in deprived 
mice but still not as much as in the treated intact group 
(fig 39 ).
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Pyrimethamine chemotherapy of P.chabaudi infection 
was also more effective in intact mice than in, T-cell 
deprived mice. This effect was most clearly seen where the 
pyrimethamine treatment (0.2 mg kg-1 or 2 mg kg-1daily for 
7 days) was given after a heavy inoculum (1.5 x 108 infected 
erythrocytes) of P .chabaudi. 3 mice recrudesced in the
T-cell deprived group though 5/(* were cured in the intact 
group (fig 40 ).
The reason for more effective antimalarial chemotherapy 
in intact P.chabaudi infected mice than in T-cell deprived 
mice is not known. This effect seems to depend partly on 
the drug dosage^ where a large enough dose of drug was given 
the chemotherapy was as effective in the T-cell deprived 
group as in the intact group (Exp. 34 and 42 ). The
time at which the chemotherapy was given also seemed to play 
a role. Though early treatment with chloroquine (10 mg kg-1 
for 7 days) was equally effective in deprived and intact 
mice, the same drug dosage schedule given late in the infection 
was less effective in the T-cell deprived group. The size 
of inoculum also plays some role. Pyrimethamine (2 mg kg ^ 
for 7 days) was equally effective in both groups infected 
with an inoculum of 1 x 107 infected RBC but less effective 
in the T-cell deprived group given a higher inoculum (1.5 x 
108 infected RBC)
The reduced effectiveness of antimalarial chemotherapy 
in T-cell deprived mice does not seem to depend on the 
antibody level. PA titres of T-cell deprived mice in P.yoelii 
infections were detectable only after day 12 of the infection 
(Jayawardena, 1975) and so if the effectiveness of anti—
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malarials depended on the antibody titre it should have 
been more effective in the late treatment than the early 
treatment but this was not so (see discussion p S 7 S ) 
Also, in my preliminary studies I found that, when hyperimmune 
serum was combined with quinine treatment, the serum and 
drug given togetherseem to act better than drug or antiserum 
given alone. However, the infection still recrudesced, 
showing that antibody was probably not an important factor 
in preventing recrudescence. Roberts et al. (1977) have 
shown that recrudescence of P.yoelii infection in Nu/Nu  mice 
after treatment with clindamycin could be prevented by 
thymus graft or by giving hyperimmune serum. They also 
showed that B-cell deficient mice (Nu/Nu mice treated from 
birth with anti JJL chain serum) were unable to control 
P »yoelii infection. According to them T-cells play a crucial 
role in preventing recrudescent malaria infection as a helper 
function in the production of antibody.
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G. Treatment of malaria infection with 
steroids and antimalarials.
1. P.chabaudi infections
a * High single dose of hydrocortisone—acetate combined with: 
chloroquine treatment
There were four groups of mice, A given hydrocortisone 
alone, B hydrocortisone and chloroquine, C chloroquine and 
D the untreated control group.
A P .chabaudi inoculum of 1 x 10^ infected erythrocytes 
was given on day 0. A single dose of hydrocortisone 
acetate (200 mg kg- "^) was given subcutaneously on day 3 
to groups A and B. Daily i.p. injections of chloroquine 
(2 mg kg“'*') were given to mice of groups B and C on days 
3 to 9. The blood films were taken on slides coated 
with brilliant cresyl blue at 2-3 day intervals, and the 
parasites as well as the reticulocytes were counted. 
Mortality was recorded daily.
The parasitaemic patterns in the untreated control 
group and the group given hydrocortisone alone were 
comparable up to day 5 with peak parasitaemias of 47$ —10 
and 47$ —4.8 respectively. By day 8 all of the mice 
treated with hydrocortisone alone, had died with a mean 
survival time of 7*5 ±0.6 days. In the untreated control 
group the parasitaeroia started to resolve from day 8 and 
the mice became aparasitaemic on day 19 (fig 43 •)•
In the infected group given chloroquine alone the 
blood filmsbocame negative on days 8 to 13 from the initial

T a b l e  X X X V I A  S t a t i s t i c a l  a n a l y s i s  o f  t h e  d a t a  i n  F i g  4 3 . » .  ( n « 6 )
Group vsjjayDat5>v 3 5 8 13 17 19 22
Chloroquine 
+ cortisone Mean 4.2 1.7
1.6 5.5 1.4 8.0 0.0
treated SD i 0.5 1.7 1.9 10.3 1.8 9.4 -
(B)
Chloroquine Mean 4.0 0 . 4 0.0 0.0 0.07 4.6 0.01
treated (C) SD * 2.0 0.5 - 0.0 0.4 0.9
Significance P < NS NS NS NS NS NS NS
Cortisone Mean 3.2 47.0 43.0 - - - -
treated (a ) SD - 0.8 10.0 5.2 - - - -
Malaria Mean 4.8 47.0 8.0 1.1 1.6 0.0 0.0
control (D) SD - 2.5 4 . 8 4.8 0.7 1.9 - -
Significance P < NS NS 0.001 - - - -
♦see table VI
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T a b l e  X X X V I B  S t a t i s t i c a l  a n a l y s i s  o f  t h e  d a t a  i n  F i g  4 4 \ - .  ( n » 6 )
Group vjteyDatS^ 3 5 8 13 17 19 22
Chloroquine 
+ cortisone Mean 1.1 0.5 0.5 5.3 11.3 12.2 9.3
treated (B) SD - 0.5 0.08 0.4 0.5 10.6 3.8 5.8
Chloroquine Mean 2.0 1.9 4.0 1.7 2.5 16.4 8.6
treated (C) SD - 1.8 1.9 3.2 0.6 0.9 12.1 3.5
Significance P < NS ÏÏS 0.05 0.001 NS NS NS
Cortisone Kean 1.1 0.9 8.0 all
treated (A) SD * 0.4 0.5 5.0
died
Malaria Mean 1.08 14.8 35.0 17.0 21.8 17.3 4.0
control (D) SD - 0.7 7.04 7.0 4.7 18.0 12.0 1.7
Sirnificance P < NS 0.001 0.001 - - - -
*see table VI
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mean parasitaemia of 4$±2. But in the chloroquine 
piiis hydrocortisone treated group the parasitaemia stayed 
above 1.4$—1.8 up to day 19 and resolved on day 22«
Apart from the hydrocortisone alone treated group, there 
was no mortality detected.
Reticulocyte counts were 0.9$ ^0.5 and 8$ -5 on days 
5 and 8 in mice given hydrocortisone alone, while in the 
untreated controls the counts were 14.8$ —7 and 35$ —7 
respectively. A significant depression (P <. 0.001)
resulted from cortisone treatment.(fig 44 )
The reticulocyte count in mice given chloroquine 
alone was 4$ -3*2 on day 8 and was significantly (P <  0.05) 
higher than that of the mice given both, chloroquine and 
hydrocortisone, though the parasitaemia was lower in the 
former. In the later part of the infection, the reticulocyte 
counts were not significantly different between the two, 
though the parasitaemia was higher in the group given both 
drugs•.
b. High single dose of hydrocortisone-acetate combined with 
quinine treatment
Pour groups of mice were used, A cortisone treated,
B given cortisone and quinine, C quinine treated and D 
untreated controls.
The P .chabaudi inoculation was 1.5 x 10 infected 
erythrocytes. Hydrocortisone acetate at a dose of 200 mg kg 
was given subcutaneously on day 1 to mice of groups A and 
B. Quinine at 100 mg kg”1 daily for 7 days was given to 
mice of groups B and C starting 2 hours after the

Tatle X X m i  Statistical analysis of the data in Fig 45• (n»8)
Croup Dat&v 1 2 3 5 7 1 0 14 17 2 1 24 28 31 34
00K“\ 4 6 5 2
~uinine + Mean 1.9 2 . 6 0.9 0.7 5 . 5 10.2 19.5 8 . 2 0.4 0.2 0.01 0.2 3.0 4 . 2 0.C1 0.0cortisone (3) SD - 0.5 0.7 0 . 3 0.4 2.4 6.8 3.3 8 . 2 0.1 0.4 - 0.2 5.4 5-4
Quinine Hear. 1.8 1.9 0.3 0.15 0.2 0 . 0 4 4.3 4.9 0.08' 0.0 0.0 0.1 0 . 0 0.0 0.0 0.0treated (C) S3 - 0.5 0.9 0.2 0.12 0.2 0.01 3.9 4.6 0.1 0.01
Significance P < IIS ns 0.001 0.02 0.001 0.001 0.001 NS 0.001 NS NS IIS NS NS ITS US
Cortosone Mean 2.0 1 0 . 6 28.4 5 2 . 6
treated (a ) S D - 0.5 3.6 6.0 8.6
¡•ialaria Mean 1.9 9.8 18.6 32.3 7.2 5.8 0.6 0.0 0.0 0.0 0.1 1.1 0.0 0 . 0 0.0 0.0control (D) SD - 0.6 3.0 3.9 6.6 1.9 0.81 0 . 5 - - - 1.1
Significance P < NS NS 0.01 0.001 • • • • • - - -
*see table VI
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hydrocortisone treatment.
The mean parasitaemia in the hydrocortisone treated 
group was significantly higher (P < O.Ol-O.OOl) than that 
of the normal untreated group on days 3 and 5. In the 
untreated group the parasitaemia reached a peak of 32.3^6.6 
on day 5 and resolved on day 17. Hydrocortisone treated 
mice had a mean peak parasitaemia of 52.6?» -8.6 on day 5 
and all the mice died, with a mean survival time of 
6.6 ¿0.6 days. Mice given quinine alone (group C) had a 
significantly lower (P <0.02-0.001) mean parasitaemia than 
those given both drugs (group B) on days 3, 5, 7, 10, 14 and 
21. During the treatment the minimum recorded parasitaemia in 
group C (quinine treated) was 0.04# ¿0.01 on day 10. The 
minimum for group B (quinine + cortisone) was 0.7# ¿0.4 on day 
5 and the parasitaemia then increased in spite of the last two 
doses of drug, to reach a peak of 19.5# ¿3.3 on day 14. The 
infection persisted longer and at a higher level in group B; 
(fig 45). There was no mortality in either of these groups.
c. Daily divided dosages of hydrocortisone-acetate combined 
with quinine treatment
7A P.chabaudi inoculum of 1 x 10' infected erythrocytes 
was given on day 0. Hydrocortisone acetate was given sub­
cutaneously as a daily dose of 30 mg kg”1 from days 2 to 
8 to groups A and B. Quinine (100 mg kg i.p.) was given 
daily to animals in groups C and D from days 2 to 8.
The parasitaemia in the hydrocortisone treated group (A) 
reached a peak on day 7 of 44# ¿12 and was significantly 
higher (P < 0.05) than that of the untreated control

Table XXXVIII Statistical analysis of the data in Pig 46. (n=8)
Group ^ a y .2 4 7 10 14 17 20 24 28 33
Quinine + Mean 0.9 0 .5 0.07 0.0? 1.0 2.2 5.0 5.4 0.4 0 .2
cortisone (B) SD - 0.4; 0 .2 0.01 C.03 1.7 - O • ^ 5.0 8.8 0.8 0.3
Ouinine it; an O.G 0.08 0.01 0.0 0.24 0.9 1 .0 0 . 0 0.03 0 .6
treated (C) SD - 0.4 0.07 0.C1 0.35 0.9 2 .4 0.44 0.9
Si nsi f icance ? < US 0.05 0.C01 0.001 i:s NS ;<s IIS NS KS
allCortisone ¡•lean 1 . 0 13.4 44.0 17.0
treated (A) S3 - 0.4 5.2 12.0 -
Malaria Hear. 1.0 11.0 29.0 2.7 G.6 0.01 0.01 0.3 0.2 0 . 0
control (D) i^ T*.O J  - 0.3 4.8 12.6- 1.9 1.2 0.01 0.01 0.3 0.2
Significance P < vr* NS 0.05 - - - - - - -
see table VI
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( 2 Q c/c— 2 . 2 , 6 )  • All the control mice survived but the 
hydrocortisone treated animals died with a mean survival 
time of 8.3 -0.8 days (fig 46 ).
When hydrocortisone and quinine treatment were 
combined, the mean parasitaemias were significantly higher 
(P < 0.05-0.001) on days 4,7 and 10 of the infection than in mice 
treated with quinine alone. All of the mice in these two 
groups survived.
2. P.berghei infections
Since the P.berghei strain is resistant to quinine 
treatment the experiments involved only hydrocortisone and 
chloroquine treatment.
Pour groups of mice were used as in the previous 
experiment.
The P.berghei inoculum given to each mouse on day 0 
was 1 x 10^ infected erythrocytes. A single subcutaneous 
injection of 200 mg kg“1 of hydrocortisone acetate was 
given to mice of groups A and B on day 2. Chloroquine at 
10 mg kg“1 daily was given to animals in groups B and C 
on days 2-8.
The pattern of infection and mortalities were 
similar in the hydrocortisone treated mice and the 
untreated controls. The mean survival time of the 
hydrocortisone treated group (16.9 -7.5 days) was also 
not different from that of the normal control (15 -3«9 days). 
The chloroquine treated group was also comparable with 
that given both hydrocortisone and chloroquine (fig 47 
P B 9 B  ) •

Table XXXIX Statistical analysis of the data in Fig 47. (n-6)
Group Datct— 2 6 9 11 13 16 19 27 29 35 38
Chloroquine 
+ cortisone 
treated (B)
Mean 
SD -
3.2
0.5
0.0 0 .0 0.0 0.0 0.01 1.5
0.9
24.710.0
26.0
5-3
35.0
10.9
32.5
0.5
Chloroquine Heap 3.8 0.0 0 .0 0.0 0.0 0.0 2.04 2.0 14.0 5 2 .0 40.0
treated (c) SD - 1.1 1.3
Significance P< NS NS NS NS NS NS NS - - - -
Cortisone Mean 3.5 2 5 .0 12.7 43.7 2 9 .0 60.0 61.0
treated (a ) SD - 2.1 17.6 2.1 2 9 .0 8.9
Malaria Mean 3.8 21.2 20.5 27.8 53.0 5 2 .0 72.0
control (D) SD - 1.3 11.0 6.5 4.8 10.1
.
Significance P< us NS 0.01 NS 0.001 - -
*see table VI
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The infections became blood negative on day 6 in 
both cases and recrudescent between days 16 and 19. There 
was no significant difference in parasitaemia and mean 
survival time for the chloroquine treated group (25 ±10.1 
days) and the chloroquine and hydrocortisone treated group 
(28.6 ±17.2 days).
DISCUSSION
Glucocorticosteroid (steroid) hormones produced in the 
adrenal cortex have striking pharmacological effects on 
lymphoid cells and tissues. These effects form part of the 
basis for the widespread use of these hormones in the 
treatment of a variety of diseases involving immunological, 
inflammatory or neoplastic diseases. Nowadays, a wide 
variety of purified compounds are used instead of the 
crude adrenocortical extracts. Fauci (1976) has shown that 
the hydrocortisones prednisolone and dexamethasone cause 
almost identical suppression of the numbers of circulating 
lymphocytes in man. According to Claman (1972) the different 
types of steroids differ in their effects on the lymphoid 
system mainly in relative potency not in biological effects.
T h e  i m m u n o s u p p r e s s i v e  e f f e c t s  o f  s t e r o i d s  h a v e  b e e n  
s h o w n  w i t h  v a r i o u s  p r o t o z o a l  i n f e c t i o n s  e . g .  T o x o b I ^ s j ®  
i n  m i c e  ( S t a h l  e t  a l . ,  1966), T r y p a n o s o m a  l e w i s !  i n  r a t s  
( S h e r m a n  a n d  R u b l e ,  1967{ P a t t o n  a n d  C l a r k ,  1968), B a b e s i a  
m i c r o t i  a n d  J } _ j j r o d h a i n ^  i n  r a t s  a n d  m i c e  ( Y o u n g ,  1973) » a n d  
i n  m a l a r i a  ( C o x ,  1968).
D i f f e r e n t  s p e c i e s  s h o w  r e m a r k a b l e  d i f f e r e n c e s  i n  
s e n s i t i v i t y  t o  s t e r o i d s .  H a m s t e r s ,  m i c e ,  r a t s  a n d  r a b b i t s
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a r e  s e n s i t i v e  t o  s t e r o i d s  b u t  m a n ,  g u i n e a  p i g s ,  m o n k e y s  
a n d  f e r r e t s  a r e  r e l a t i v e l y  r e s i s t a n t  t o  t h e m  ( d a m a n ,  1 9 7 2 ) .  
S t e r o i d  t r e a t m e n t  i n  t h e  s t e r o i d  s e n s i t i v e  s p e c i e s  p r o d u c e s  
p r o f o u n d  l y m p h o p e n i a ,  a t r o p h y  o f  t h e  t h y m i c  c o r t e x ,  s h r i n k a g e -  
o f  l y m p h  n o d e s  a n d  t h e  s p l e e n  a n d  i m p a i r m e n t  o f  a n t i b o d y  
p r o d u c t i o n  ( d a m a n ,  1 9 7 5 ) .  F a u c i  ( 1 9 7 6 )  r e f e r r i n g  t o  o t h e r  
w o r k e r s ,  s t a t e d  t h a t  t h e  i m m u n o s u p p r e s s i v e  e f f e c t s  o f  s t e r o i d s  
i n c l u d e  d e c r e a s e d  m i g r a t i o n  o f  c e l l s  i n t o  i n f l a m m a t o r y  s i t e s ,  
c i r c u l a t i n g  l y m p h o p e n i a  a n d  m o n o c y t o p e n i a ,  d e c r e a s e d  
i m m u n o g l o b u l i n  l e v e l s  a n d  i m p a i r e d  e x p r e s s i o n  o f  c u t a n e o u s  
d e l a y e d  h y p e r s e n s i t i v i t y .  Y u  e t  a l .  (1974) d e m o n s t r a t e d  
t h a t  b o t h  T  a n d  B  l y m p h o c y t e s  a r e  a f f e c t e d  b y  p r e d n i s o l o n e  
b u t  t h a t  T - c e l l  l y m p h o p e n i a  i s  m o r e  p r o n o u n c e d .  H o w e v e r ,  
a c c o r d i n g  t o  d a m a n  (1975) t h e  s u p p r e s s i v e  e f f e c t s  o f  
s t e r o i d s  o n  c e l l  m e d i a t e d  i m m u n i t y  m a y  b e  d u e  n o t  t o  a n y  
i n h i b i t i o n  o f  l y m p h o c y t e  f u n c t i o n  b u t  r a t h e r  t o  i n h i b i t i o n  
o f  m a c r o p h a g e  f u n c t i o n  • .
I n  m a l a r i a  i n f e c t  i o n s ,  i m m u n o s u p p r e s s a n t  t h e r a p y  i s  u s e d  
i n  t h e  m a n a g e m e n t  o f  n e p h r o t i c  s y n d r o m e  a s s o c i a t e d  w i t h  
P . m a l a r i a e  ( K i b u k a m u s o k e ,  1968), a n d  i n  t h e  t r e a t m e n t  o f  
c e r e b r a l  m a l a r i a  c a u s e d  b y  P . f a l c i p a r u m  ( W o o d r u f f  a n d  
D i c k i n s o n ,  1968; O r i c e l l o ,  1968 a n d  S m i t h s k a r a p  a n d W o l t h u i s ,  
1971). S m i t h s k a m p  a n d  W o l t h u i s  (1971) s u g g e s t e d  t h a t  
s t e r o i d s  r e d u c e  o r  p r e v e n t  c e r e b r a l  a n d  p u l m o n a r y  o e d e m a  
b y  p r e s e r v i n g  t h e  n o r m a l  f u n c t i o n  o f  c a p i l l a r y  e n d o t h e l i u m .  
M i g a s e n a  a n d  M a e g r a i t h  (1967) h a v e  s h o w n  t h a t ,  i n  P . k n o w l e s i  
m a l a r i a  i n f e c t i o n  i n  m o n k e y s ,  c h l o r o q u i n e  a s  w e l l  a s  
c o r t i s o n e  r e s t o r e s  t h e  n o r m a l  n e t  m o v e m e n t  o f  a l b u m i n  a c r o s s  
t h e  b l o o d  b r a i n  b a r r i e r  w i t h i n  o n e  h o u r .  O n  t h e  o t h e r  h a n d  
R e i d  a n d  N k r u m a h  (1972) d o u b t e d  t h e  v a l u e  o f  s t e r o i d s  i n
298
the treatment of cerebral malaria. They demonstrated
increased levels of fibrin degradation products in cerebral
malaria patients and that cerebral intravascular
coagulation occurs in severe falciparum malaria. Hall
(1977) in his review on the treatment of severe P.falciparum
infection, suggested that steroid treatment is not helpful
in a diffuse vascular disease such as falciparum malaria.
Schneider (1953) did not find any effect of cortisone on
parasitaemia or liver function in two patients with P .vivax
infections. Schmidt and Squires (1951) showed that cortisone
in daily doses of 10 mg kg-1 during the primary attack of
P .cynomolgi infection in monkeys produced a striking v
increase in parasitaemia; when given during the chronic 
phase of the infection, severe recrudescence of the infection
occurred. There was also marked reduction in the sizes of
peripheral lymph nodes and the spleen with lymphopenia in
the treated animals. The authors described the effects of
cortisone treatment as closely similar to splenectomy.
There are differences of opinion on the action of 
cortisone in experimental malarias. Pindlay and Howard 
(1952) demonstrated that after intramuscular injection of 
5 mg of cortisone acetate 30 min before and 6 hrs and 4 days 
after inoculations of P.berghei into mice, the parasites 
appeared early and the mice died quicker than the controls. 
Tandon and Bhattacharya (1970) showed that when p.berghei 
infected mice were treated with 1 mg of dexamethasone every 
12 hours for 12 days, the parasitaemia increased 4 fold 
over that of untreated controls. Interestingly this effect, 
according to the authors, was due to an increase in 
gametocytes rather than asexual forms. Carrescia (1961)
2 9 9
a l s o  s h o w e d  t h a t  m i c e  i n f e c t e d  w i t h  P . b e r g h e i  a n d  
t r e a t e d  w i t h  p r e d n i s o l o n e  ( 0 . 5  m g  -  1 . 2 5  m g )  d i e d  m o r e  
r a p i d l y  t h a n  t h e  c o n t r o l s .
T h e r e  a r e  o t h e r s  g r o u p s  o f  w o r k e r s  w h o  h a v e  o b t a i n e d  
q u i t e  d i f f e r e n t  r e s u l t s .  R o b e r t s  (1954) t r e a t e d  P . b e r g h e i  
i n f e c t i o n s  i n  m i c e  a n d  i n  h a m s t e r s  w i t h  c o r t i s o n e  a c e t a t e .  
T h o u g h  h e  u s e d  t h e  s a m e  d o s a g e  a s  F i n d l a y  a n d  H o w a r d  (1952) 
h e  d i d  n o t  g e t  t h e  r a p i d  i n c r e a s e  o f  p a r a s i t a e m i a ;  r a t h e r  
t h e  i n f e c t i o n  w a s  f o u n d  t o  b e  i n h i b i t e d .  S i n g e r  (1954b) 
t r e a t e d  P . b e r g h e i  i n f e c t i o n s  i n  m i c e  w i t h  d i f f e r e n t  
s c h e d u l e s  o f  c o r t i s o n e  e . g .  ( i )  0 . 2 5  m g  d a i l y  f r o m  2  d a y s  
b e f o r e  i n f e c t i o n  a n d  t h e n  t h r o u g h o u t  t h e  i n f e c t i o n ,  ( i i )  5 m g  
o f  d r u g  a  f e w  m i n u t e s  b e f o r e  o r  s o m e  d a y s  a f t e r  t h e  i n f e c t i o n  
( i i i )  5  m g  o f  c o r t i s o n e  f o r  8  s u c c e s s i v e  d a y s  s t a r t i n g  
2 d a y s  b e f o r e  o r  6  d a y s  a f t e r  i n f e c t i o n .  T h e  d r u g  
d e c r e a s e d  t h e  p a r a s i t a e m i a ,  a n d  r e t i c u l o c y t o s i s  a n d  
a n a e m i a  w e r e  h e l d  i n  c h e c k .  H e  t h o u g h t  t h a t  t h e  r e d u c e d  
p r o d u c t i o n  o f  r e t i c u l o c y t e s  w h i c h  s e r v e s  a s  a  s u i t a b l e  n i d u s  
f o r  t h e  p a r a s i t e  s e r v e d  t o  l i m i t  t h e  p a r a s i t a e m i a .  J a c k s o n  
( 1 9 5 5 )  p r o v e d  t h e  s a m e  f a c t  b y  s h o w i n g  t h a t ,  w h e n  i n t r a ­
m u s c u l a r  i n f e c t i o n s  o f  5  m g  o f  c o r t i s o n e  a c e t a t e  w e r e  g i v e n  
d a i l y  f r o m  2  d a y s  b e f o r e  t o  2  d a y s  a f t e r  P . b e r g h e i  i n f e c t i o n  
i n  r a t s ,  t h e r e  w a s  a  t w o - f o l d  d e c r e a s e  i n  p a r a s i t a e m i a ,  a 
d e c r e a s e  i n  r e t i c u l o c y t e  c o u n t ,  a n d  a n  i n c r e a s e  i n  s u r v i v a l  
t i m e .  S c h n e i d e r  (1953) r e p o r t e d  t h a t  c o r t i s o n e  h a d  n o  
e f f e c t  o n  P . b e r g h e i  i n f e c t i o n  i n  m i c e ,  w h e n  t h e y  w e r e  t r e a t e d  
w i t h  1 0  m g  k g " 1  b o d y  w e i g h t  f r o m  t h e  d a y  o f  a p p e a r a n c e  o f  
t h e  i n f e c t i o n  u n t i l  t h e  d a y  o f  d e a t h .
I n  P . g a l l i n a c e u m  i n f e c t e d  c h i c k e n s ,  t r e a t m e n t  w i t h
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50 mg of cortisone for 24 days did not have any effect on 
the parasitaemia or on the functions of the liver. Cox 
(1974^ compared the effects of betamethasone on mice 
infected with P.chabaudi or P.yoelii by treating them at 
various intervals after the infection. The P.chabaudi 
infections were more severe in the treated animals and 
P.yoelii infections were depressed by betamethasone. The 
author suggested that the effect was due to the depression 
of reticulocytosis by the drug. The malarial antibody 
levels in the betamethasone treated animals were lower than 
the controls.
In my experiments hydrocortisone acetate was used. This 
is rather insoluble, is slowly absorbed and therefore has 
a 'depot effect'. If one used soluble compounds, in 
dosages roughly equivalent to those of insoluble compounds, 
effects may be difficult to see unless very large amounts 
or repeated administration were used (Claman, 1972).
I used a single subcutaneous dose of 200 mg kg~^
(4 mg per mouse) or daily doses of 30 mg kg-'*' (0.6 mg per 
mouse) for 7 successive days. I wanted to simulate the 
treatment of the human situation and my drug schedule was 
started only after the appearance of the parasitaemia.
It has been shown that steroids are most effective in 
depressing the early stages of the immune response but have 
no effect on the immunity once it has been established in 
malaria infection (Cox, 1968). Since hydrocortisone 
treatment was started within 1—3days of the infections, in 
all my experiments, the maximal immunosuppressive effect 
could be expected.
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P .chabaudi produces a benign resolving infection in 
CBA mice, but all of the cortisone treated mice died at the 
first peak of the parasitaemia, within 8 days. Reticulocyte 
counts were significantly depressed from day 5 by comparison 
with those of untreated controls (fig 44 p s s 6 ) • The 
suppressive effect of cortisone on reticulocytosis is well 
documented (Singer, 1954b; Jackson, 1955; Cox, 1974e).. The 
cause of the death of P .chabaudi-infected mice when treated 
with cortisone may be due to three reasons. First of all 
P.chabaudi infection in CBA mice is potentially virulent in 
nature. The virulent nature of this parasite in mice has 
been shown by Ott (1969) » Cox (1970) and Carter and Walliker
(1975). In CBA mice 2 or more blood passages produced a much 
more virulent infection (Lwin>unpublished data). Secondly, 
the immunosuppressive effect of cortisone on T-cells, B-cells 
and on macrophages (Claman, 1975 ) may play a role. Thirdly, 
since P .chabaudi favours mature red cells and cortisone 
suppresses reticulocytosis, when the mature RBC are heavily 
parasitised (50# parasitaemia) but only a fraction of the 
normal number of reticulocytes are released, the mouse will 
naturally develop a severe anaemia and die (fig 44 P S 8 ^  )• 
This final point can be seen more clearly when we compare 
the results of cortisone treatment with another self-resolving 
malaria, P.yoelii.in mice. Barker and Powers (1971) 
showed that hydrocortisone treatment given 1 day before and 
throughout the infection of P.yoelii in mice , suppressed 
the initial parasitaemia, but impaired both immunity and 
recovery. Cox (1974°) proposed that the potentiation of 
P.chabaudi-Inf eotion in betamethasone-treated mice was due
to a depression of reticulocytosis. In mice immunosuppressed
Dy i-ceii deprivation but where there is no impaired 
reticulocytosis, P.yoelii infections are fatal (Jayawardena 
e~t al»» 1977) while P.chabaudi infections are not. (Exp IV 1 e 
p *137 ) . Thus in cortisone treatment, the effect of 
impairment of reticulocytosis may be a more decisive factor 
in the virulent nature of P .chabaudi than its immunodepressive 
effect on the immune response.
Antimalarial therapy was less effective when combined
with hydrocortisone treatment. On the basis of results 
obtained by drug treatment of T-cell deprived mice subcurative 
doses of chloroquine and quinine were used in order to 
bring out any differences in the response to treatment.
There were indications that chloroquine treatment also was 
more effective than hydrocortisone and chloroquine given 
together though the results were not significant. Parasitaemi 
in the quinine treated group were significantly different 
(P< 0.02 - 0.001) from those of the hydrocortisone plus 
quinine treated groups between days 4-10, though the 
parasitaemias were very low in both.
Corticosteroid causes the pronounced lymphopenia of T- 
cells as well as B-cells in mice, and macrophage function 
is also supposed to be inhibited (see this discussion pe37). 
The reduced effectiveness of antimalarial drugs when combined 
with hydrocortisone is thus similar to results from 
treatment of T-cell deprived mice. Although the number of 
reticulocytes was significantly lower on day 8 (P <  0.05)
in the hydrocortisone/chloroquine treated group, no mortality 
occurred because the parasitaemia (1.6^  —1.9) on that day
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Hydrocortisone treatment of P.berghei infection did 
not have a significant effect on parasitaemia or mortality 
after antimalarial therapy compared with controls.
Schneider (1953) and Pulton (1954) demonstrated that 
cortisone acetate treatment of mice or rats infected with 
P .berghei did not significantly effect the infection when 
compared with the controls. Cox (1968) also did not find 
any significant effect on the normal course of P .vinckei 
infection and mortality in mice treated with high doses of 
betamethasone. But, as stated earlier, others have shown 
and discussed that steroids potentiate P.berghei infection in mice 
as a result of immunosuppression (Findlay and Howard, 1952) 
or increased gametogenesis (Tandon and Bhattacharya, 1970).
There are still others who have demonstrated that steroids 
depress the course of P .berghei infection in mice. According 
to them, this effect is due to the depression of reticulo- 
cytosis, without which P.berghei cannot grow very well 
(Singer, 1954b and Jackson, 1955)«
According to Cox (1968) steroids do not have any effect 
on the parasitaemia of P.vinckei in mice which kill the mice 
within 6 days; but when the infection normally persisted 
6-9 days, steroids enhanced the parasitaemia. Young (1973) 
demonstrated that steroids had no action on parasitaemias 
of a virulent strain of B.rodhaini in mice though it 
enhanced the benign l^roicirot^ infection. The same is true 
with trypanosome infections. Steroids did not have any 
influence on the course of infection with virulent strains 
of T.gambiense, T.brucei or T.congolense in rats but the 
benign strains of T.congolonse and T.rhodeoiense infections 
were aggrevated by the steroids (Petana, 1964) . Thus it
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seems, that steroids do not affect the outcome of virulent 
infections like P.berghei, but they only affect benign 
strains. This perhaps is the balancing effect of the 
activation of suppressor T-cells by the virulent organisms 
(Jayawardena and Waksman 1977) and reduction of antibody 
production, lymphopenia and prevention of the function of 
macrophages by the steroids on the one hand and the 
reticulocytopenia produced by the steroid on the other.
The effect of chloroquine and cortisone on P.berghei 
infection in mice was similar to that of chloroquine alone 
both in terms of the course of infection and in mean survival 
time (exp 02 p e 9 3 ) <  However Cantrell and Kendrick
(1963) have shown that cortisone in daily doses of 100- 
200 mg kg“1 reduced parasifaemia by 25# in P.berghei 
infected mice and acted synergistically with all the 
antimalarials. These authors did not think that the effect 
was due to the depression of reticulocytes.
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H. Malaria and protein-energy malnutrition
1 • P.chabaudi infections in mice maintained on protein—energy 
deficient diets
Two groups of weanling mice were used, one fed on 4# 
protein diet and the other on a 21# protein diet. PABA 
(0.05#) was added to the drinking water of all animals.
In mice fed on the 21# protein diet, the initial mean 
body weight went up from 16.6 g (-0.7) to 18 g (-1.0) during 
a period of 4 weeks prior to infection. Mice on the 4# 
protein diet showed a loss of weight during the same period 
from 16.5 g (¿0.6) to 11.4 g (¿0.9). On day 32 of the 
malaria infection, mean body weights in the 21# protein 
and 4# protein groups were 21.3 g (¿1.7) and 9*3 g (¿0.7) 
respectively. At the end of the experiment (day 60) the 
respective weights were 22.5 g (¿2.1) and 8.6 g (¿0.9).
7The P.chabaudi inoculum was 10'infected erythrocytes. 
Parasitaemia was detectable in both cases on day 1 and maximal 
on day 6 with 41.8# (¿1) in mice fed on the 21# protein diet 
and 38# (¿4.6) in mice fed on the 4# protein diet. The 
parasitaemia in the 4# protein diet treated group was more 
prolonged and resolved on day 28 while the other group 
resolved on day 17. Also the second peak of the parasitaemia 
appeared 6 days later in the low protein diet treated 
group (day 37) than that of the control group (day 33),(fig 48 ).
There were no deaths in either group.

Table XL Statistical analysis of the data in Fig 48 .(n«6)
Group ^Jay
Dat^v.
1 2 6 QJ 1 1 14 17 2 0 28 33 37 40 49 52
21c/b protein Kean 0 . 2 1.3 4 1 . 8 14-3 1.3 0.03 0.0 0 . 0 0 . 2 0.5 0.0 0.0 0.0 0.0
treated SD - 0.1 0 . 2 1.0 3.6 0 . 6 0.05 0.1 0.9
iff) protein Mean 0.4 1.5 3 8 . 0 1 6 . 8 3.2 2.9 2.7 0 . 0 2 0.0 0J31 0.9 1 . 2 0.0 0.0
treated SD - 0 . 2 0.7 4*6 1 3 . 0 0.4 1.7 2.7 0.04 0  . 0 2 1.4 1.3 0.0
Significance P < NS NS NS NS 0.001 0 . 0 1 0.05 NS 0.001 NS NS 0.05 NS NS
♦see table VI
»
- ^
2 • Quinine treatment of P.chabaudi infections in protein— 
energy deficient mice
Mice were again maintained on either a 4# or a 21# 
protein diet from weaning time for 40 weeks. Table 
shows the weight changes that occurred.
The P.chabaudi inoculum was 1.6 x 10*^  infected 
erythrocytes. Quinine (100 mg kg- "^) was given to the two 
drug treated groups from days 2-8 of the malaria infection.
The infection patterns in both groups, the control and 
the treated groups were similar to those of the previous 
experiment (fig 49 ).
The effect of quinine treatment in both groups was 
similar. Treatment in mice on the 21# protein diet 
reduced the parasitaemia from 7# (-2) to 0.1# (-0.05) on 
day 8. The infection resolved on day 20. In mice on the 
4# protein diet, the quinine treatment reduced the initial 
parasitaemia of 9 .2# (-0.5) to 0.12# (¿0.09) on day 8 and 
parasitaemias were totally resolved on day 25»
DISCUSSION
It has been shown that weanling mice kept on a low protein 
diet showed a generalised loss of lymphoid tissue which was 
greater in the thymus than in the spleen and least in the 
mesenteric lymph node. After studying the chemotherapy of 
malaria infections in T-cell deprived mice, a study was 
made of the effects of drug treatment of malaria infections 
in "nutritionally T-cell deprived" mice.

Table XLI Statistical analysis of the data in Fig 4 9  (n=6 )
Group DatS^v 2 4 8 11 14 20 25 28 35 39
Quinine treatment Mean 7.0 2.7 0.1 0.5 0.7 0.0 0.08 0.9 0.0 0.0
(211*- protein diet) SD - 2.0 1.1 0.05 0.3 0.4 0.07 0.1
Quinine treatment Mean 9.2 5.3 0.12 0.3 1.1 0.01 0.0 0.0 0.0 0.0
(4^ protein diet) SD - 5.0 4.2 0.09 0.5 0.6 0.02
Significance P < NS' IIS NS NS NS NS 0.02 0.001 NS NS
Control Mean 5.0 44.0 13.0 2.2 0.3 0.0 0.09 0.5 0.0 0.0
(21$ protein diet) SD - 3 . 0 1 1 . 0 4.6 2 . 0 0.25 0.1 0.3
Control Mean 9 . 2 4 1 . 0 2 0 . 0 4.3 1.9 0.07 0.04 0.03 0.0 0.0
(41» protein diet) SD - 2 . 0 6 . 8 7.6 3.2 0 . 6 0.1 0 . 0 1 0 . 0 2
Significance P < 0 . 0 2 NS NS NS 0.001 NS NS 0 . 0 1 NS NS
♦see table VI
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FIGURE 49 - P. chabaudi The effect of quinine treatment 
(lOOmg kg day x 7) on protein-energy- 
deficient mice innoculated with 1 x 107 infected 
R.B.C.
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The mean body weight of the mice on the low protein 
diet went down from 16.5 g (-0.6) to 8.6 g (-0.9) after 
100 days on the diet while the weight of the control mice 
increased from 16.6 g (±0.7) to 22.5 g (±2.1). Bell et al.
(1976) have also shown the decrease in body weight of the 
mice kept on a 4# protein diet. Mice fed on this diet 
consumed less food per day than mice fed on a 20# protein 
diet, though they consumed more food per gram of body weight.
P.chabaudi infections in mice on the low protein diet 
did not resolve as rapidly as infections in mice on the 
21# protein diet. Similar results have been obtained by 
Suntharasami and Marsden (1972) in P.yoelii infections in 
mice with protein energy deficiency, where mice on the low 
protein diet suffered from a more severe anaemia and 
prolongation of the infection.
Proteins serve many diverse functions in the body: as 
catalysts, structural elements and contractile systems; for 
nutritional storage; as vehicles of transport; as hormones; 
and as protective agents like antibodies (Lehninger, 1970). 
The effects obtained by protein energy malnutrition cannot 
be pinned down therefore to defects in the immune mechanism 
alone. However, the prolongation of parasitaemia in 
P.yoelii infections (Suntharasami and Marsden, 1972) and 
P.chabaudi infections may be due to the diminished 
responsiveness of the thymus in these animals. As was shown 
earlier (p*i37<”>B***) T-cell deprivation by thymectomy and 
treatment with high doses of ATS caused a chronic non- 
resolving type of infection whereas thymectomy plus lower 
doses of ATS caused a chronic infection which apparently 
resolved after 86 days. Thus, the prolongation of infection
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depends on the level of depletion of T-cells. Bell etal.
(1976) have shown that mice fed on low protein diet 
show involution of the thymus. Also, many have shown 
impairment of cell-mediated immunity in protein-energy 
deficiency (Smythe et al., 1971; Chandra, 1974; Fergusen 
et al., 1974) and selective effects on thymus-dependant 
antibody responses (Malave and Layrisse, 1976).
Quinine treatment of infected mice on 4# and 21# protein 
diets was equally effective whereas quinine treatment of 
T-cell deprived mice infected with either P .chabaudi or 
P.berghei was not as effective as treatment of the intact 
control mice. The treatment of P.chabaudi infection in 
mice fed on a 4# diet was expected to be less effective. 
Skinsnes and Woolridge (1948) showed that antibiotic 
treatment of pneumococcus infection in protein—energy 
deficient mice (fed on 1.8# protein diet) took significantly 
longer than that of normal controls.
In natural conditions, protein-energy malnourished 
children are usually suffering from other virus, bacterial 
or parasitic infections which might aggravate and complicate
the condition
I. Concurrent infections with malaria 
parasites and schistosomes.
Both malaria and schistosomiasis infections have been 
well documented for their immunosuppressive effects on various 
antigens.WHO Chror^L975)graded malaria as the most important, 
and schistosomiasis the second most important, parasitic 
disease of the world. Again, these two diseases co-exist 
together in some parts of Africa. So it will be of great 
interest to study the interaction of k.mansoni and P .chabaudi 
infections in the laboratory.
1. The effect of S.mansoni infection on P.chabaudi infection
The experimental mice were exposed percutaneously to 
infection with 15 cercariae on two occasions separated by 
an interval of one week.
The mice were separated into 4 groups. Group A mice
nwere challenged by an inoculum of 10 P .chabaudi infected 
erythrocytes, 4 weeks after exposure to S.mansoni. Groups 
B, C and D were given similar challenge infections 6, 9 and 
12 weeks after the schistosome infection. Malaria 
parasitaemias and mortalities were recorded and at the end 
of the experiment, the mice were perfused to show the worm 
loads. Body weight, spleen weight and the liver weights 
were also recorded.
In group A mice (P.chabaudi infection 4 weeks after 
exposure to S.mansoni) malaria parasitaemia was comparable 
in both the experimental and the malaria control groups.
Peak parasitaemiao were 31.8# (±8.7) in group A and 36#

Table XLIIA Statistical analysis of the drta in Pic 50 a. ("“6)
Group DntiN 3 5 7 10 14 17
21 24 28 31 35 46 51
Ilalaria
infected
control
Mean 2.8 20.2 3 1 . 8 3.2 0.9 2.8 0.0 0.1 0.5 0.01 0.1 0,02 0.0
SI) - 1.4 10.9 8.7 4.0 1.0 5-7 0.0 0.1 1.1 0.02 0.2 0.04 0.0
Schistosomiasis 
+ malaria inrected 
(after 4 weeks)
Mean 
SD -
2.5
1.9
17.0
14.7
36.0
10.6
4.0
2.9
0.3
0.5
0.1
0.2
0.3
0.5
0.0
0.0
0.01
0.01
0.2
0.4
0.0
0.0
0.1
0.1
0.0
0.0
Significance P < NS NS NS NS NS NS NS NS NS NS NS NS NS
•see table VI
PC H
C ( 
N1 A
GI 
PAK
A&l
tl 
MIA
M M

Table XLIIB Statistical analysis of the data in Fig 501». (n-6)
*see table VI
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M e a n  p e r c e n t a g e  p a r a s i t a e m i a s  i n  C B A  m i c e  
i n o c u l a t e d  w i t h  1 x  T O 7  P .  c h a b a u d i - i n f e c t e d  
RBC 6  w e e k s  a f t e r  S .  m a n s o n i  i n f e c t i o n
D A Y S  A F T E R  M A L A R I A L  I N F E C T I O N
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Table XLIIC Statistical analysis of the data in Fig 50^.
(n- 6)
* see table VI
Table XLITD Statistical analysis of the data in
Fie 50d ("-6)
Table XLIIC Statistical analysis of the data in Pig 50^.
(«- 6)
* see table VI
Table XLITD Statistical analysis of the data in 
Pic 50A  ("-6)
Group ^2ayDatJi'N 2 6 9 12 16
Malaria
infected
control
Kean 
SD -
3.6
0.9
27.5
8.2
1 .4
0 .4
0 .3
0 .1
0.01
0.01
Schistosomiasis 
+ malaria infected 
(after 12 weeks)
Mean 
SD -
1 .8
0 .9
7 .9
7 .7
1.1
1 .5
0 .0
0 .0
0 .0
c.o
Significance P< 0.01 0.001 NS 0.001 NS
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F I G U R E  5 0 c  M e a n  p e r c e n t a g e  p a r a s i t a e r . i i a s  i n  C B A  m i c e
i n o c u l a t e d  w i t h  1 x  1 0 7 P .  c h a b a u d i - i n f e c t e d  
RBC 9  w e e k s  a f t e r  S .  m a n s o n i  i n f e c t i o n
3 2 0
F I G U R E  5 0 d  M e a n  p e r c e n t a g e  p a r a s i t a e m i a s  i n  C B A  m i c e
i n o c u l a t e d  w i t h  1 x  1 0 ^  P .  c h a b a u d i - i n f e c t e d  
RBC 1 2  w e e k s  a f t e r  S .  m a n s o n i  i n f e c t i o n
Bf j
.11.
(±10.6) in the malaria controls both on day 7. The spleen/ 
body weight ratios were 1.37# with concurrent infections 
and 0.6# in the malaria controls. The mean worm load in the 
experimental group v/as 11.4 (±2.07) worms (fig 50a and e).
In group B (malaria challenge 6 weeks after S.mansoni 
infection) the pattern of parasitaemia was different from that 
of the controls. Peak parasitaemia was significantly lower 
(P <0.01) in the control (17.7#) on day 8 as compared to 40# 
in the experimental group and the infection resolved by day 16 
instead of day 26. The spleen/body weight ratio was 0.57# in 
the malaria control group and 1.3# as a result of the double 
infection. The mean worm recovery was 9.4 (±2.3) from the 
experimental group (figs 50b and e) .
In group C mice (P.chabaudi infection given 9 weeks after
S.mansoni infection) the highest mean parasitaemia was 2.3# 
(±1.6) on day 7, while controls reached a peak of 35.6# on the 
same day. The parasitaemia was also significantly different 
(P <0.05-0.001) from the controls on days 4, 7 and 16. The 
infection in group C mice resolved earlier (day 16) than in the 
malaria controls (day 23). The spleen/body weight ratio was 
0.96# in the malaria control group and 1.64# in the doubly 
infected group. The mean worm recovery was 11.2 (±3.2).
(fig 50c and e).
In group D (P.chabaudi infection given 12 weeks after 
the S.mansoni infection) the maximal parasitaemia was seen 
on day 6, 7.9# (±7.7). This was significantly lower than 
that of the controls (P< 0.001) on days 2 and 6. The spleeV 
body weight ratio was 0.78»/. in the malaria control group
3 2 1
FIGURE 50e1
Numbers o f  works recovered on 
perfusion from S. mansoni-in fected  
CBA mice o f  fou r experimental 
groups 
FIGURE 50e2
Spleen/bodyweight ra tios  in mice 
in fected  with S. mansoni and/or 
P. chabaudi
Number o f  weeks P. chabaudi 
in jected  a fte r  S. mansoni:
A = 4 weeks 
B = 6 weeks 
C = 9 weeks
D = 12 weeks j
M = malaria (P. chabaudi)
S = schistosom iasis ( S. mansoni)
co
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Table XLIIIA Protocol for infection of mice with single and 
bisexual S.Tnanronl and P«ohaband 1 and time of 
perfusion in experiment I 2.
Group
No. of 
mice
Days after cercarial infection
Day 0 8 weeks 10 weeks
A 6 Single sex (50 cercariae) - Perfusion
B 6 Single sex (50 cercariae) Malaria infection Perfusion
• C 6 Bisexual (35 cercariae) - Perfusion
I) 6 Bisexual (35 cercariae) Malaria infection Perfusion
E 6 - Malaria infection Perfusion
3 2 4
and 1.58£ in the experimental group. The mean worm recovery 
mas 8.8 (il.8) worms.(fig 50d and e).
2. The effect of single sex S.mansoni infection on a 
subsequent malaria infection
In the previous experiment, there was a suppression of 
the malaria infection in mice infected with P .chabaudi 6,. 9 
or 12 weeks after exposure to S.mansoni cercariae. So this 
experiment was planned to find out the effect of a single 
sex infection of S.mansoni, which lacks egg production and 
subsequently is without granuloma formation in the liver. 
There were five groups of mice. Mice in groups A and B were 
infected percutaneously with 50 male cercariae and mice in 
groups C and D were given bisexual infections by exposure 
to 35 cercariae. P „chabaudi 1 x 10' infected erythrocytes 
were given on the 8th week after cercariae infection to 
groups A, C and £. Groups B and D acted as single and 
bisexual S.mansoni infected aontrol. groups and E as the 
malaria control group, (see table XLIIIA).
The mice wore perfused 3 weeks after malaria infection. 
Body weight, spleen weight and liver weight were recorded 
at the time of perfusion.
Parasitaemias in malaria control mice were similar to 
those obtained in previous experiments. The malaria 
parasitaemias in mice given single sex worm infections were 
not much different from those of the controls and the 
infections were resolved by day 16. The spleen/body weight

Table XLIIIB Statistical analysis of the data 
in Fig 51» (n"6)
* see table VI
Table XLIIIC Statistical analysis of the data 
in Fig 51. (n-6)
Group Ss^ yDatfe' 2 5 9 12 16 19
Malaria
infected
control
Bisexual 
Schistosomiasis 
+ malaria infected
Mean
SB -
Kean 
SD -
2.4 57.0 5.2 2.9 0.1 0.0 
1.3 5.7 1.5 1.7 0.2 0.0
1.7 23.0 7.1 0.05 0.0 0.0
0.6 3.6 2.1 0.03 0.0 0.0
Significance P< NS 0001 0.01 0.01 NS NS
FIGURE 51a Mean percentage parasitaemias in CBA mice
inoculated with 1 x 107 P. chabaudi-infected 
RBC 3 weeks after bisexual or single-sex 
(male) S. mansoni infection
326
3 2 7
F IGURE 51b The total number of worms S. mansoni 
recovered from the mice in Fig. 51a
30-
20
10-
A - Single sex S. mansoni infection + malaria 
B - Single sex S. mansoni infected control 
C - Bisexual S. mansoni infection + malaria 
D - Bisexual S, mansoni infected control
if* M 
A
i
C 0
Table XLI7A Frotocol for the infection of nice with P.chabaudi end S.mansoni (primary and challenge) 
and tine of perfusion in Experiment I 3*.
No. of Days after cercarial infection
Group mice 0 7 14 49 54 75
A 10 Schistosomiasis 
(25 cercariae) 
infection
Schistosomiasis 
(25 cercariae) 
infection
Schistosomiasis 
(25 cercariae) 
infection
- Schistosomiasis 
(200 cercariae) 
infection
Perfusion
B IO' - - - • Schistosomiasis 
(200 cercariae) 
infection
Perfusion
C 10 Schistosomiasis 
(25 cercariae) 
infection
Schistosomiasis 
(25 cercariae) 
infection
Schistosomiasis 
(25 cercariae) 
infection
liai aria 
infection
Schistosomiasis 
(200 cercariae) 
infection
Perfusion
I) 10 • • Malaria
infection
Schistoco'iif sis 
(200 cercariae) 
infection
Perfusion
ratio was higher in the doubly infected mice (0.8$) than 
in mice infected with male worms alone (0.3#). The malaria 
infection with mature bisexual. S .mansoni cercariae. was 
depressed (P <,.001) on day 5 with a peak parasitaemia of 23# 
(-3-6) and the infection was resolved on day 16 (Table XLIIIC). The 
spleen/body weight ratio was 1.27# in the doubly infected 
group and 0.53# in the S.mansoni alone infected group.
The worm loads in the single sex infections were 28 
(-7.2) for the experimental group and 24.8 (-4) for the 
control group. The bi-sexually infected groups had 18 (±8) 
worms in the experimental group and 16.7 (-5.7) in the 
aontrol group, (fig 51b).
3. The effect of P.chabaudi infection on S. mansoni infection
It was shown in experiment IVB that immunodépression in 
P .chabaudi infection to SRBC was greatest during the peak 
period of the parasitaemia, usually days 5 - 7 of the 
infection. Experiments were planned to determine whether 
this immunodépression would affect immunizing or challenge 
infections with S.mansoni.
a. The effect of acute P.chabaudi infection on an immunizing
S.mansoni infection
There were four groups of mice in this experiment (see 
table XLIVA). .
P.chabaudi infections of 1.5 x 107 infected erythrocytes 
were given to mice of groups C and D on day 0. On day 5 
immunizing doses of 35 S.mansoni cercariae were given
3 2 9

Table XLIVB Statistical analysis of the data in Fig 52. (n-10)
* see table VI
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FIGURE 52b Percentage ratios of the spleen or liver and 
the body weight of mice from Fig. 52a.
(S = spleen, L = Liver, CC = Challenge Control)
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FIGURE 52c Total number of (S. mansoni) worms recovered
from the mice immunized (at peak of P. Chabaudi 
infection) and challenged with S. mansoni infection
(CC = Challenge control)
100-1 - r -  —
50- I 1
80- j-
60-
to-
20-
I M i i . C I I  A L L  CC 
- M A L A R I A
I M M . C I I A L l  CC 
. M A L A R I A
perçutaneously to animals in groups A and C. Challenging 
infections (200 cercariae) of S «mansoni were given 6 weeks, 
later. Perfusion for worm recovery was performed 3 weeks 
after the challenge infection. Malaria parasitaemias in 
mice of groups C and D were similar to one another (sea 
table XLIVB and fig 52a).
The spleer^body weight ratio was highest in the group 
C mice (1.27#) infected with malaria, immunized with
S.mansoni cercariae and challenged,and lowest in the (B) 
schistosome challenge control group (0.31$)• The liver/ 
body weight ratio was also highest in group C (7.556) and 
lowest in group D (4.75») where the S .mansoni challenge 
infection was given to malaria-infected mice.(fig 52h) .
In counting the recovered worms, the adult worm number 
reflected the intensity of the immunizing infection, while 
schistosomula were derived from the challenge infection.
The adult worm recovery in the immunized control group was 
8 (-3.3) and that from the malaria-infected group was
12.1 (-5.4). The schistosomula worm recovery in the 
challenged control group (group B) was 63*8 (-11.2) and that 
of the immunized and challenged control group was 18.4 
(±18.4) representing a reduction in worm burden of 71.2# 
(±28.9). The schistosomula recovered from challenge 
controls previously exposed to P .chabaudi (group D) was
65.2 (±12.1) and from mice immunized and challenged with
S,mansoni after malaria infection (group C) was 18.2 (±19.5) 
with a percentage reduction of 72.2 (±29.6). Thus, the 
P.chabaudi infection did not affect the immunizing ability 
of S.manooni corcariae.(fig 52c)
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Table XLVA Protocol for the Infection of mice with S.mansonl 
(primary and challenge) and P.chabaudl and time
of perfusion in experiment I 36» •
No. of Days after malaria infection
Group Mice 0 5 42 63
A 10 - Schistosomiasis
infection
Schistosomiasis
challenge
Perfusion
B 10 - - Schistosomiasischallenge
Perfusion
C 10 Malaria
infection
Schistosomiasis
infection
Schistosomiasis
challenge
Perfusion
D 10 Malaria
infection
- Schistosomiasischallenge
Perfusion
■
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Table XLVA Protocol for the infection of mice with S.mansoni 
(primary and challenge) and P.chabaudi and time 
of perfusion in experiment I 3b.
No. of Days after malaria infection
Group Mice 0 5 42 63
A 10 - Schistosomiasis
infection
Schistosomiasis
challenge
Perfusion
B 10 - - Schistosomiasischallenge
Perfusion
C 10 Malaria
infection
Schistosomiasis
infection
Schistosomiasis
challenge
Perfusion
D 10 Malaria
infection
Schistosomiasis
chalience
Perfusion
3 3 6
to• The effect of acute P.chabaudi infection on a challenge 
infection with S.mansoni.
The plan of the experiment is shown in table 
The S.mansoni challenge infection was given when the 
malaria infection was at its peak. Group A and group C 
mice were immunized percutaneously with 25 cercariae of 
S.mansoni on day 0. The immunization was repeated one and 
two weeks later to ensure that infection occurred and to 
ensure that mice survived by not giving a single high dose 
of cercariae. The P.chataaudi infections were given on the 
7th week of the S.mansoni infection to animals of groups 
C and D. All mice were challenged with 200 cercariae of 
S.mansoni 5 days' after the P »chabaudi inoculation. Perfusion 
for worm recovery was performed on the 3rd week of the 
challenge infection.
The mean percentage parasitaemia of the P.chabaudi
infection in the group previously immunized with S.mansoni
(group C) was significantly depressed (P <  .02 - .001)
by comparison with the controls on days 2f 5 and 7 and the
infection alsoi resolved earlier on day 13 instead of day 19. 
(fig 53a).
The spleeiVtoody weight ratio was highest in the group
C mice immunized and challenged with S.mansoni and infected
with P.chabaudi (3.46$) and was lowest in the malaria-
infected control challenged with S.mansoni (group D) (0.98£). 
(fig 53b)
The numbers of schistosomula recovered on perfusion 
are shown in fig 53c. There was a highly significant 
reduction in the numbers recovered from immunized mice but 
the malaria infection during challenge had no significant.

Table XLVB Statistical analysis of the data in Fig 53^ - .(n»10)
Group N n yDatàv 2 5 7 9 13 16 19 25
Malaria + Mean 1.1 21.0 22.0 2.1 0.1 0.02 0.0 0.0
Schistosomiasis SI) Ì 0.4 7.5 9.0 2.6 0.04 0 . 0 4 0.0 0.0
Schistosomiasis Mean 0.5 5.2 8.0 1.7 0.0 0.0 0.0 0.0
+ malaria SD - 0.3 4.9 11.9 VX • OD 0.0 0.0 0.0 0.0
Significance P < 0.02 0.001 0.001 NS 0.001 NS NS NS
*see table VI,
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F I G U R E  5 3 a  M e a n  p e r c e n t a g e  p a r a s i t a e m i a s  i n  C B A  m i c e
i n o c u l a t e d  w i t h  1 x  1 0 7  P .  c h a b a u d i - i n f e c t e d  
RBC 7  w e e k s  a f t e r  p r i m a r y  S .  m a n s o n i  i n f e c t i o n  
a n d  w i t h  a  c h a l l e n g e  d o s e  o f  c e r c a r i a e  g i v e n  
o n  d a y  o f  t h e  m a l a r i a  i n f e c t i o n
F I G U R E  5 3 b
t-
3-
1
SP
LE
EN
/B
OD
Y 
WT
.
3 3 9
P e r c e n t a g e  r a t i o s  o f  t h e  s p l e e n  a n d  b o d y  w e i g h t  
o f  t h e  m i c e  i n  F i g .  5 3 a
A  -  S .  m a n s o n i  i n f e c t e d  c o n t r o l  
B -  S .  m a n s o n i  c h a l l e n g e  c o n t r o l  
C  -  S .  m a n s o n i  i m m u n i z e d  a n d  c h a l l e n g e d  w i t h  
m a l a r i a  i n f e c t i o n  
D -  m a l a r i a  i n f e c t e d  c o n t r o l
S S
A
S S M SC
M
0
F I G U R E  5 3 c  T o t a l  n u m b e r  o f ( $ .  m a n s o n i ) w o r m s  r e c o v e r e d  f r o m
3
t h e  m i c e  i n  F i g .  5 2 a
( Imm = i m m u n i z e d ,  C h a l l  = c h a l l e n g e ,  CC = c h a l l e n g e  c o n t r o l )
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effect. The adult worm recovery in groups A and C were 
also similar.
DISCUSSION
There has been a lot of interest in concomitant 
infections with malaria and other organisms including viruses, 
bacteria, protozoa and some helminths. The malaria parasite 
has a complex continuous life cycle with considerabla 
structural changes taking place every few hours. This 
unending process of cellular re-organization allows for 
considerable antigenic plasticity, and for a massive and 
ever-changing antigenic challenge, which in turn stimulates 
a complex host response (Brown, 1975) as would another 
parasite like S.mansoni, which induces equally complex, host 
responses. This complexity sets a requirement for extensive 
experimentation before drawing any conclusions on inter­
actions in such infections.
The effect of S .mansoni on P .chabaudi infection seemed 
to depend on the timing of the malaria infection in relation 
to that of the schistosomiasis. Schistosomiasis had no 
effect on malaria infection in mice when the mice had been 
exposed to S.mansoni 4 weeks before the malaria infection 
(fig 50 a ). At the 4th week of a schistosomiasis 
infection, male and female worms start pairing (Clegg, 1965). 
Probably the malaria infection was not affected by the immune 
response induced by the immature worms at this stage of the 
infection.
Smithers and Terry (1969) in their review on the
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immunology of schistosomiasis suggested that adult 
schistosome worms are of paramount importance in stimulating 
immunity. The reviewers drew their conclusions from 
experiments in which animals were immunized with non- 
pathogenic strains or species, or with irradiated cercariae,
(no mature worms resulting from these immunizing procedures).
The immune response on the 4th week of S.mansoni infection 
has been shown in mice (Sher et al., 1974) and in rats 
(Perez et al.t 1974). In mice, the decrease in recovery of 
schistosome challenges from the lungs occurs in two separate 
stages following a primary infection (Sher et al., 1974); 
a first stage which arises between 1-4 weeks after exposure 
and a second stage appearing at 7 weeks and onwards. The 
first stage reflects a delay in the migration of the parasite 
and this effect can be passively transferred to normal mice 
with serum fractions which contain mainly IgC^ antibodies 
(Sher et al.t 1975).
P.chabaudi infection was significantly suppressed in 
mice exposed to S.mansoni infections 6, 9 or 12 weeks before 
the malaria infection (fig 50b,c,d ). These results
are in agreement with that of Yoeli (1956) , who had shown 
that P.berghei infections in the field vole were milder and 
less virulent when given 4—7 weeks after S .mansoni. P»yoelii 
parasitaemia was also shown to be markedly suppressed in 
mice previously infected (5 weeks before) with S.mansoni 
(Lewinsohn, 1975) •
The mechanism of suppression of malaria by the schistosomes 
after 6 weeks of infection is not known as there are many 
events happening at this time. Schistosomes start producing
eggs on the 34-35th day (5th week) of the infection (Clegg, 
1965). It has also been shown that at the onset of egg 
production there is an increase in total immunoglobulin 
levels (Evans and Stirewalt, 1957; Sadun and Walton, 1958; 
and Smithers and Walker, 1961), or precipitating antibodies 
(Senterfit, 1958) and of reagin-like antibodies (Ogilvie 
et al., 1966 and Edwards et al., 1967). In fact, eggs provide 
a considerable antigenic stimulus to the host leading to -the 
production of circulating antibody and possibly a condition 
of specific delayed type hypersensitivity (Warren et al., 
1967). Immunodepressive effects are also shown after 6 weeks 
of infection. Brito et al. (1976) have shown the depression 
of humoral immune responses, and Arujo et al. (1977) and 
Pelley et al. (1976) have demonstrated tha depression of 
cell mediated immunity at the and 12th week respectively 
(see page 51 ). Mota-Santos et al. (1977) claimed that the
immunosuppression was induced by adult worms and not by eggs. 
Pronounced pathological lesions due to granuloma formation 
around eggs in the liver are found from the 6 th week of the 
infection (Dewitt and Warren, 1959).
The suppression of malaria infection may be due to non­
specific antibody induced by both eggs and adult worms. It 
has been shown that specific IgG to schistosomes was less 
than 4# of the total IgG in monkeys infected with S.mansoni 
(Freeman et al., 1970). So there may also be a polyclonal 
activation of B-cells in S.mansoni infection as suggested 
for T.brucei infection in mice (Hudson et al., 1976). If • 
polyclonal activation of B-cells exists in S.mansoni infection 
a certain amount of antibody reacting to malaria parasites 
whioh could be produced could suppress malaria infection.
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Other possible mechanisms include the non-specific 
activation of macrophages, either via T-cells (mediators) 
or directly causing them to liberate mediators which produce 
degeneration of parasites within circulating erythrocytes 
(Allison and Clark, 1977).
Portal hypertension in mice infected with S.mansoni 
starts to increase after 5 weeks of infection (Warren, 1961). 
This can cause a decreased flow of blood in the liver and 
a slowing down of circulation in the enlarged spleen which 
might help to clear the malaria infection quicker. Bowdler 
(1975) has reviewed the functions of the spleen and stated 
that the spleen acts as a filter to remove particulate 
materials from the circulation (both microscopic and sub- 
microscopic particles), which is principally mediated by 
vascular structures. The spleen contains the densest 
accumulation of macrophages in the body and it serves as 
a focus of phagocytosis. However, Cheever and Warren (1964) 
have shown that hepatic blood flow per 100g body weight 
remained within normal limits in mice infected with S.mansoni 
up to 11 weeks after infection, despite the development of 
portal hypertension.
Single sex (male) infections did not confer immunity 
to malaria infection given 8 weeks after cercarial infection. 
Though the result is not conclusive, it seems as if egg 
production is necessary for the suppressive effect on the 
malaria infection. The eggs produced by bisexual infection 
can act either through the stimulation of immune mechanisms 
(Warren et al., 1967) or by producing hepatic granuloma
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formation causing the increase of portal hypertension as
discussed earlier. But before drawing any conclusion some 
more experiments should be performed with malaria infection 
and irradiated cercariae, which do not give rise to mature 
egg-producing worms. This would give information on whether 
suppression of malaria depends on adult worms (bisexual) or 
not. Malaria infection should be given at intervals after 
intravenous injection of viable eggs to find out the effect 
of schistosome egg antigens in immunity to malaria infection.
The effect of P .chabaudi infection on both primary and 
secondary (challenge) infections with S.mansoni was also 
studied. It had no demonstrable effect on either numbers 
of adult worms (primary infection) or schistosomula 
(challenge infection) recovery, even though the primary 
cercarial infection was given at the peak of the malaria 
infection (fig 52* P 3 3 *i ). This may have been because 
the immunosuppressive effect of the P.chabaudi infection 
was not potent enough or did not last long enough. However, 
Abdul-Wahab (1974) showed a decrease in the size of granulomas 
around S.mansoni eggs injected intravenously into mice 16 
days after P.berghei infection.
The immunodepressive effect of P « chabaudi has been shown 
to correlate with the parasitaemia level (Exp . B la piSB ).
P.chabaudi infection was significantly suppressed in mice 
infected 6, 9 or 12 weeks after S.mansoni infection (Exp. 11 
P 3 1 3  ). So at this low level of parasitaomia with relatively
less immunodepressive effect there may not be any significant 
effect on S.mansoni infection, either on the number of adult
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worms or on schistosomula recovered
V. SUMMARY AND CONCLUSIONS
P .chabaudi in CBA mice produces a benign synchronous 
and reproducible pattern of infection with 3 waves of 
parasitaemia. The infection in T—cell deprived mice, 
also,is not fatal but parasitaemia is maintained for 
longer than 120 days.
P.berghei infection in CBA mice is invariably fatal.
The parasitaemias in both intact and in T-cell deprived 
mice are similar but the mean survival time is 
significantly longer in T-cell deprived mice.
Thymectomy alone does not alter the infection in any 
way.
The magnitude of the primary antibody response to SRBC 
in P.chabaudi infections was related to the degree of 
parasitaemia. When the parasitaemia was low, either 
early in the infection or during the chronic phase, 
the antibody response to SRBC was not depressed as it
was during the primary peak of high parasitaemia.
<
The effect of P.chabaudi on the secondary and tertiary 
responses to SRBC also varied according to the 
parasitaemia at the time the priming dose of SRBC was 
given. If the primary immune response to SRBC was 
significantly depressed due to SRBC being given at the 
time of the peak of parasitaemia, the subsequent 
responses to SRBC were also very much suppressed.
In all cases there was a more rapid fall off in anti- 
SRBC antibody titres in malaria infected mice than in 
uninfected controls. Though this effect seemed to be
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due to increased catabolism of immunoglobulins in malaria 
infected mice, it could not be confirmed by experiments 
on the passive transfer of antibody to sheep cells.
3. The antimalarial drugs quinine and pyrimethamine did 
not have any immunodepressive effect on the antibody 
response to SRBC. On the other hand chloroquine at a 
high dose level (50 mg kg- "^) showed some immunodepression 
of anti-sheep cell antibody titres but low doses
(5 mg kg-1) did not do so.
4. P.chabaudi infection in CBA mice produces a sterile, 
solid type of immunity. The immunity conferred by 
suppressive chemotherapy depended^on the duration and 
the intensity of the recrudescent parasitaemia, both
of which depend on the drug dosage schedule. Prolonged 
maintenance of a low level of parasitaemia by means of 
subcurative chemotherapy produced a solid immunity.
On the other hand, the immunity bestowed by curative 
chemotherapy was related to the timing of the treatment. 
Though immunity could be induced by treatment on the 
first day of the infection, the maximal iimnunity was 
obtained by treating late in the infection.
5. When comparing the effectiveness of chemotherapy on
the intact and T-cell deprived mice, the two parasites,
P . c h a b a u d i  a n d  P . b e r g h e i ,  b e h a v e d  d i f f e r e n t l y .  In 
P . c h a b a u d i  i n f e c t i o n s  a n  i n t a c t  i m m u n e  s y s t e m  is
b e n e f i c i a l  t o  t h e  h o s t  a n d  h e l p s  t o  r e s o l v e  t h e
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infection. Chemotherapy was more effective in intact 
than in T-cell deprived mice and the possible role of 
the immune mechanism is considered.
6. P.berghei infections kill both intact and deprived mice 
but the deprived mice have significantly longer mean 
survival times. In this case, antimalarial chemo­
therapy is more effective in T-cell deprived animals 
than in the intact controls. Though the exact mechanism 
is not known, the possible involvement of the immune 
mechanism is again considered.
7. When the recrudescent populations from both intact and 
T-cell deprived mice after chemotherapy of both P .chabaudi 
and P.berghei infections were tested for drug sensitivity 
they were always similar to that of the stocks used
to initiate the infections.
8 .  H y d r o c o r t i s o n e  a c e t a t e  t r e a t m e n t  o f  P . c h a b a u d i  i n f e c t i o n s  
i n  m i c e  i n v a r i a b l y  p r o d u c e d  a  f a t a l  o u t c o m e .  A n t i -  
m a l a r i a l  c h e m o t h e r a p y  c o m b i n e d  w i t h  h y d r o c o r t i s o n e  
a c e t a t e  w a s  l e s s  e f f e c t i v e  t h a n  t h e  a n t i m a l a r i a l  g i v e n  
a l o n e  ( q u i n i n e  o r  c h l o r o q u i n e ) .
T h e  h y d r o c o r t i s o n e  d i d  n o t  m o d i f y  P . b e r g h e i  i n f e c t i o n s  
w h e n  g i v e n  a l o n e  o r  i n  c o m b i n a t i o n  w i t h  a n t i m a l a r i a l s .
T h e  i m p o r t a n c e  o f  r e t i c u l o c y t e  d e p r e s s i o n  i n d u c e d  b y  
t h e  c o r t i s o n e  a s  w e l l  a s  i t s  i m m u n o d e p r e s s i v e  e f f e c t  
i s  d i s c u s s e d .
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9. Protein energy deficiency in CBA mice infected with 
malaria induced a severe weight loss, anaemia and 
prolonged parasitaemia. However, chemotherapeutic 
effects in such mice were similar to those on malaria- 
infected controls.
10. The effect of S.mansoni infection on P.chabaudi infection 
was studied in mice. The malaria parasitaemia was 
significantly suppressed in mice infected with S.mansoni 
6, 9 or 12 weeks previously but not 4 weeks previously. 
Single sex (male)infections given 8 weeks before did
n o t  m o d i f y  t h e  m a l a r i a  p a r a s i t a e m i a .  T h e  p o s s i b l e  
n a t u r e  o f  n o n - s p e c i f i c  i m m u n i t y  c o n f e r r e d  b y  t h e  e g g s  
a n d / o r  a d u l t  w o r m s  w a s  d i s c u s s e d .
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